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Divided into three distinct research areas, this thesis investigates the synthetic utility of 
enynones and ynamides towards the formation of biologically relevant structures.  
 
The first volume of work (Chapter 2) describes the gold-catalysed double alkylation of 
indole by enynones. The [6,5,7]-tricycles formed in this reaction are generally provided 
in excellent yield with complete regioselectivity. Optimisation of the procedure, a 
thorough substrate investigation, and mechanistic insights are discussed within. 
 
The gold-catalysed rearrangement of ynamido esters is described in Chapter 3. 
Following 1,3-acyl transfer, nucleophilic addition of indole to the intermediate 
allenamide provides a novel enamide scaffold. The substrate scope has been assessed, 
with high yields provided for most examples. 
 
The final chapter concerns the Ireland-Claisen rearrangement of ynamido esters, with 
post-rearrangement decarboxylation furnishing aminodienes. Following a substantial 
optimisation study, a range of ynamido esters were screened, providing a range of 
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Gold metal has been utilised for many purposes; the most common of which focus on its 
physical attributes. Elemental gold is a dense, soft and ductile metal with a bright 
yellow colour, and as such is traditionally considered to be attractive, being made into 
ornate decorations and jewellery.
1
 Gold is also used extensively within the electronics 
industry due to its electrical conductivity, ductility and also its high resistance towards 
corrosion and tarnishing.
2
 Historically, gold was also used as part of the monetary 
system due to its desirability.
3,4
 Although the physical uses and attributes of gold have 
been well investigated, it was generally perceived to be catalytically inactive, possibly 
due to the inherent stability of elemental gold, which can exist in its elemental form in 
nature.  
 
1.2 Transition metal catalysed transformations and gold 
 
The use of transition metals in chemistry has been able to effect many synthetic 
transformations that would have been otherwise impossible employing traditional 
organic methods.
5
 The chemistry of the majority of the transition metal complexes is 
generally well understood and has been well utilised in a variety of transformations 
including hydrogenations, cross-coupling and metathesis reactions. 
 
There were a number of scattered reports of the catalytic use of gold however they were 
generally inferior when compared with the use of alternative transition metal catalysts.
6
 
However, two observations noted in the 1980s would alter the assumption that gold was 
catalytically inactive: the low temperature oxidation of carbon monoxide using 
supported gold catalysts
7












1.3 First uses of gold 
 
1.3.1 Low temperature oxidation of carbon monoxide 
 
 
Figure 1 – Traditional oxidation of carbon monoxide with Hopcalite catalysts 
 
The oxidation of carbon monoxide to carbon dioxide is an important industrial process, 
required during the combustion or partial oxidation of hydrocarbons. Previously, 
Hopcalite catalysts (mixed oxides of manganese and copper) were used to effect the 
oxidation of carbon monoxide, however they suffer from poor activity at room 
temperature, as well as being moisture sensitive.
9
 Alternative transition metals/transition 
metal catalysts can also be used for this oxidation, but all suffer from either; poor 
activity at ambient temperatures
10
, loss of activity over time
11
 or restricted 
applications.
12,
 Gold composite catalysts prepared by Haruta and Yamada, from the co-
precipitation from an aqueous solution of chloroauric acid and the nitrate of various 
transition metals, were shown to have both significant activity, even at -70 °C, and 
considerable stability compared to previously used catalysts. 
7, 13
 The most active 
catalyst system, 5 atom% Au/α-Fe2O3, remained active for seven days after initial 




1.3.2 Vinyl chloride synthesis 
 
 
Figure 2 – Structure of vinyl chloride 1 and PVC 2 
 




Vinyl chloride 1 is the monomer required for the formation of polyvinyl chloride 2 
(PVC), which was the 4
th
 most produced plastic in 2010.
14
 Therefore the efficient 
formation of vinyl chloride is an important industrial process and was historically 
carried out by the hydrochlorination of acetylene utilising mercuric chloride supported 
on carbon as the catalyst.
15
 This catalyst becomes inactive over time due to the 




A range of metal chloride catalysts were supported on carbon and gave a range of 
activities for the hydrochlorination reaction.
17, 18
 Mechanistic insights into the reaction 
indicated that the rate-determining step involves the addition of HCl to the metal 
acetylene complex and it can therefore be assumed that the stability of the metal 




Attempts to correlate the relative catalytic activities of each complex, with a number of 
molecular parameters were undertaken to establish theoretically which metal would 
furnish the most active catalyst. The attempted correlations based upon the electron 
affinity of the metal chlorides failed to give a satisfactory relationship, although this 
only treats the interaction as a one electron process. The mechanism of interaction may 
involve more than one electron, as such utilising the standard reduction potential for 
each complex would be a more appropriate parameter.  It could then be predicted from 
this data that Au, specifically Au
3+
, would be an extremely active catalyst, and this has 
been confirmed experimentally.
18
 The catalytic hydrochlorination of acetylene using 
carbon supported gold(III) chloride (2 mol%) and platinum(II) chloride (2 mol%) gave 
85% conversion of acetylene with a selectivity of >99.9% at 61 °C.
20
 Under similar 
conditions, mercury(II) chloride remains inactive, with temperature exceeding 140 °C 
being necessary for any significant conversion. 
 
1.4 Relativistic effects and gold 
 
These two examples have shown that gold can be a highly stable and exceptionally 
active catalyst for transformations that involve the manipulation of triple bonds, 
potentially implying that gold has a greater affinity for π-electron density than other 
transition metals. 
 




Interest in gold catalysis has increased markedly since the 1980s, and as such research 
to provide explanations for the observed activity of gold has been extensively 
conducted. From a theoretical viewpoint, relativistic effects help to elucidate the 
patterns of reactivity seen for the transition metals, in particular gold. 
 
The theoretical basis for relativistic effects comes from the joining together of quantum 
mechanics and special relativity.
21
 The term “relativistic effects” refers to occurrences 





As the atomic nuclear charge (Z) of an atom increases, the velocity of the electrons 
occupying node-less orbitals increases and, as a result of relativity, their mass is also 
increased.
23
 These relativistic effects lead to an energetic stabilisation; with the s-
electrons being more tightly bound to the nucleus than if the effects were absent.
24
 The 
contraction of the s-orbitals, and to a lesser extent p-orbitals, more effectively shields 
the nuclear charge from the remaining electrons, in particular the d- and f-electrons.
23
 
The consequence of this is an overall destabilisation of the d- and f-orbitals, and radial 
expansion.
25
 These effects scale approximately with Z
2
, and are particularly important 
for elements with Z > 72, and are of a comparable magnitude to the shell structure 





Figure 3 – Calculated relativistic contraction of the 6s oribitals of elements with 55<Z<100 
 
When the relativistic and non-relativistic radii of the 6s orbitals for elements with Z 
between 55 and 100 are compared there is a local minimum for Au indicating that Au 




has the largest relativistic effects for elements with Z < 100.
25, 26
 As a consequence of 
this, the nonrelativistic 5d and 6s orbital energies of Au are comparable to those of the 
4d and 5s orbital energies of Ag, however when relativistic effects are considered the 
energies differ in both the metal atoms and their hydrides, MH2.
26, 28
 Another 
consequence of relativistic effects is an associated bond-length contraction, with the Au-
L bond distance being shorter than that of the corresponding Ag-L bond, with this 
contraction also strengthening the Au-L bond compared to Ag-L bond.
25, 26, 28
 These 
large relativistic effects also lower the energy of the lowest unoccupied molecular 
orbital (LUMO), therefore making it increasingly Lewis acidic.
22
 This can also be 
corroborated by the unusually high electronegativity of Au (2.4) when compared to Ag 
(1.9), where Lewis acidity generally correlates with the electronegativity of a species.
22
 
This increase in electronegativity and Lewis acidity of Au are therefore both a direct 




Alkynes have long been the favoured substrates in the field of homogeneous gold 
catalysis, due to the propensity of Au to interact strongly with the alkyne moiety. 
Alkynes contain two orthogonal π-orbitals, both containing two electrons, which  Lewis 




The coordination of the Au(I) metal centres with alkyne functionalities was investigated 
by Behrens et al. by the isolation and crystallisation of [(3,3,6,6-tetramethyl-1-
thiacyclohept-4-yne)AuCl].
30
 The complex was shown to contain an extremely strong 
alkyne-gold bond, with a Au-C bond length of 2.10 Å in the Au(I) complex, being of a 
comparable magnitude to a Au-C-σ bond (2.00 to 2.08 Å). Also the C≡C bond 
lengthened from 1.209 Å in the free alkyne, to 1.244 Å in the Au(I) complex indicating 
the lessening of triple bond character, again proving the existence of a strong Au-alkyne 
interaction. 
 





Figure 4 – Part of the polymeric chain of solid [(3,3,6,6-tetramethyl-1-thiacyclohept-4-yne)AuCl] (60% 
thermal ellipsoids) 
 
As the Au(I) cation is large and diffuse it can be considered to be a “soft” Lewis acid, 
which will preferentially activate “soft” electrophiles, such as π-systems.22 However, 
when comparing the bond energies of Au(I)-ethylene and Au(I)-ethyne complexes, 
there is actually a 10 kcal mol
-1
 energy stabilisation in favour of the Au(I)-ethylene 
complex.
31
  However, Au-alkyne complexes are more reactive than their Au-alkene 
counterparts; this can be attributed to the discrimination of the nucleophile in selecting 
between Au(I) activated electrophiles.
32
 When comparing the relative energies of the 
ethyne and ethylene LUMOs, it becomes apparent that alkynes have lower energy 
highest occupied molecular orbitals (HOMO) and LUMO than the corresponding 
alkene, in turn making them less nucleophilic and more electrophilic.
32
 This could 
therefore account for the witnessed “alkynophilicity” observed in Au catalysed 
transformations. 
 
1.5 Gold catalysed transformations 
 
Transition metal transformations have become ubiquitous in organic synthesis; with 
arguably the most important class of reactions being the formation of C-C bonds, 
allowing for the construction of the frameworks contained within complex molecules. 
Although these coupling reactions have traditionally been performed by other transition 
metals such as palladium and nickel, gold has emerged as a catalyst that is also able to 
carry out these tasks. Fundamentally, there are two classes of C-C coupling reactions; 








1.5.1 C-C bond formation 
 
As was the case with palladium catalysis, homo-coupling was the first reported cross 
coupling reaction performed by gold, however this used stoichiometric quantities of 
gold.
33
 The use of catalytic amounts of gold to promote such transformations was then 
investigated, however, it is important to note that after the cross-coupling has occurred 
Au(III) will be reduced to Au(I), needing to be re-oxidised back to the catalytic species 
faster than the disproportionation of Au(I) to Au(III) and Au(0). 
 
Homocoupling 
The first example of catalytic homo-coupling catalysed by gold, utilising an external 





Scheme 1 – Gold-catalysed homocoupling of 1-chloro-4-methoxybenzene 3 
 
This homo-coupling of arenes demonstrates that gold is capable of inserting into Ar-H 
bonds and reductively eliminating to furnish symmetrical biaryl 4, and that the use of 
phenyliodonium diacetate, a hypervalent iodine reagent, is sufficient for the reoxidation 
of Au(I) to Au(III).  
 
Following the success of this reaction, a domino cyclisation/oxidative coupling reaction 









Scheme 2 - Tandem cyclisation and homocoupling of naphthalen-1-yl propiolate 5 
 
After the initial Au-catalysed activation of the alkyne moiety, cyclisation and 
subsequent re-aromatisation occurs. Before protodeauration of 6 can occur, the aurated 
intermediate is capable of catalysing the cyclisation of a second molecule of 5. After 
oxidative coupling to furnish 7, Au(I) is then reoxidised to Au(III) by the peroxide to 
allow catalytic turnover.  
 
It is possible to intercept the aurated intermediate with alternate coupling partners to 
avoid dimer formation, and to allow further product elaboration. 
 
 
Scheme 3 – Tandem acyl transfer and coupling of oct-3-yn-2-yl acetate, 8 
 
Although 9 is the main product, post rearrangement dimerisation and protodeauration 




Suzuki cross coupling 
Another important transition metal catalysed transformation is the coupling of an aryl 
halide and an organo-boron reagent, the Suzuki reaction.
37
 The transition metal usually 




utilised for this reaction is Pd(0) which has a d
10
 electron configuration, therefore Au(I), 
also d
10
 could also potentially catalyse suzuki cross-couplings. 
 
 
Scheme 4 – Gold-catalysed Suzuki cross coupling 
 
Under Au(I) catalysed conditions, the cross-coupled product 14 is formed with good 
conversion and 100% selectivity, and has similar activity and selectivity to analogous 
palladium catalysts.
38
 However, González-Arellano et al. have shown that when Au(III) 
is used under the same conditions, homo-coupling is the only product.
39
 This dichotomy 
of products isolated from Au(I) and Au(III) catalysis of the same reaction is common 
and will be explored in later sections.  
 
Sonogashira cross coupling 
Another key transition metal catalysed reaction is the Sonogashira reaction, the 
coupling of vinyl or aryl halides with terminal alkynes using a palladium catalyst, a 




Following the success of replacing palladium with gold in the Suzuki cross-coupling, 
Wang et al. believed it would be possible to conduct a copper-free Sonogashira cross-
coupling utilising gold catalysis.
41
 Au(I) has the same d
10
 electronic configuration as 
Cu(I) and is capable of interacting with alkynes in the required manner, therefore it 






Scheme 5- Sonogashira cross coupling of phenyl acetylene 15 and 2-bromopyridine 16 





Whilst conducting experiments to determine the mechanism of the Au-promoted cross-
coupling, Echavarren et al. found that [AuX(PPh3)] could not oxidatively insert into a 
number of Ar-X bonds.
43
 As such, the claims of the ability of gold to conduct 
palladium-free Sonogashira couplings were rejected, with trace palladium impurities 
being responsible for the cross-couplings. However, González-Arellano et al. have 
carried out gold-catalysed Sonogashira reactions utilising both gold nanoparticles and 
Au(I) Schiff base complexes and have demonstrated that palladium is not in fact needed 




Gold has also been found to be an efficient transmetalation catalyst in palladium 
promoted Sonogashira cross-coupling reactions, with many benefits over copper(I) 
iodide, such as; cleaner reaction profiles and the ability to use technical grade solvents 





The transition metal catalysed isomerisation and rearrangement of unsaturated systems 
allow for the formation of structural elements not accessible through thermally 
promoted reactions. The cyclisation of enynes by transition metals allow for the rapid 
construction of numerous carbo- and heterocycles from linear substrates.  
 
Toste et al. hypothesised that transition metal-alkyne complexes could be electrophilic 
enough to react with simple alkenes, however it was found that only a cationic Au(I) 





Scheme 6 – Cyclisation of 1,5 enyne 18 





It has been hypothesised that enyne cyclisations proceed via a Au(I)-carbene 
intermediate of type 19, which can subsequently be trapped with olefins (Scheme 7 and 





Scheme 7 – Enyne cyclisation followed by olefin trapping 
 
Following the 5-exo-dig of 21, a second cyclisation can occur to construct the tetracycle 
22 as a single isomer.
49
 It is also possible to utilise external olefinic nucleophiles to 





Scheme 8 – Enyne cyclisation with cyclohexene 24 incorporation 
 
1.5.2 C-O bond formation 
 
Carbon-oxygen bonds are ubiquitous in nature, from simple sugars to complex natural 
products, as well as being present in a plethora of pharmaceutical drugs, therefore the 
development of novel methods for the formation of C-O bonds is of the utmost 
importance. Au-alkyne complexes have already been shown to be inherently 
electrophilic; therefore the reaction of these complexes with nucleophilic oxygen should 









An excellent example of gold catalysed C-O bond formation was reported by Hashmi et 





Scheme 9 – Gold-catalysed furan synthesis from ketone 26 
 
Following the attack of the ketone onto the alkyne to furnish furan 27, AuCl3 further 
catalyses a Diels-Alder cyclisation, with subsequent ring opening and re-aromatisation 
providing phenol 28. Selective formation of both the furan and phenol derivatives was 




Utilising carbonyls as the nucleophilic oxygen source has subsequently been applied by 





Scheme 10 – Furan formation followed by cyclopropanation of intermediate 32 
   
Nucleophilic attack of the oxygen onto the Au-alkyne complex 30 furnishes the furan 
moiety, with subsequent cyclopropanation of the Au-carbenoid intermediate 32 
furnishing the tricycle 33.
53
 A multitude of gold catalysed furan syntheses that also 




include tandem cyclisations have been reported enabling multiple C-O and C-C bonds 




Subsequent studies have shown it is possible to synthesise furan derivatives from 
starting materials containing a wide range of functionality, with alcohols being 





Scheme 11 – Furan synthesis from alcohol 34 
 
Following alkyne activation, an anti-5-exo-dig cyclisation by the hydroxyl group occurs 
to afford the aurated intermediate 35. Proto-deauration regenerates the catalytic species, 




Epoxides have also been used as the nucleophilic oxygen source in numerous syntheses, 





External oxygen sources can also be utilised in gold-promoted nucleophilic addition 










Scheme 12 – Acetal formation by nucleophilic addition of ethane-1,2-diol to alkyne 38 
 
After the initial alcohol addition to the activated alkyne and proto-deauration, an enol 
ether intermediate is formed, however a rapid isomerisation to the more stable acetal 39 
occurs. The addition of the diol occurs exclusively at the most sterically encumbered 
carbon atom of the alkyne to give the cyclic acetal 39.  
 
Ketones by alkyne hydration 
Previous methods for the hydration of alkynes have employed the use of mercury salts 
(HgO-H2SO4/HgO-BF3), however, alternative methods have been sought to eliminate 
the use of these toxic complexes. Unfortunately, the catalytic systems developed, along 
with the HgO complexes, require the use of acidic additives, high temperatures or both. 
Corma et al. have shown that cationic gold(I) is capable of affecting the hydration of 





Scheme 13 – Regioselective gold-catalysed alkyne hydration 
 
Dimethyl ketals are formed as intermediates in this transformation as the addition of 
MeOH to the alkyne is faster than H2O (as determined by 
1
H NMR), with subsequent 
hydrolysis providing the ketone 41. The absence of acidic promoters within this reaction 










Whilst investigating the formation of alkylidene lactones from the corresponding 
acetylenic acids, Pale et al. discovered an interesting dichotomy between the Au(I) and 





Scheme 14 – Contrasting reactivity of pent-4-ynoic acid 42 under gold(I) and gold(III) catalysis 
 
The use of Au(I) chloride gave the expected 5-exo-dig product 43, however Au(III) 
chloride provides the dimerised product 44, although in modest yield. As shown 
previously, Au(III) was capable of catalysing the dimerisation of α,β-unsaturated ketone 
5, although an external oxidant was necessary to promote catalyst turnover, which may 
explain the poor yield for this reaction.  
 
Boron enolate formation 
Sheppard et al. have shown it is possible to synthesise a range of boron enolates from 






Scheme 15 – Boron enolate formation and subsequent diastereoselective aldol reaction 
 




Following the gold-catalysed formation of boron enolate 46, which is isolable, the aldol 
reaction with butyraldehyde occurs, with subsequent rearrangement, to give 47 in 
excellent yield and good diastereoselectivity. The synthetic utility of this reaction was 
demonstrated by the further functionalisation of the aldol products by oxidation, Suzuki 
or Chan-Lam couplings. 
 
1.5.3 Gold catalysed C-O bond formation in total synthesis 
 
Fortner et al. have taken advantage of gold’s ability to activate alkynes to nucleophilic 
attack by hydroxyl groups during the synthesis of the eastern half of (+)-cephalostatin 1 





Scheme 16 – Late-stage gold-catalysed cyclisation en route to (+)-cephalostatin 1 50  
 
The use of the Au(I)-catalysed 5-endo-dig cyclisation, towards the end of a complex 
total synthesis, onto a highly substituted internal alkyne demonstrates the power of gold 
catalysis.  




1.5.4 C-N bond formation 
 
Another important class of carbon-heteroatom bond is that with nitrogen, being 
ubiquitous in nature and biologically active molecules. Novel methods for the 
introduction of a wide range of nitrogen containing functional groups are therefore 
desirable, especially under non-forcing conditions. Having demonstrated the ability of 
gold to catalyse the nucleophilic addition of heteroatoms to alkynes, it follows that 
nucleophilic nitrogen can also be employed. 
 
Hydroamination of alkynes 
With analogous reactivity to the C-O bond forming reactions, it is possible to promote 
the nucleophilic addition of nitrogen to an alkyne. 
 
 
Scheme 17 – Formation of enamine 53 by hydroamination of 52 with 2-methoxyaniline 51  
 
This reaction affords N-arylimine 53 as a single regioisomer under mild conditions, with 
control experiments ruling out a simple Michael addition of the aniline 51 to the alkyne 
52.
64
 Further examples building up increased molecular complexity via tandem reaction 









Scheme 18 – Hydroamination of dimethyl but-2-ynedioate 55 followed by gold-acetylide addition 
 
After the initial hydroamination of 55 by quinolone 54, the iminium intermediate 57 
reacts with the terminal alkyne, as the Au-acetylide 58, to give the enamine 59. This 






Scheme 19- Pyrrole formation by 5-endo-dig cyclisation of aziridine 60 
 
As with the furan syntheses utilising nucleophilic oxygen, nitrogen heterocycles can 
also be formed using Au-catalysis. A number of routes have been devised however two 




general strategies are employed for pyrrole formation; aziridine opening and the 
intramolecular cyclisation of 1-amino-3-alkyn-2-ols.
55, 56, 66, 67
 After the familiar 5-endo-
dig cyclisation of the aziridine 60 with the Au(I)-activated alkyne, the ammonium 
cation is quenched by β-hydride elimination and aziridine ring-opening to give 
spirocyclic intermediate 62. Subsequent Au(I)-catalysed ionisation provides an allylic 
cation which undergoes Wagner-Meerwein rearrangement/ring expansion to furnish the 










Scheme 20 – Synthesis of pyrrole 66 from 1-amino-3-alkyn-2-ol 65 
 
The hydroxyl group is necessary for re-aromatisation following cyclisation and proto-





Another nitrogen-containing heterocycle that has been synthesised utilising Au-catalysis 
is indole. Arcadi et al. reported the first general synthesis of indole from o-





Scheme 21 – Arcadi’s indole synthesis 
 
Previous examples of Au-promoted indole formation require electron withdrawing 
groups on the nitrogen atom to successfully promote the reaction, with extremely 
forcing conditions needing to be employed to encourage catalyst turnover when no 




electron withdrawing groups are present.
69
 Subsequent research has shown that it is 
possible to carry out tandem processes to increase complexity in the reaction products, 
with Li et al. synthesising N-vinylindoles in one-pot via the double hydroamination of 





Scheme 22 – Double hydroamination of alkynes en route to indole 71 
 
After initial activation of the terminal alkyne 56 by gold(III) triflate, formed in situ from 
gold(III) chloride and silver(I) triflate, the first hydroamination provides imine 70, with 




















Indole 72, the trivial name for benzopyrrole, comes from the combination of indigo and 
oleum, as a result of the aromatic compounds’ isolation from natural indigo dye.71  
 
 
Figure 5- Indole, 72 
 
Since its isolation, indole has become a privileged structure, a term first used by Evans 
et. al. in 1988, and is defined as “a single molecular framework able to provide ligands 
for diverse receptors”.72 As such, indole scaffolds have been utilised in a wide range of 
applications including fragrances, agrochemicals, pigments, material science, as well as 
being a key motif in a wide range of natural products.
73
 Due to its high affinity for a 
wide range of receptors, the [5,6] bicyclic framework of indole has also been exploited 
extensively in the field of medicinal chemistry. 
 
 
Figure 6 – Serotonin 73, Reserpine 74, Strychnine 75 and Vinblastine 76 containing the privileged indole 
nucleus 
 
Serotonin 73, also known as 5-hydroxytryptamine (5-HT), is a neurontransmitter which 
plays a variety of roles in physiology including cardiovascular function, sensory 




perception and behaviour and is one of the oldest signalling molecules, being found 
throughout history.
74
 Reserpine 74, a lipid-soluble indole alkaloid, first isolated from 
India snake root R. serpentine Benth in 1952, is a potent central nervous system 
depressant.
75
 Reserpine was introduced as one of the first drugs for the treatment of 
anxiety and mental disorders, and it is still used today.
76
 Strychnine 75 is an extremely 
complex natural product, having 7 fused rings and 6 contigous stereocenters. It is also a 
well-known poison (~50 mg is lethal for an adult human), which blocks postsynaptic 
inhibition in the spinal cord by antagonising the transmitter glycine.
77
 Vinblastine 76, 
isolated from Catharanthus roseus,
78
 acts as a potent chemotherapeutic agent by 
inhibiting cell mitosis.
79
 It is particularly interesting as it contains both an indole and an 
indoline motif. 
 
Due to the range of pharmacological efficacy of indole containing alkaloids, significant 
effort has gone into devising de novo syntheses of these molecules, which allow for the 
formation of analogues by subtle structural modification. 
 
1.6.1 Indole synthesis 
 
Considering the pharmaceutical importance of the indole nucleus and its derivatives it is 
not surprising that methods which allow for the rapid formation of indoles with varied 
functionality have garnered considerable attention. Some of the most popular are 
described below. 
 
Fischer indole synthesis 
What is now known as the Fischer indole synthesis was first reported in 1883, by the 






Scheme 23 – First example of the Fischer indole synthesis 
 




Since then many variants of the synthesis have been reported, utilising Lewis and 
Brønsted acids, as well as thermal and microwave promoted cyclisations. 
 Scheme 24 – Fischer indole synthesis en route to MDL 103371, 83 
 
Watson et al. reported a polyphosphoric acid mediated fischer indole protocol on route 
to the synthesis of MDL 103371, a potential treatment of stroke. The power of this 





Larock indole synthesis 
An alternative synthesis of indole was reported by Larock in 1991, utilising palladium 





Scheme 25 – Larock indole synthesis 
 
This reaction proceeds via regioselective syn-insertion into the alkyne, ligand 
displacement by the aryl nitrogen atom and reductive elimination to furnish the desired 
indole derivative 86. Due to the simplicity of this reaction and its functional group 









Bartoli indole synthesis 
Another novel method for the preparation of indoles was reported by Bartoli et al. 
which features a [3,3]-sigmatropic rearrangement analogous to the Fischer indolisation 






 This method has been used to synthesise 7-bromoindole 92 as part of the concise 





Scheme 26 – Bartoli indole synthesis towards the synthesis of hippadine 93 
 
The indole syntheses shown thus far all benefit from their generality, as well as the 
commercial availability of the starting materials involved, allowing for the synthesis of 
diverse indole frameworks.  
 
1.7 Reactions of Indole 
 
Indole is an electron-rich aromatic, with the non-bonding nitrogen lone pair overlapping 
with the conjugated π-system, allowing for alternate resonance structures. 
 
 
Scheme 27 – Indole resonance structures 
 
Of the many resonance structures available to indole, the most important are 94 and 95, 
which place the negative charge on the C-3 and C-2 carbons respectively. The 
thermodynamically favoured resonance structure is 94 due to the retention of benzenoid 
character of the bicycle, with 95 having perturbed this system. These qualitative 




observations are further supported by the NMR spectrum of indole, with the C-3 proton 
being the most shielded, as well as frontier electron density calculations.
88
 As such, 
derivitisation of indole is commonly achieved through electrophilic aromatic 
substitution at the C-3 position, which is ~10
13




Classical electrophilic aromatic substitution, usually seen for benzene and its derivatives 
can also be employed in the reaction of indole. 
 
 
Scheme 28 – C-3 nitration of 1-(phenylsulfonyl) indole 96 
 
Although the direct nitration of indole proceeds poorly,
90
 Gribble et al. have shown that 
N-protection with electron withdrawing groups facilitates nitration under reasonable 
conditions.
91
 It is worth noting that under traditional nitration conditions inextractable 
products were formed, potentially due to the acid-catalysed polymerisation of indole.
92
   
 
Friedel-Crafts  
The Friedel-Crafts reaction is one of the most important C-C bond forming reactions in 
organic chemistry, with Friedel-Crafts acylations allowing for the formation of aryl 
ketones.
93
 Due to the inherent reactivity of indole, attempted acylations using acetic 
anhydride in acetic acid gave mainly 1,3-diacetylindole,
94
 however Gribble et al. were 





Scheme 29 – C-3 Acylation of 5-fluoro-1-(phenylsulfonyl) indole 98 
 










Scheme 30 – C-3 formylation of indole 72 by Vilsmeier reaction  
 
This reaction is the most efficient route for the formation of 3-formylindoles, and can 
even be used on indoles bearing an electron-withdrawing group at the C-2 position.
97
 





Deng et al. have described the enantioselective Friedel-Crafts reaction of indoles with 





Scheme 31 – Friedel-Crafts reaction of indole 72 and aldehyde 101 
 
This reaction is applicable to a wide range of indoles and aldehydes, as well as α-
ketoesters. Previous attempts to install hydroxyl groups chirally using metal catalysts 
only provided high enantioselectivities for the nucleophilic addition of indole to ethyl 








Nair et al. have developed the formal double Friedel-Crafts reaction of indole 72 and 





Scheme 32 – Double Friedel-Crafts alkylation of indole 72 by benzil 104 
 
The indolocarbazole framework has many of the biological properties of indolyl 
analogues, such as antitumor, antimicrobial and antihistaminic activity, but also shows 





The Pictet-Spengler reaction has been utilised extensively in the synthesis of indole- 
and isoquinoline-alkaloids,
103
 predominately using strong Brønsted acids to promote the 





Scheme 33 – Gold-catalysed Pictet-Spengler reaction 
 
Youn has shown it is possible to use gold(III) chloride and silver(I) triflate to catalyse 
the cyclisation of indole onto imines under mild conditions to afford tetrahydro-β-
carbolines.
105
 It is worth noting that in this case, acylation of the imine was required to 
enhance reactivity.  
 
Jacobsen et al. have shown it is possible to carry out the Pictet-Spengler reaction of 
indole 108 enantioselectively in the total synthesis of (+)-yohimbine 111, a 
monoterpenoid alkaloid with diverse biological activity.
106
 






Scheme 34 – Enantioselective Pictet-Spengler reaction en route to (+)-yohimbine 111 
 
The chirality installed in the Pictet-Spengler cyclisation is the template for a highly 




As well as the addition to electron-deficient systems such as carbonyls and imines, it is 
also possible to promote indoles addition to carbon electrophiles. Nakao and Hiyama et 






Scheme 35 – Nickel catalysed hydroheteroarylation of trimethyl(prop-1-yn-1-yl)silane 85  
 
This methodology has also been applied to a range of heteroaromatics, giving 
regioselective hydroarylation products, however if trimethylphosphine is used as the 









It is also possible to achieve intramolecular hydroarylation of alkynes by indole, with 






Scheme 36 – Divergent gold(III)- and gold(I)-catalysed synthesis of tricycle 115 and 116 
 
In this divergent transformation, cationic Au(I) complex 117 facilitates a 7-exo-dig 




Analogous to the reaction of alkynes, the nucleophilic addition of indoles to 
unfunctionalised alkenes has only recently received significant interest. Platinum 
complexes have shown to be successful for this, with the stability of the platinum(II) 









Scheme 37 – Platinum-catalysed intramolecular alkene addition of indole 118 
 
A range of protected indole derivatives successfully underwent the 6-exo-trig 




Hydroarylation of indole is also possible using palladium(II) complexes, however due 
to the inherent instability of the σ-alkyl-palladium(II) species, unsaturated products are 
isolated through β-hydride elimination from these intermediates.  
 
 
Scheme 38 – Nucleophilic addition of indole 72 to tert-butyl acrylate 121 at both C-3 and C-2 position 
  




Although both reactions are believed to go through the same reactive intermediate, 124; 
in polar solvents alkenylation of indole at C-3 was observed, following rearomatisation 
and Heck-type reaction. In contrast, under protic reaction conditions, charge 
stabilisation of intermediate 124 allows for the migration of the C-3-PdX bond to the 





Another method for the preparation of C-2 alkenylation of indoles is the phase transfer 





Scheme 39 – Conjugate addition of indole 72 to 1,3-diphenylprop-2-yn-1-one 125 
 
Michael addition 
The 1,4-addition (or conjugate addition) of a carbanion, or other nucleophile, to 
activated olefins such as α,β-unsaturated carbonyl compounds is known as the Michael 
reaction. The Michael reaction is widely used in organic synthesis for its ability to 
rapidly construct C-C bonds. 
 
 
Scheme 40 – Asymmetric Michael addition en route to (-)-α-kainic acid, 129. 
 
In this example, Rubio et al. have affected the asymmetric Michael addition of 









Although traditionally using activated methylene nucleophiles, such as 




Scheme 41 – Lewis acid catalysed Michael addition of indole 72 into but-3-en-2-one 130 
 
Although the Lewis acid catalyst allowed for the pioneering Michael addition of indole 
to methyl vinyl ketone 130 (MVK), the substrate scope was narrow, and mainly 
confined to the addition to MVK.
115
  However, Harrington and Kerr later published a 
general procedure for the Michael addition of indole to a variety of α,β-unsaturated 
carbonyl compounds using ytterbium(III) trifluoromethanesulfonate.
116
 Subsequent 
studies have shown that a wide array of catalysts are able to promote the Michael 
addition of indole to MVK, the results of which are highlighted in an excellent review 




An example of particular interest was the gold(III) chloride promoted Michael addition 





Scheme 42 – Gold-catalysed Michael addition of indole 72 into 1-phenylprop-2-en-1-one 133 
 
It is postulated that instead of acting as a traditional Lewis acid, the gold(III) directly 
attacks the C-3 position of indole, affording an arylgold(III) species as the reactive 
intermediate. This mechanism of action has also been proposed by Li et al. in their 








The asymmetric metal-catalysed addition of indole to simple α,β-unsaturated carbonyl 
systems has proved difficult, however Bandini et al. pioneered the use of a (R,R)-
[Al(salen)Cl] complex, in the presence of a lutidine additive, to give high 






Scheme 43 – Enantioselective Michael addition of indole to α,β-unsaturated ketone 134 
 
Although the vast majority of conjugate addition chemistry occurs at the more reactive 
C-3 position of indole, C-2 and N-1 functionalisation can become competitive if C-3 





Scheme 44 – Michael addition of indole 72 at C-2 and N-1 positions  
 
It was noted that the C-3 substituent, as well as reaction media, greatly affect the 
regioselectivity of the reaction, with aprotic solvents favouring N-adducts, and protic 
solvents increasing the percentage of C-2 adduct formed, however a general tendency 
towards N-substitution is maintained. 
 
It has previously been demonstrated by Arcadi et al. that indole is capable of 









Scheme 45 – Arcadi’s double alkylation of indole 72 with dibenzylidene acetone 140 
 
At the time, this was the solitary example of this reaction-type, affording the fused 
[6,5,7] tricycle 141 as a mixture of diastereomers, it is worth noting that this was the 
solitary example of such a transformation and only symmetrical divinyl ketones (DVKs) 
were explored.  




2. GOLD-CATALYSED DOUBLE FRIEDEL-CRAFTS 
ALKYLATION OF INDOLE WITH ENYNONES 
 
2.1 Background Information 
 
Work previously undertaken in the Carbery group has sought to exploit divinyl ketones 





Scheme 46 – Double alkylation of indole 72 by DVK 142 
 
This Brønsted acid catalysed transformation yields a complex fused-tricyclic indole 
product 143 in a highly regio- and diastereoselective manner. The importance of this 
tricyclic scaffold can be highlighted by three structurally related indoles, recently 
reported in medicinal chemistry literature as offering potent biological activity. 
 
 
Figure 7 – Three biological active indole containing [6,5,7] tricycles. Indole 144, carboxamide 145 and Indolo-
carboxylic acid 146.  
 
Indole 144 is a potent aurora kinase inhibitor, displaying quantitative bioavailability in 
mouse model tumour xenographs.
124
 Carboxamide 145 represents the most potent 
SIRT1 inhibitor to date, and as such has been suggested as a lead towards 
therapeutics.
125
 Indolo-carboxylic acid 146 is a potent and selective fatty-acid binding 
protein (FABP) inhibitor.
126
 It is worth noting that the specified [6,5,7] scaffolds offered 




maximum biological activity in their respective assays when compared to the analogous 
[6,5,6] and [6,5,5] scaffolds.  
 
2.2 Concept Development 
 
Building on the Brønsted acid catalysed annulation of indole by DVKs we sought to 
expand the scope of such transformations. With this in mind we chose to consider 
structurally related ketonic double electrophiles, such as enynones, with the view to 
forming novel, functionalised tricyclic indole structures. 
 
 
Figure 8 – Enynone 147 and potential tricycle 148 
 
With a clear medicinal rationale, we reasoned that a novel and flexible approach to such 
[6,5,7]-tricyclic indoles might open new areas of chemical space for exploration in a 
small-molecule discovery context. Two requirements were identified for the synthesis 
of the desired [6,5,7]-tricyclic core; the facile synthesis of enynones with the ability to 
incorporate a range of functionality, and a suitable catalyst to promote the reaction. It 
was decided to investigate ketone 147 as the initial substrate, as both Michael acceptors 
have differing steric and electronic considerations. It was concluded that the most facile 
method for the synthesis of 147 would be via the addition of a metal-acetylide to an 
unsaturated aldehyde, followed by oxidation of the resultant alcohol. 
 
 
Scheme 47 – Enynone 147 synthesis 
 




Following lithiation of phenylacetylene and addition to crotonaldehyde, an alcohol is 
produced, however attempts to isolate this intermediate gave poor yields (~20%), 
whereas oxidation of the crude reaction material gave the desired enynone 147 in 
improved yield.  
 
With the requisite enynone in hand, an initial examination was conducted using 
enynone 147 and indole 72 in the presence of the previously successful strong Brønsted 
acid promoter, 2,4-dinitrobenzenesulfonic acid. 
 
 
Scheme 48 – Brønsted acid-catalysed mono-alkylation of indole 
 
The clean intermolecular enone Friedel-Crafts reaction was observed under acidic 
conditions in quantitative yield, however no cyclised product 148 was observed. The 
lack of annulation could be due to the inability of the Brønsted acid to sufficiently 
activate the ynone to nucleophilic attack. To encourage the formation of the desired 





















1 DNsOH 0:100:0 
2 FeCl3.6H2O 25:75:0 
3 PtCl2 90:10:0 
4 CuOTf 30:70:0 
5 PdCl2 83:17:0 
6 Pd(PPh3)2Cl2 12:88:0 
7 AuPPh3Cl 100:0:0 
8 AuPPh3Cl/AgSbF6 100:0:0 
9 NaAuCl4.2H2O 33:45:22 
[a] Determined by 
1
H NMR analysis of crude reaction mixture 
 
Although the majority of the Lewis acidic metals evaluated promoted the Michael 
addition to the enone, they failed to provide the annulated product 148. Pt(II) and Pd(II) 
complexes have both been shown to activate alkynes under a variety of conditions, 
however were unable to facilitate the cyclisation of this substrate.
110, 127
 Suprisingly, 
Au(I) also proved to be unsuccessful, failing even to promote the initial Michael 
addition to the enone. As shown in chapter one, Au(I) has been shown to be highly 
alkynophilic, allowing for the addition of a range of nucleophiles to alkyne containing 
substrates. However, due to the quantitative isolation of 147, we can see the Au(I) 
catalyst is not sufficiently activating to promote the intermolecular addition of indole to 
the enone in this context. The sole exception was the readily available sodium 
tetrachloroaurate(III) dihydrate, offering 22% conversion after 24 hours, however, 
mono-addition product 150 and starting material 147 were also present. The 
regiochemistry of the annulated product 148 was determined by NOESY spectroscopy, 
with NOEs between the 5-position proton of indole and the methyl group and the N-H 
of indole with the ortho protons of the phenyl ring. 






Figure 9 – NOEs that confirm regioisomer of annulated product 
 
With the aim of increasing the conversion of this transformation, solvent optimisation 
was undertaken.  








1 CH2Cl2 33:45:22 - 
2 PhMe 50:49:1 - 
3 Et2O 40:30:30 - 
4 DMF 35:65:0 - 
5 EtOH 0:38:62 - 
6 MeCN 0:0:100 96 
7 MeCN
[b]
 0:0:100 99 
8 MeCN
[b], [c]
 0:0:100 98 
[a] Determined by 1H NMR analysis of crude reaction mixture. [b] 2 mol% catalyst 
used. [c] Reaction conducted for 4 h. 
 
Toluene, a non-polar, aprotic solvent was shown to be a poor reaction solvent, 
providing only a limited quantity of 148. Dimethylformamide (DMF) also failed to 
facilitate the annulation, although this may not be suprising as DMF can bind to Au, 
potentially limiting its reactivity.
128
 Diethyl ether only shows marginal improvement 
over dichloromethane. However when highly polar solvents (Entries 5-8) are used a 




dramatic increase in tricycle 148 formation occurs. It is clear that in acetonitrile the 
reaction efficiency is markedly improved (Entries 6-8), with the ability to reach full 
conversion within four hours with only 2 mol% catalyst loading. Pleasingly, this 
reaction affords a single regioisomer, with initial addition to the enone occurs at the C-3 
position of indole. 
 
To establish that the Michael addition product 150 is in fact a reaction intermediate en 
route to the [6,5,7]-tricycle 148, in situ reaction monitoring by 
1
H NMR was conducted. 
 
 
Figure 10 – 1H NMR monitoring of tandem cascade reaction (CD3CN at 20 °C; 500 MHz) ■=147, ■=150, 
■=148 
 
As can be seen in figure 10, mono-addition product 150 is present (20%) before the 
observable formation of tricycle 148, with associated consumption of 147. There are 
two possible mechanisms that are possible for the annulation of 150; the direct C-2 
addition of indole to the ynone fragement to provide 148, or C-3 addition of indole to 
the ynone affording spirocycle 151, followed by migration of the α,β-unsaturated 
moiety to afford 148.  
 
 
Figure 11 – Possible spirocyclic intermediate 







H NMR monitoring experiment it is worth noting that no signal indicative 
of the spirocyclic compound were observed, discounting this as the mechanism for the 
formation of 148. 
 
The ability for enynones to act as double-electrophiles in this reaction is in stark 





Scheme 49 – Addition of 2-methylfuran 153 to enynone 152 
 
After initial Michael addition to the enone, the resultant intermediate undergoes 
cycloisomerisation rather than a second alkylation of furan. However, a handful of 





















2.3 Indole Scope 
 
With optimised conditions in hand, a range of indoles were examined with a view to 
demonstrating the flexibility and diversity of this reaction protocol. 
 
Table 3 – Indole scope 
 
[a] Reaction conducted for 24 h. 
 




As can be seen, electron-rich indoles are compatible with this methodology, furnishing 
the relevant [6,5,7]-tricycle 157 in excellent yield. Electron-deficient indoles are also 
tolerated, however in the case of methyl indole-5-carboxylate an extended reaction time 
is required to allow for full conversion of starting material. The indole annulation is also 
unperturbed by substitution on the benzeniod fragment of indole, judged by the range of 
methylindole and chloroindole regioisomers able to participate in the reaction, affording 
tricycles 159-164. The functional group tolerance of this reaction is demonstrated by the 
ability to utilise an unprotected hydroxyl group in this tandem process, 167. In 
particular, the incorporation of synthetic handles, such as boronate ester 165 and iodide 
166, offers the opportunity for further synthetic elaboration post-reaction. The 
commercial availability of the starting materials and ease of synthesis of a diverse array 
of indole derivatives, coupled with the reactions functional group tolerance, gives this 
transformation wide applicability.  
 
Previous studies into the Brønsted acid-catalysed annulation of indoles carried out in 
our group showed that N-substitution of indole is not compatible with the reaction.
130
 In 
the gold-catalysed reaction, N-methyl indole 168 reacts smoothly to give the desired 
product 169, however, the Au(III) catalyst has to be added portionwise in order to 




Scheme 50 – Double alkylation of N-methylindole 168 by enynone 147 
 
Another important class of heterocycles are azaindoles; formally 1H-pyrrolo[2,3-
x]pyridines – where x describes the position of the pyridyl nitrogen. Azaindoles are a 









Scheme 51 – Failed alkylation of 7-azaindole 
 
The attempted double alkylation of 7-azaindole 170 returned a quantitative amount of 
starting material, with even highly forcing conditions previously used for the Michael 
addition of azaindoles (EtOH, 140 °C, sealed tube) failing to provide even the mono-
addition product.
132
 Interestingly, the reaction was not fully homogeneous, containing 
visible particulates, and it has been shown previously that azaindoles are capable of 
binding to a number of metals, including silver and platinum.
133
 The lack of reactivity in 
our case may demonstrate the poisoning of the catalyst by the pyridyl nitrogen of the 
azaindole. 4-, 5-, and 6-azaindoles were also subjected to the reaction conditions, 
however, as with 7-azaindole no reaction occurred. 
 
To explore the use of alternative nucleophiles, 2,5-dimethyl pyrrole 172 was employed 
as the double nucleophile, with the aim of synthesising structurally related products. 
 
 
Scheme 52 – Mono-alkylation of 2,5-dimethylpyrrole 172 by enynone 147 
 
Unlike indole, pyrrole is most nucleophilic at the C-2 position, however we chose the 
substrate 172 in which both of these positions have been substituted. This decision was 
in attempt to avoid the potential of one pyrrole unit adding to two enynone units, with 
the reduced nucleophilicity of the C-3 position helping to temper the reactivity. 
Although the reaction was heated to reflux for 16 hours, only the initial Michael-
addition product 173 was formed, with the return of the remaining starting material 147.  
 
 




2.4 Enynone Scope 
 
Having assessed the generality of this reaction with regards to the indole reaction 
partner, a series of experiments were undertaken to synthesise a range of enynones 
bearing a variety of functional groups in an attempt to probe the limitations of this 
tandem process. Although there are a large number of commercially available 
functionalised terminal alkynes, to fully explore the structural scope of the Au(III)-
catalysed double alkylation of indole, a number of non-commercially available 
acetylenes were first synthesised.  
 
 
Scheme 53 – Synthesis of 1-ethynyl-4-(trifluoromethyl)benzene 177 
 
Following the procedure layed out by Jenny et al., Sonogashira coupling of 
ethynyltrimethylsilane 175 and aryl bromide 174 proceeded smoothly.
134
 Deprotection 
of 176 was then necessary, with removal of the silyl group occurring quantitatively, as 
determined by 
1
H NMR conversion. Purification of the terminal acetylene 177 proved 
difficult due to co-elution with by-products during flash chromatography, however it 




Another alkyne to be synthesised was 2-ethynylnaphthalene 180 in order to ascertain if 
additional alkyne substitution would be tolerated in the double addition. Using the 
procedure reported by Pu et al., Sonogashira coupling and subsequent deprotection 









Scheme 54 – Synthesis of 2-ethynylnaphthalene 180 
 
To incorporate additional heteroatom functionality into the tricyclic product, it was 
envisaged that a propargyl alcohol could be utilised in the acetylide addition to 
crotonaldehyde. In order to avoid deprotonation of the alcohol in the following step, 
prop-2-yn-1-ol 181 was protected with tert-butylchlorodimethylsilane (TBSCl) to afford 





Scheme 55 – Silyl protection of  prop-2-yn-1-ol 181 
 
With the requisite terminal alkynes in hand, and due to the modularity of the synthesis 
of enynones, a range of aliphatic and aromatic groups were able to be incorporated into 






















 Product Yield [%] 
1 Me H 4-MeC6H4 183 60 
2 Me H 4-OMeC6H4 184 52 
3 Me H 4-CF3C6H4 185 16 
4 Me H 2-Napth 186 56 
5 Me H nBu 187 48 
6 Me H CH2OTBS 188 67 
7 Me H TMS 189 51 
8 Me Me Ph 190 57 
9 iPr H Ph 191 58 
10 Ph H Ph 192 58 
11 Ph H 2-Napth 193 54 
12 Ph H nBu 194 42 
13 H H nBu 195 44 
14 H H Ph 196 48 
15 H Me Ph 197 55 
 
To determine the electronic requirements of the reaction, an electron-rich and electron-
poor substrate, 184 and 185 respectively, were synthesised. The poor yield for the 
synthesis of 185 may be a result of the electron-withdrawing ability of the 
trifluoromethyl group. To examine the electronic and steric restrictions on the reaction 
186-197 were synthesised. The synthesis of enynones containing additional heteroatom 
functionality was conducted by the synthesis of protected alcohol 188 (Table 4, entry 6). 
Addition of aromatic functionality (entries 10-12) will alter the sterics and electronics of 
the α,β-unsaturated system, providing additional conjugation, as well as the ability to 
potentially stabilise charged intermediates. In particular, enynone 194 has an alkyl-
group appended to the alkyne, allowing the electronics of both electrophilic centres to 




be altered. Entries 13-15 bear no substitution on the alkene terminus of the enone, again 
altering the steric and electronics of the system. Enynone 190 was synthesised in order 
to evaluate the potential diastereoselectivity of the initial Michael addition (entry 8).   
 
With a range of structurally diverse enyonones synthesised, the scope of the Au(III)-
catalysed cascade was evaluated. 
 















1 183 Me H 4-MeC6H4 6 23 198 98 
2 184 Me H 4-OMeC6H4 24 23 199 82 
3 185 Me H 4-CF3C6H4 16 23 200 73 
4 186 Me H 2-Napth 8 23 201 81 
6 187 Me H nBu 24 82 202 79 
7 188 Me H CH2OTBS 18 23 203 0
[a]
 
8 189 Me H TMS 18 82 204 98
[b]
 
9 191 iPr H Ph 18 23 205 72 
10 190 Me Me Ph 18 23 206 73
[c]
 
[a] Based on 1H NMR analysis of crude reaction mixture. [b] yield of mono addition product. [c] 4:1 dr 
based on 1H NMR analysis of crude reaction material 
 
As can be seen the reaction can tolerate electron-rich and poor aromatic ynone 
substitution (Table 5, entry 1-3). Increased steric bulk of the enynone is also permitted 
in this reaction, with napthyl enynone 186 and iso-propyl enynone 191 reacting well 
(entries 4 and 9). The reaction of 188 provided no product by 
1
H NMR analysis of the 
crude reaction mixture, even when the reaction mixture was heated to reflux (entry 7). 
TMS enynone 189 provided quantitative return of the Michael addition product, with no 




annulated product being isolated (entry 8).  When an alkyl ynone fragment is utilised, 
the reaction rate is markedly slower than enynones bearing aromatic functionality on the 
ynone, with heating to reflux necessary to promote the annulation step (entry 6). 
Enynone 190 gave a 4:1 syn/anti ratio of tricyclic product 206 based on 
1
H NMR 
analysis of the crude reaction material. This diastereoselectivity was confirmed by 
single crystal X-ray diffraction analysis of the major isomer. 
 
Figure 12 – XRD analysis of of tricycle 206 
 
Table 6 – Aromatic enone scope 
 
 
Entry Substrate R1 R2 Time [h] Temp [°C] Product Yield 
1 192 Ph Ph 24 82 207 77 
2 193 Ph 2-Napth 24 23 208 97 
3 194 Ph n-Bu 72 82 209 47 
 
When compared to the alkyl enones (Table 5), aryl enones required more forcing 
conditions to promote reaction. Extended reaction time was required for the reaction of 




194, containing both an aromatic enone and alkyl ynone fragment (Table 6, entry 3), 
with both starting material and mono-addition products also being isolated. Observation 
of the reaction by TLC shows that mono-addition occurs quickly, although not as 
rapidly as with alkyl enones, and annulation is slow. The alkyl ynone fragment is more 
electron-rich than its aromatic analogues, with the increased electron-density on the 
alkyne potentially lowering the electrophilicity of the ynone, thus retarding the reaction 
rate. 
 
Table 7- Terminal enone scope 
 
 
Entry Substrate R1 R2 Time [h] Temp [°C] Product Yield [%] 
1 195 H Ph 12 23 210 99 
2 196 H nBu 96 82 211 60 
3 197 Me Ph 8 23 212 76 
 
Terminal enones are also tolerated in this reaction, with the reaction of α-substituted 
enone 197 proceeding well (Table 7, entry 3), albeit in lower yield than the fully 
unsubstituted enone 195 (entry 1). Mirroring the trend seen previously, alkyl ynone 196 















2.5 Product elaboration 
 
To display the synthetic utility of our iodo- and boronic ester- functionalised tricycles 
166 and 165, it was decided to carry out simple Suzuki cross-couplings with 





Scheme 56 – Suzuki coupling reaction of 165 and 166 
 
Both tricycles are excellent coupling partners, with the cross-coupling reactions 
proceeding in near quantitative yield. This is further demonstrated by the coupling of 








2.6 Mechanistic Insights 
 
Having developed the gold-catalysed double alkylation of indole with enynones, it was 
decided to probe the mechanism of this transformation, and elucidate the role of the 
gold(III) catalyst. Arcadi et al. hypothesised the presence of a C-3 aurated indole 
intermediate 217 in the conjugate addition to α,β-unsaturated ketones.122 
 
Figure 13 – Arcadi’s proposed mechanism for Au-catalysed Michael addition of indole 
 
Regioselective nucleophilic attack of indole onto Au(III) chloride gives an indolyl-
gold(III) species 217, which subsequently undergoes 1,4-addition to the α,β-unsaturated 
ketone to give a σ-alkyl-gold species. The organogold intermediate undergoes proto-
deauration, facilitated by the proton liberated in the electrophilic aromatic substitution 
step. This hypothesised mechanism is supported by mass spectroscopy. When 
stoichiometric amounts of sodium tetrachloroaurate (III) dihydrate and indole are 
combined the positive ion electrospray mass spectra (ESI-MS) shows ion peaks at m/z = 
348 and 350, which match calculated isotope distribution patterns for [indolyl-AuCl]
+
. 
When C-3 substituted indoles were utilised in the reaction, C-2 alkylated products were 
isolated, however it was not explicitly stated that C-2 auration was in fact occurring. 
 




A number of gold-catalysed transformations found in the literature utilise sodium 
tetrachloroaurate(III) to facilitate reaction, however it has been assumed that gold(III) 
chloride is the catalytically active species, generated in situ from the sodium 
tetrachloroaurate pre-catalyst.
122
 To ascertain whether gold(III) chloride is the 
catalytically active species within our reaction, gold(III) chloride was employed in the 
double alkylation of indole 72 with 147. 
 
 
Scheme 57 – Test reaction using gold(III) chloride as catalyst 
 
The reaction proceeds smoothly, affording 148 in quantitative yield after only two 
hours, a notable increase over the rate witnessed when sodium tetrachloroaurate is 
employed (4 hours). The observed increase in rate for this reaction may be attributed to 
the gold catalyst already being in its active state. This result, combined with literature 
precedence,
122
 allows us to be  confident that gold(III) chloride is the catalytically active 
species in our reaction. 
 
To confirm the mechanism proposed by Arcadi et al. for the intermolecular conjugate 
addition of indole to enones, a number of experiments were designed. First to ascertain 
if the gold(III) catalyst is acting as a traditional oxophilic Lewis acid, dimethyl enynone 
189 was subjected to acid catalysed conditions. 
 
 
Scheme 58 – Acid catalysed mono-alkylation using dimethyl enynone 190 
 
The mono-addition product 218 formed in this reaction had a diastereomeric ratio of 2:1 
in favour of the anti-product (see appendix 6.3.4), whilst this is the same relative 




stereochemistry as in the annulated product, the diastereomeric ratio is marginally 
different from the gold-catalysed transformation (4:1 syn/anti). Under acid catalysed 
conditions, ketone 218 is readily enolised, with subsequent tautomerisation affording a 
thermodynamic mixture of diastereomers. This would indicate that the gold catalysed 
transformation may be under kinetic control, due to the discrepancy between 
diastereomeric ratios. 
 
To confirm this hypothesis the major diastereomer of 206 was resubjected to the gold-
catalysed reaction conditions, as well as being subjected to acidic and basic conditions. 
 
 
Scheme 59 – Subjection of 206 to gold-catalysed conditions, acidic and basic conditions 
 
Resubjection of 206 to the gold(III)-catalysed reaction conditions resulted in no loss of 
diastereoselectivity, however both acidic and basic conditions showed degredation of 
diastereomeric excess. These findings help support the hypothesis that gold is not acting 
as an oxophilic Lewis acid in our transformation, as no loss of diastereoselectivity is 
witnessed under gold-catalysed conditions. 
 
As a final test to confirm our belief of C-3 auration, it was necessary to synthesise C-3-
2
H-168. As the C-3 position of indole is the most nucleophilic, simply stirring in 









Scheme 60 – Formation of C-3 2H-168 
 
Investigation then began to assess if the deuterium content of C-3-
2
H-168 would be 
transferred to the annulated product under the Au(III) catalysed reaction conditions. 
 
 
Scheme 61 – Reaction of C-3-2H-168 with enynone 147  
 
Interestingly no deuterium was incorporated into the product 169, contrary to what 
might be expected for a Michael addition. It was believed that the Au(III) catalyst was 
solely responsible for the loss of deuterium incorporation, as the deuterium content of 
C-3-
2
H-168 is retained for over four days in acetonitrile alone. 
 
To support this hypothesis, a 
1
H NMR experiment was devised in which C-3-
2
H-168 
would be subjected to gold catalysed conditions, mirroring those in Scheme 62. 
 
 
Scheme 62 – Subjection of C-3-2H-168 to Au-catalysed reaction conditions 
 
It was found that the NMR solvent contained a small amount of water, ~ 11% relative to 
indole. When gold(III) chloride was added there was a significant reduction of 




deuterium content of indole C-3-
2
H-168 almost immediately, as well as an associated 
consumption of all water in the NMR solvent. This would indicate that the gold(III) 
chloride has replaced the deuterium at C-3 with both protons from each water molecule 
present in the sample. The speed of this deuterium displacement indicates the 
interaction of gold(III) and the C-3 position of indole, again implying that auration of 
indole as the mechanism for the intermolecular alkylation of indole. 
 
The rapid auration of indole 72 at the 3-position, along with the retention of 
diastereoselectivity upon subjection of tricycle 206 to gold-catalysed conditions, help to 





Although the role of the gold catalyst in the intermolecular alkylation of indole is now 
understood, the mechanism of action of Au(III) in the intramolecular annulation is still 
not clear. With the aim of clarifying the mechanism of our optimised double alkylation 
of indole, a 
1
H NMR experiment was devised. It was decided to subject mono-addition 
product 219 to the reaction conditions, in order to potentially observe the in situ 
formation of any C-2 aurated intermediates, such as 220. Stoichiometric quantities of 
sodium tetrachloroaurate(III) would be necessary to allow for quantitative analysis of 




Figure 14 – Possible intermediate 220 formed as part of the double alkylation of indole 
 
Making use of the Brønsted acid-catalysed Michael reaction, the test substrate 219 was 
synthesised for the 
1
H NMR experiment. 
 





Scheme 63 – 1H NMR substrate synthesis 
 
With the required substrate in hand: 219 in CD3CN was added to a dry NMR tube 
followed by addition of sodium tetrachloroaurate(III) dihydrate. Unfortunately, 
resolution of the C-2 proton and one of either the C-5/C-6 protons was not possible in 
acetonitrile, making it unfeasible to assess any degradation of C-2 protonation. 
However, the reaction was allowed to proceed at 70 °C, giving full conversion after just 
one hour, a significant rate enhancement over the previous cyclisation of this substrate 
(24 h, 82 °C, 79% yield), even taking into account the increased catalyst loading. 
 
 
Scheme 64 – 1H NMR experiment to assess reaction mechanism 
 
The Au(III) catalyst used in this reaction exists as the dihydrate, and it was reasoned 
that the presence of two equivalents of water could be responsible for the dramatic rate 
enhancement seen in the 
1
H NMR experiment. To confirm this hypothesis, the 
previously slow reaction substrates (Table 6, entry 6 and Table 7, entries 1 & 3) were 
resubjected to the same reaction conditions, however, now with two equivalents of 









Table 8 – Results of addition of water in the double alkylation of indole by enynones 
 
 
Entry Substrate R1 R2 R3 H2O (equiv.) Time [h] Product Yield [%] 
1 187 Me H n-Bu 0 24 202 79 
2 187 Me H n-Bu 2 4 202 82 
3 192 Ph H Ph 0 24 207 77 
4 192 Ph H Ph 2 3 207 99 
5 194 Ph H n-Bu 0 72 209 47 
6 194 Ph H n-Bu 2 18 209 69 
 
As can be seen, the addition of two equivalents of water dramatically reduces the 
reaction times of the slowest reactions, in some cases the reaction proceeds ~8 times 
faster than in the absence of water (Table 8, entries 3 & 4). Although this is a very 
interesting result, it does not help to elaborate the mechanism of action of the gold 
catalyst. 
 
In an attempt to determine whether Au(III) is capable of aurating the C-2 position of 







Scheme 65 – Synthesis of 2-deutero N-methyl indole, C-2-2H-168 
 
Following lithiation at C-2, the reaction was quenched with deuterium oxide to afford 
C-2-
2
H-168 with 98% deuterium incorporation. N-Methyl indole was used to 
circumvent the appearance of protons from any other source in the following reactions. 
 





Scheme 66 – Deuterium studies using C-2-2H-168 
 
The reaction proceeds in a comparable time and yield to that using N-methyl indole 
(Scheme 50), however the deuterated product was not observed, with quantitative 
proton incorporation in the product. It was hypothesised that proton incorporation could 
arise from either the use of non-deuterated solvent, or trace amounts of water in the 
reaction. To investigate these variables a range of experiments were carried out.  
 
Table 9 – Deuterium incorporation evaluation 
 
Entry Solvent Time [h] Yield [%] D-incorporation [%] 
1 CD3CN 24 44 0 
2 CH3CN
[a]
 72 36 0 
3 CD3CN
[a]
 72 26 0 
4 CH3CN
[b]
 72 30 0 
5 CD3CN
[b]
 72 28 0 
6 CD3CN
[c]
 72 34 0 
[a] 4 Å MS added [b] silylated reaction vessel used [c] Teflon® reaction vessel used 
 




When the reaction was carried out in deuterated reaction media (Table 9, entry 1), no 
deuterium incorporation was observed in the cyclic product, eliminating the possibility 
of protonation due to solvent. The other possibility was protonation from trace water in 
the reaction, however the inclusion of molecular sieves (entries 2-3) did not stop 
protonation of the product, however reaction times were greatly increased, along with a 
decrease in yield. To eliminate the possibility of protonation from trace protons 
associated with the reaction vessel, silylated (entries 4-5) and Telfon® (entry 6) reaction 
vessels were used, however no deuterium incorporation was witnessed. These findings 
are highly surprising, with no obvious source of protons being responsible for the lack 
of deuterium incorporation in 148.  Another interesting finding is the drastic increase in 
reaction time and lowering of yield when water is fully excluded from the reaction, 
which may indicate that even adventitious water in the nitrogen supply is playing an 
important role in the catalytic cycle. 
 
To try and determine at what point in the reaction protonation of C-2-
2
H-168 was 
occurring, it was subjected to the reaction conditions in a 
1
H NMR experiment.  
 
 
Scheme 67 – Subjection of C-2-2H-168 to reaction conditions 
 
In stark contrast to the C-3-
2
H-168, no decrease in deuterium content of C-2-
2
H-168 
was observed even after four days. It was reasoned that when the C-3 position of C-2-
2
H-168 is unsubstituted, the gold associates with it rather than the less nucleophilic C-2 
position. To test this hypothesis a model substrate was synthesised with similar 
functionality to the actual reaction substrate for use in 
1
H NMR experiments. 
 





Scheme 68 – Synthesis of test substrate 222 for 1H NMR experiment 
  
Even after brief subjection to the reaction conditions, a significant decrease in 
deuterium incorporation is witnessed. This observation, coupled with the previous 
1
H 
NMR experimental results, would indicate that protonation only occurs once the C-3 
position of C-2-
2
H-168 is substituted. 
 
To quantitatively assess the rate of deuterium-exchange of 222, the model substrate was 
resubjected to the reaction conditions and monitored by 
1
H NMR. 
     
 
Scheme 69 – Results of 1H NMR reaction 
 
Figure 15 - 1H NMR monitoring of test substrate 222 under reaction conditions (CD3CN at 20 °C; 400 MHz) ■= 








































Upon subjection to the reaction conditions, the deuterium content of 222 is rapidly 
diminished with the rate of protonation slowing over time, however constant 
degradation of the deuterium content does continue. As was previously demonstrated by 
the formation of the test substrate, the 
1
H NMR experiment reveals that deuterium 
incorporation as C-2 is diminished under the reaction conditions. The time-scale for this 
reduction of deuterium content is considerably faster than the reaction timescale, 
therefore it is possible that protonation occurs before annulation. The replacement of 
deuterium in this test substrate is however slower than that of the C-3-
2
H-168. These 
findings do indicate the possibility of auration at C-2 after the intermolecular alkylation 
of indole, however it is not possible to ascertain whether this is the reactive intermediate 
in the annulation reaction step. It is possible that C-2 auration takes place, but due to the 
sluggish rate of reaction for the annulation step, it is equally feasible that gold(III) co-
ordination to the ynone is the preferred reaction pathway. 
 










Scheme 70 – Proposed mechanism for Liu’s tandem annulation of 1,2-bis(alkynyl)-2-en-1-ones with indole 
As can be seen, this reaction proceeds via 5-endo-dig cyclisation of the carbonyl to 
afford the cationic intermediate 224, which is subsequently trapped by indole. The 
proposed mechanism for the indole/yne cyclisation again supports an alkyne activation 
pathway. 
 
Based on our findings, a tentative mechanism for the overall reaction is proposed. 
 





Figure 16 – Tentative mechanism for the double alkylation of indole by enynones 
 
C-3 auration of indole by gold(III) chloride provides the reactive intermediate 217, 
which is capable of undergoing cuprate-type addition to enynone 147. Protonation of 
mono-addition product 228 regenerates the catalyst, which is then capable of alkyne 
activation. 7-endo-dig cyclisation of 150 gives the aurated tricycle 229, which can be 


















A highly efficient Au-catalysed cascade process is presented, offering access to 
medicinally relevant [6,5,7]-tricyclic indoles. The reaction is operationally simple, 
allowing for the use of technical grade reagents without the exclusion of water or air.  
 
The generality of our transformation allows for a wide range of indoles to be utilised, 
including indoles bearing electron rich and poor functionality, unprotected hydroxyl 
groups as well as function handles for late stage elaboration. Cross-coupling of 165 and 
166 has shown that it is possible to carry out post-cyclisation functionalization of our 
reaction products. Due to the structural modularity of our synthesis, a diverse range of 
enynones have been employed as the double electrophiles in our reaction, with reaction 
generally proceeding in high yield. It has been shown that enynones bearing alkyl 
functionality at the alkyne terminus are inferior substrates for the cascade, requiring 
extended reaction times and higher temperatures to affect annulation.  
 
Whilst undertaking reactions to determine the reaction mechanism, it was found that the 
addition of stoichiometric quantities of water accelerates the rate of reaction for certain 
substrates, and in two cases drastically increasing the yield of reaction. 
 
Through a series of deuterium-labelling experiments, it has been shown that auration of 
indole at C-3 occurs, with cuprate-type addition to the enone responsible for the 
intermolecular alkylation of indole. Studies to elucidate the mechanism of the 
intramolecular cyclisation in our system have shown that auration at C-2 of indole is 
possible when the C-3 position is substituted. It is hypothesised that alkyne activation 
by Au(III) is in fact the reaction pathway due to the reaction rate of annulation 












2.8 Future work 
 
A logical continuation of this body of work would be further elaboration of the enynone 
scaffold. Performing the double alkylation on indole 230 with enynone 147 would allow 
for the rapid construction of indolo-carboxylic acid 146 analogues. 
 
 
Figure 17 – Possible example of a double alkylation of indole-7-carboxylic acid 230  
 
To build up further complexity in our products, cyclic enynones of type 233 could be 
utilised, allowing for the synthesis of tetracyclic scaffolds. 
 
 
Figure 18 – Potential tetracycle 233 formation from cyclic enynone 233 
 
Besides a more comprehensive substrate scope study, an extension of the nucleophile 
scope could examine the application of use alternative electron rich heteroaromatics 
such as N-methylpyrrole 235, 1,2,3-trimethylpyrrole 236 and benzofuran 237. 
 











































3.1.1 Alkynes, ynamines and ynamides 
 
Alkynes are versatile synthetic motifs, made up of a linear C-C triple bond; as such they 




Figure 20 – Example of an alkyne 238, ynamine 239 and ynamide 240 
 
A useful sub-group of alkynes are those containing terminal heteroatom substituents, as 
when utilised in reactions traditionally carried out by alkynes, they allow for the facile 
incorporation of heteroatom containing groups into the reaction products, which allows 
for subsequent transformations.
141
 Nitrogen imparts a strong electronic bias to the 
alkyne due to the ability of nitrogen to donate its lone pair into the alkynyl moiety, 





Figure 21 – Electronic bias of ynamides 
 
The use of ynamines in organic synthesis has been widely studied, with cycloaddition 
reactions having gained the most attention. Ficini et al. reported the formal [2+2] 









Scheme 71 – Cycloaddition of ynamine 241 with cyclohexenone 242 
 
Although ynamines offer expedient routes to complex products, their inherent reactivity 
and sensitivity to hydrolysis have restricted their applications. To increase the stability 
of ynamines, without significantly diminishing their reactivity, electron-withdrawing 
groups have been appended to the nitrogen atom. Ynamides reduce the electron 
donating ability of the nitrogen atom, by incorporating the nitrogen in an electron-
withdrawing group such as oxazolidinones, sulfonamides, carbamates and lactams. 
 
 
Figure 22 – Representative structures of a range of ynamides 
 
This modification increases their stability and therefore increases the potential 
applications of ynamides in organic synthesis. A number of in-depth reviews of 
ynamide chemistry have been published, however only selected gold-catalysed 













3.1.2 Gold-catalysed reactions of ynamides 
 
Cycloaddition 
The vast majority of ynamide chemistry has been focused around cycloadditions, 
forming multiple C-C bonds in one step, allowing access to complex ring scaffolds.  
 
 
Scheme 72 – Gold-catalysed [4+2] cycloaddition of ynamide 245 
 
Although typically using ruthenium complexes to affect cyclisation, gold has been 
shown to be an excellent catalyst for such transformations, with arylynamide 245 






Scheme 73 – Formal [3+2] cycloaddition of ynamide 250 with N-ylide 249 
 
 




Davies et al. envisaged that conjugated N-ylides would not only be able to add to 
ynamides under gold-catalysed conditions, but also quench any aurated intermediate, 
providing formal [3+2] cycloaddition products.
146
 Following auration of ynamide 250, 
addition of N-ylide 249 occurs at the carbon α- to nitrogen of 251, quenching the 
positive charge on nitrogen. Elimination of pyridine affords the gold-carbenoid 
intermediate 253, which undergoes cyclisation and demetalation to afford oxazole 254. 
 
Cycloisomerisation 
Analogous to the reactivity of enynes discussed previously, 1,6 ene-ynamides are 
capable of being activated by gold (I) catalysis.
147
   
 
 
Scheme 74 - 1,6 Ene-ynamide 255 cycloisomerisation 
 
Due to the inherent reactivity imparted by nitrogen, the product expected from the 
cycloisomerisation, 258, is not isolable following flash chromatography. Desilylation 













Two complimentary procedures have been developed for the oxidation of ynamides that 




Scheme 75 – Regioselective oxidation of ynamides 260 and 262 under gold-catalysed conditions 
 
Following auration of the respective ynamides, nucleophilic attack by the external 
oxidant occurs. Expulsion of the cationic group, diphenyl sulphide and pyridine 
respectively, gives a gold carbenoid. In the case of phenyl ynamide 260, a second 
equivalent of oxidant can be incorporated giving α-keto imide 261. Conversely, when 















3.2 Concept development 
 
Propargylic esters have proved to be valuable organic building blocks in the field of 
metal catalysed transformations, particularly in the field of gold catalysis.
150
 Subjected 
to gold catalysis, these molecules undergo either 1,2- or 1,3- acyl migration, leading to 
either [Au]-carbene complex or allene seen in Figure 21.
151
 There are many factors 
which can influence which of these intermediates is formed within a reaction, including 
the propargylic, acetylenic and the acyl substituent, however no general trend has been 
observed.
152
 Interestingly, research by Cavallo et al. has shown that both the carbene 
and allene can be easily interconverted, indicating that substrate substitution will 
influence which of these intermediates react further.
151
   
 
 
Figure 23  – Potential reaction pathways for the gold-catalysed acyl migration of propargyl esters  
 
These intermediates are highly reactive and allow for further transformations to be 
conducted. We envisaged that the gold catalysed rearrangement of ynamido esters 
would allow for regioselective 1,3-acyl migration due to the electronic bias of the 
ynamide. This reaction would provide acyloxy-allenamides seen in Figure 22, which are 
previously unreported. 
.   
 
Figure 24 – Hypothesised allenamide product from the gold-catalysed reaction of ynamido esters. 




3.2.1 Retrosynthetic analysis 
 
In order to evaluate the viability of a gold-catalysed ynamide rearrangement, synthesis 
of a model ynamido ester was required. Performing a reterosynthetic analysis of 264, it 
can be envisaged that ynamido alcohol 266 would be a suitable precursor, synthesied by 
simple ester formation. In turn, ynamido alcohol 266 should be readily accessible from 




Figure 25 – Reterosynthetic analysis of ynamido ester 264 
 
Hsung et al. have reported a general synthesis of ynamides, with primary ynamido 
propargylic alcohols being synthesized in good yield.
153
 This method involves the 
copper-catalysed coupling between a sulfonamide and bromoalkyne.  
 
 
Scheme 76 – Hsung’s synthesis of protected ynamido alcohol 269 
 
This method appears to be a viable route for the synthesis of the required synthetic 
intermediate, with bromoalkyne 272 readily formed via the NBS-promoted bromination 









3.3 Synthesis of model substrate 
 
With literature precedence for the formation of ynamido alcohol 266, silylation of 
propargylic alcohol 267 was first required. Unfortunately silylation under standard 






Scheme 77 – Failed hydroxyl protection 
 
After further investigation, a set of alternative conditions were discovered for the 
silylation step, using triethylamine as the base, with these conditions providing the 





Scheme 78 – Synthesis of protected alcohol 271 
 
With the protected alcohol 271 in hand, bromination was attempted using 
Barbazanges’s conditions for the bromination of TMS-acetylene.155 It was found that 
recrystallisation of N-bromosuccinimide prior to use in the reaction, increased the yield 
of bromoalkyne 272 from 81% to 88%. Favourably, both this and the previous reaction 
can be carried out on large scale (~50 grams) without any loss of yield. 
 
 
Scheme 79 – NBS promoted bromination of terminal alkyne 271 




With the synthesis of the bromo-alkyne 272 completed, it was now necessary to couple 
this product with oxazolidin-2-one 273 to afford ynamide 274. It was found that 
following the procedure laid out by Hsung failed to give satisfactory yields (Table 10, 
entry 1), with large quantities of starting material remaining even after 48 hours.
156
 An 
investigation into the reaction conditions was therefore undertaken in an attempt to 
improve on the literature conditions. 
 
Table 10 – Ynamide formation optimisation 
 
Entry x  [mol%] y  [mol%] Temp [°C] Yield [%] 
1 5 10 60 42 
2 20 40 60 51 
3 20 40 110 64 
4 40 80 110 65 
5 100 200 110 63 
 
At 60 °C, increasing the catalyst loading provided marginally increased reaction yield 
(Entry 2), however, when increased temperatures were employed the yield was again 
improved (Entry 3). The ability to isolate and recycle any remaining starting material 
from this reaction compensates for the lower reaction yields. 
 
Fluoride promoted deprotection of ynamide 274 was then carried out to allow for the 









Scheme 80 – Fluoride promoted deprotection of ynamido alcohol 266 
 
It became apparent that the temperature at which the TBAF is added to the reaction is 
vital, with addition at ambient temperature only providing a 65 %. When the reaction 
was carried out at 0 °C, the fluoride-promoted deprotection gave alcohol 266 in 87 % 
yield after just one hour.  
 
Although many methods of esterification would be appropriate for the formation of 264, 
the by-products of EDCi promoted couplings can conveniently be removed from the 
reaction mixture through weak acid-base extraction, with products often needing no 
further purification.  Coupling of alcohol 266 and phenylacetic acid 265 under 
conditions developed in the Carbery group gave the required ynamido ester in good 



















3.4 Reaction optimisation 
 
With the model substrate in hand, we attempted the formal [3,3]-rearrangement of 
ynamido ester 264. It was decided that a cationic gold(I) catalyst would be optimum for 






Scheme 82 – Initial reaction 
 
Upon addition of the catalysts, instant consumption of the starting material was 
witnessed, with TLC analysis of the crude reaction mixture showing three products. 
Trace amounts of 275 were isolated from the crude reaction mixture, potentially formed 
by the hydrolysis of the hypothesised allenamide intermediate 276.  
 
 
Figure 26 – Hypothesised mechanism of hydrolysis towards the formation of 275 
 
Although one product from the reaction had been isolated, TLC analysis of the crude 
reaction mixture had shown the formation of two additional products. Attempts to 
isolate these products by flash chromatography proved unsuccessful with no mass being 
returned even following a methanolic flush. Efforts to isolate these additional reaction 
products by alumina chromatography proved equally fruitless, with recrystallisation 
unfeasible due to the lack of crysallinity of the products. 
 




It was hypothesised that the desired allenamide 276 was being formed as part of the 
reaction, but due to its inherent reactivity, it is possible that the cationic gold(I) complex 
was capable of catalysing subsequent reactions of this intermediate.  
 
 
Figure 27 – Proposed reaction intermediate 
 
Kimber et al. have shown it is possible to use cationic gold(I) complexes to catalyse the 





Scheme 83 – Gold-catalysed nucleophilic addition to allenamide 277 
 
We believed it may be possible to carry out a tandem gold(I)-catalysed transformation, 
with nucleophilic addition to allenamide 275 following the formal [3,3]-rearrangement.  
Interception of allenamide 275 with indole 72 should reduce the reactivity of the 
products, allowing for purification of the reaction products, with the advantage of 
incorporating the indole nucleus into our scaffold. 
 
 
Scheme 84 – Tandem rearrangement and nucleophilic addition to afford enamide 279 
 




The tandem process gave enamide 279 as a single regioisomer in modest yield, 
confirming that allenamide 276 is indeed formed in our reaction. Although the 
nucleophilic addition of indole does occur, a large quantity of the starting material is 
still converted into the two unidentified products. To increase the yield of enamide 279, 
a number of reaction variables were investigated. 
 
Table 11 – Reaction optimisation 
 
Entry Additive Temp [°C] Time [min] Yield [%] 
1 AgSbF6 25 5 32 
2 AgPF6 25 5 59 
3 AgPF6 0 20 62 
4 AgPF6
[a] 
0 20 61 
5 AgPF6 -30 45 63 
6 AgPF6 -78 180 0 
7 AgPF6 -30 to 25 45 52 
8 AgPF6
[b] 
-30 45 70 
9 AgPF6
[b],[c] 
-30 45 93 
[a] concentration = [0.2 M], [b] catalysts added portionwise, [c] fresh AgPF6 used 
 
An improvement of yield is witnessed on changing to silver hexafluorophosphate (Table 
11, entry 2), although the two unidentified products were still present. In order to slow 
the formation of the side products, the reaction was cooled to 0 °C, however no 
appreciable increase in yield was observed (entry 3). Cooling the reaction to -30 °C 
provided no increase in yield, however, no side products were formed, with the 
remaining mass returned as starting material (entry 5). Further cooling of the reaction 
resulted in no reaction due to catalyst insolubility (entry 6). As starting material 
remained on reaction at -30 °C, a reaction was initiated at low temperature and 
subsequently warmed to room temperature. Although all starting ynamide 264 was 




consumed, a decrease in yield was observed, with the two side products being formed 
(entry 7). It was noted that at -30 °C, the catalyst was sparingly soluble in the reaction 
mixture, potentially accounting for the return of starting material at this temperature. 
Addition of the catalyst portionwise to counteract this observation gave an increase in 
yield to 70% (entry 8). It is worth noting at this point that silver hexafluorophosphate is 
highly hygroscopic, rapidly becoming liquid under atmospheric conditions. When a 
fresh batch of the silver hexafluorophosphate was used under our optimised conditions a 
dramatic increase in yield of enamide 279 was witnessed. 
 
3.5 Nucleophile scope 
 
With optimised conditions discovered for the tandem gold-catalysed reaction of 
ynamido esters and indole, it was decided to assess the generality of this process. To 
this end, a range of functionalised indoles were reacted with ynamide 264. 
 
Table 12 – Indole scope 
 
Entry Indole Product Yield [%] 
1 5-Me 280 89 
2 5-I 281 92 




5 6-OMe 284 92 
 
Electron neutral indoles perform the addition well, proceeding in high yield (Table 12, 
entries 1-3), with 5-iodo indole allowing for further elaboration of the reaction product 
281 (entry 2). Electron poor indoles also undergo the reaction, affording 283, however, 
reaction yield is reduced. The decrease in yield may be due to the decreased 
nucleophilicity of the indole slowing the addition reaction, allowing for the formation of 




side-products (entry 4). The reaction is also tolerant of alternate indole substitution, as 
demonstrated by the formation of 284.  
 
Although the reaction affords a single geometrical isomer, analysis of the reaction 
products by 
1
H NMR did not provide sufficient information to determine the absolute 
alkene geometry of the product. Enamide 281 was found to be crystalline, with single 





Figure 28 - XRD analysis of of tricycle 281 
 
3.5.1 Alternative nucleophiles 
 
Kimber et al. have shown it is possible to utilise a range of nucleophiles for the addition 
to allenamides, including electron-rich aromatics, anilines, N-methyl pyrrole and 2-
methyl furan.
160
 In order to assess the scope of our reaction with regards to the 
nucleophilic addition, a range of nucleophiles were employed in our tandem process. 
 





Scheme 85 – Attempted addition of 4-methoxyaniline 285 to ynamido ester 264 
 
Although Kimber has shown aniline can undergo addition to allenamides (Scheme 83), 
when subjected to our optimised reaction conditions, none of the desired product was 
observed, with the reaction exclusively providing the hydrolysis product 275. This may 
indicate that 4-methoxyaniline is not nucleophilic enough to trap our allenamide before 
it undergoes further transformations. This mirrors the findings seen when using methyl-
indole-5-carboxylate (Table 12, entry 4), as although the desired product was formed, 
substantial quantities of by-product were also formed, indicating that reaction success is 
highly dependent on the nucleophilicity of our nucleophile. 
 
 
Scheme 86 – Alternative nucleophiles afford exclusively hydrolysis product 275 
 
Both 2-methyl furan 286 and 1,3,5-trimethoxybenzene 287 gave the hydrolysis product 
275 seen in previous reactions, suggesting that they may also not be nucleophilic 









3.6 Ynamido ester scope 
 
Having demonstrated the scope of reaction with regards to the nucleophile employed, a 
range of ynamido esters were synthesised to determine the scope of the gold-catalysed 
[3,3]-rearrangement. 
 
Table 13 – Carbodiimide promoted esterifications 
 
Entry R Product Yield [%] 
1 4-MeC6H4 288 74 
2 4-OMeC6H4 289 79 
3 4-NMe2C6H4 290 68 
4 4-FC6H4 291 57 
5 4-IC6H4 292 71 
6 3,4-(O2CH2)C6H3 293 60 
 
 
Utilising the same methodology as previously employed in the synthesis of our test 
substrate, a range of aromatic esters were synthesised to explore the electronic 
limitations of the reaction (Table 13).  Electron rich, neutral and poor substrates were 
prepared by carbodiimide promoted esterification, in an aim to probe the electronic 
requirements of our reaction. An acetate ester analogue 295 was prepared via an 










Scheme 87 – Acetate ester 295 synthesis 
 
With the required substrates in hand, the scope of the ynamido ester rearrangement was 
explored using our optimised conditions. 
 
Table 14 – Indole scope 
 
Entry Substrate R Product Yield [%] 
1 288 4-MeC6H4 296 85 
2 289 4-OMeC6H4 297 74 
3 290 4-NMe2C6H4 298 87 
4 291 4-FC6H4 299 79 
5 292 4-IC6H4 300 92 
6 293 3,4-(O2CH2)C6H3 301 56 
7 295 H 302 89 
 
 
As can be seen the reaction tolerates electron rich and neutral substrates, with methoxy- 
and dimethylamino- substrates reacting well (Table 14, entries 2-3). Halogenated 
substrates also smoothly undergo rearrangement and nucleophilic addition (entries 4-5), 
with 300 allowing for future functionalisation of the reaction products. When 
piperonylic acid derived substrate 293 is used the yield is lowered (entry 6), this may be 
due to the addition of steric bulk in the meta-position. Alkyl ester 295 was also capable 




of undergoing the [3,3]-rearrangement, affording 302 in excellent yield, demonstrating 
that phenylacetic esters are not necessary for reaction success. 
 
3.6.1 Chirality transfer  
 
Many catalytic methods exist for the enantioselective formation of complex molecules, 
many of which rely on the use of chiral ligands to induce chirality in the final product. 
An alternative method for the formation of chiral molecules involves the transfer of 
chirality from a substrate through to the desired product. 
 
Due to their availability, and ability to be prepared with high enantioselectivity, chiral 
propargylic alcohols have garnered much attention in gold-promoted asymmetric 
transformations.
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 Toste et al. have demonstrated the gold(I)-catalysed [3,3]-Claisen 






Scheme 88 – Chirality transfer in the Claisen rearrangement of 303 
 
Allenes have also been shown to be capable of transferring their chirality to their 
products, with Yamamoto et al. reporting both a gold(I)-catalysed intramolecular 










Scheme 89 – Allene chirality transfer 
 
Reactions such as these highlight the ability of gold to catalyse enantioselective [3,3]-
rearrangements as well as the ability to promote the nucleophilic addition to allenes 
with retention of stereochemistry. This led us to hypothesise that, starting from a 
suitable chiral propargylic alcohol, it may be possible to achieve chirality transfer from 
an ynamido ester to the intermediate allenamide by formal [3,3]-rearrangement. 
Subsequent chirality transfer in the nucleophilic addition of indole to allenamide 275 
could potentially lead to enantioenriched enamide products.  
 
 
Scheme 90 – Chiral substrate synthesis 
 




To this end, starting from (S)-propargylic alcohol (S)-267, a chiral substrate was 
prepared to test this hypothesis. Following our optimised route for the synthesis of 
ynamido esters, optically active ynamide (S)-264 was prepared in good yield. 
Subjection of (S)-264 to our optimised reaction conditions afforded enamide 281 in 
good yield, however no optical activity of the product was witnessed, implying a loss of 
stereochemical information during our transformation.  
 
 
Scheme 91 – Attempted chirality transfer in the reaction of (S)-264 
 
The loss of optical activity in our molecule may be explained by the structure of the 
intermediate allenamide formed in the reaction. Fensterbank et al. have reported that 
gold allene complexes generally adopt two types of structure, depending on the 





Figure 29 – Potential intermediates of types 310, 311 and 312 formed during the synthesis of 281 
 
The stereochemical information is retained in species 310, however, the axial chirality 
of the allene is lost in species 311 and 312. It may therefore be possible that although 
the reaction is concerted, providing a chiral allenamide, the intermediate gold-allene 
complex is no longer chiral, denying chirality transfer during the intermolecular 
addition of indole to the allenamide intermediate. 
 
 




3.6.2 Alternative ynamides 
 
To further expand the scope of our tandem process it was decided to incorporate the 
nitrogen of our ynamide into a sulfonamide. Sulfonamide containing ynamides have 
been utilised extensively in ynamide chemistry, and this modification to our substrate 
would explore the scope of our reaction with regards to the electronic withdrawing 
nature of our ynamido esters. To this end, sulfonamide 315 was synthesised according 
to a modified route from the synthesis of the oxazolidinone analogues.     
 
 
Scheme 92 – Synthesis of sulfonamide 315 
 
In conjunction with our other studies it was found that although the coupling of 
oxazolidinone works well under Hsungs’ conditions, the coupling of alternative 
ynamides works with mixed success. Utilising conditions reported by Danheiser et al.
165
 
provides the desired ynamide 313 in good yield, with subsequent deprotection and 
esterification providing the desired ynamido ester 315. 
 





Scheme 93 – Hydrolysis during the reaction of 315 
 
When subjected to our optimised conditions, hydrolysis of sulfonamide 315 occurs to 
give 316 in near quantitative yield. The formation of 316 implies that the intermediate 
allenamide formed in this reaction is less reactive towards nucleophilic addition than the 






























A novel gold-catalysed tandem reaction of ynamido esters has been reported, with 
formal [3,3]-rearrangement of affording allenamide intermediates which undergo 
nucleophilic addition by indole. 
 
Through the process of reaction optimisation it was found that suppression of side-
product formation is essential for reaction success, with allenamide intermediates 
having to be “trapped” at -30 °C to afford the resultant enamide products in high yields. 
 
A range of functionalised indoles were used for the intermolecular trapping of the 
reaction intermediates, affording the resultant enamide products in excellent yield, with 
all products being formed as single regioisomers. The use of 4-methoxyaniline 285, 2-
methylfuran 286 and 1,3,5-trimethoxybenzene 287 all resulted in the formation of an 
undesired side product, potentially from the hydrolysis of the allenamide intermediate. 
 
An investigation into the ester portion of our molecule revealed the reaction is tolerant 
of a wide range of phenyl acetate esters, as well as an alkyl variant. 
 
Under our optimised conditions, chiral ynamido ester (S)-264 did not provide chirality 
transfer through to the product, potentially indicating that the reaction proceeds through 
intermediates that lead to loss of stereochemical information.   
 
The use of sulfonamide 315 led exclusively to the formation of hydrolysis product 316, 
implying that the gold-catalysed nucleophilic addition to the intermediate allenamide is 













3.8 Future work 
 
A logical extension of this work would be to attempt to halt the formation of the 
hydrolysis by-products from this reaction, which may be achieved by the use of strictly 
anhydrous conditions. This has the potential to increase the time for the intermediate 
allenamide to react with the respective nucleophiles before side-products are formed. 
 
Another area of study might focus on an investigation into the identity of the side-
products formed during the reaction at ambient temperature, with an aim to forming 
products which may be purified by recrystallization to avoid the need for 
chromatography. 
 
In an attempt to carry out our tandem process enantioselectively, a chiral gold(I) catalyst 
may be employed. Widenhoefer et al. have demonstrated the enantioselective addition 





















4.1.1 The Ireland-Claisen rearrangement 
 
The first thermal rearrangement of aliphatic and aromatic allyl vinyl ethers was 





Scheme 95 – Example of an aliphatic and aromatic Claisen rearrangement 
 
Although examples of ester enolate Claisen reactions had been previously reported, the 
first by Tseou and Wang in 1937, they suffered from poor yields and the need for 
forcing reaction conditions.
168
 Since that initial discovery in 1937 there were reports of 
similar rearrangements that made use of sodium metal, sodium hydride and Et2NMgBr 





Scheme 96 – Mechanism for the Ireland-Claisen rearrangement 
 
The Ireland-Claisen rearrangement is a variant of the Claisen [3,3]-sigmatropic 
rearrangement, first reported in 1972 by Robert Ireland, whereby an allylic ester is 
subjected to a lithium dialkylamine base in the presence of a silylating agent at low 
temperature.
170
 The silyl ketene acetal formed suppresses alternative reaction pathways 




such as Claisen-type condensation and decomposition via a ketene pathway, allowing 
the desired [3,3]-sigmatropic rearrangement to occur. γ,δ-Unsaturated carboxylic acid 
products are afforded following protic workup. 
 
4.1.2 Alkynyl Claisen & Ireland-Claisen Rearrangements  
 
Although not as prominent, the Claisen and Ireland-Claisen rearrangements have also 
been carried out on substrates containing alkynes. The first example of which was 
reported by Harfenist in 1971, where 4-(prop-2-ynyloxy)aniline 324 was converted to 
the corresponding chromene 326.
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 After the initial Claisen rearrangement, 





Scheme 97 – First Alkynyl Ireland-Claisen rearrangement 
 
As with the alkene Claisen rearrangement, alternative heteroatoms can be employed in 
the linker to furnish new products. This was shown by Saito and Hanzawa, in which 
they replaced the propargyl ether with propargylic anilines.
172
 The resultant indoles 
formed are valuable synthetic building blocks, ubiquitous in the field of natural products 
and pharmaceutical compounds. 
 
 





Scheme 98 – Propargyl anilines in the Ireland-Claisen rearrangement 
 
The above reaction was believed to proceed via an allene intermediate; however no 
efforts were made to isolate this intermediate. Studies by Wang et al. enabled the 

























4.2 Concept development 
 
The Carbery group has previously published a novel Ireland-Claisen rearrangement of 






Scheme 100 – Example of an enamide Ireland-Claisen rearrangement 
 
The importance of development of novel methods for the synthesis of β-amino acids is 
highlighted by their reduced susceptibility to proteolytic degradation when compared to 
α-amino acids. This has allowed for their incorporation into a number of pharmaceutical 
molecules, with Taxol 334 showing favourable properties in cancer chemotherapy. The 
β-amino acid side chain has been shown to be necessary for biological activity.175  
 
 
Figure 30 – Taxol 334, β-amino acid side-chain highlighted in red 
 
It was hypothesised that ynamido esters may undergo a similar reaction to the enamido 
Ireland-Claisen rearrangement, yielding 2,3-substituted β-amino acids, containing an 
allene at the 3-position. This transformation would offer unique functionality for β-
amino acids, allowing for further functionalisation of  the reaction products. 
 





Scheme 101 – Hypothesised product of an ynamide Ireland-Claisen rearrangement 
 
4.3 Initial investigations 
 
Having a clear rationale for the development of the ynamido Ireland-Claisen 
rearrangement, the ynamido ester 263, previously utilised in the gold(I)-catalysed 
rearrangement of ynamido esters, was selected as a test substrate. 263 was then 
subjected to the groups’ optimised rearrangement procedure in order to evaluate the 
viability of an ynamido Ireland-Claisen rearrangement. 
 
 
Scheme 102 – Decarboxylation following the Ireland-Claisen rearrangement of ynamido ester 263 
 
The hypothesised outcome of this reaction was β2,3-amino acid 336, however, the 
isolated product was conjugated diene 335, with the mass balance being made up of 
starting material 263. It was postulated that the expected product is being formed in the 
reaction, but due to the inherent reactivity of the allenamide, decarboxylation occurs 
post-rearrangement. To account for the observed product, a tentative mechanism is 
proposed. 
 





Figure 31 – Proposed mechanism for the formation of amino diene 335 
 
Following the formation of the silyl ketene acetal 337 and subsequent [3,3] sigmatropic 
rearrangement, the reaction is quenched with 1M HCl/brine. At this point the 
trimethylsilyl-oxygen bond is cleaved, giving the free carboxylic acid 338. The nitrogen 
can then donate its lone pair into the nitrogen-carbon bond, forming an iminium ion, 
allowing a [1,5] hydride shift to occur, leading to decarboxylation and quenching of the 
iminium ion. 
13
C NMR analysis of the crude reaction mixture shows no signals 
indicative of allene 336. This is the first example of an ynamido Ireland-Claisen 
rearrangement, with the intermediate 338 undergoing facile decarboxylation at ambient 
temperature. 
 
4.3.1 Literature precedence 
 
Baldwin et al. have shown that under forcing conditions the products of alkynyl Ireland-









Scheme 103 – First decarboxylative alkynyl Ireland-Claisen rearrangement 
 
This was the first examples of a decarboxylative Ireland-Claisen rearrangement, and it 
was believed that after the initial [3,3] sigmatropic rearrangement, a [1,5] hydride shift 
occurred facilitating the decarboxylation. The disadvantage of this reaction is that it has 
to be carried out under extremely forcing conditions, with temperatures as high as 250 
°C being employed in order to give the desired product 339. Since this initial discovery 
a handful of decarboxylative Ireland-Claisen variants have been reported. 
 
Craig showed that it was possible to achieve similar results using allylic α-
tolylsulfonylacetate esters as the rearrangement substrates; however this still required 





Scheme 104 – Ireland-Claisen rearrangement of allylic α-tolylsulfonylacetate ester 340 
 
When allylic tosylmalonate esters were employed under the same conditions it was 





Scheme 105 – Ireland-Claisen rearrangement of allylic tosylmalonate ester 342 
 




The addition of an extra electron withdrawing group at the enolisable centre is thought 
to weaken the carbon-carbon bond to the carboxylic acid group after rearrangement 
therefore making decarboxylation a more facile process.  
 
4.4 Reaction optimisation 
 
With this promising result in hand, it was decided to undertake a series of experiments 
to optimise the formation of the diene product 335. As a large quantity of starting 
material remained after the Ireland-Claisen rearrangement shown in scheme 102 the 
reaction time was extended to allow for further consumption of starting material.  
 
Table 15 – Initial reaction optimisation 
 
Entry Solvent x (equiv.) Time [h] Yield [%] Z/E 
1 THF 1.3 24 40 >95:5 
2 THF 1.3 48 41 >95:5 
3 THF 0 24 0 >95:5 
4 Toluene 1.3 24 13 >95:5 
5 THF
[a]
 1.3 24 25 >95:5 
[a] NaHMDS used 
 
Extended reaction times were found to increase the yield of diene 335 significantly; 
however extending the reaction timescale to two days offered no further conversion. 
Omission of chlorotrimethylsilane was detrimental to the reaction, with no product 
being isolated. Substitution of tetrahydrofuran with toluene diminishes the yield, as does 
the replacement of LiHMDS with NaHMDS. Sodium may give a less ordered transition 
state than the lithium base following enolate formation, as it co-ordinates less strongly 
than lithium, which may impact reaction yield. It should also be noted that the 
remaining starting material can be reclaimed from the reaction mixture and recycled. 





In an effort to increase the yield further, the temperature of deprotonation was explored, 
with the reactions only being allowed to proceed for 90 minutes to allow for the rapid 
comparison of conditions.  
 
Table 16 – Investigation into reaction initiation temperature 
 
Entry Temp (°C) Yield (%) Z/E 
1 -95 21 >95:5 
2 -78 10 >95:5 
3 -40 0 n/a 
4 -20 0 n/a 
5 0 0 n/a 
 
It can be seen that by increasing the initiation temperature of the reaction that no diene 
335 is formed, instead returning quantitative amounts of starting material. Conversely, 
decreasing the reaction temperature provides a significant increase in yield. Although it 
would be expected that deprotonation of 263 would occur more rapidly at increased 
temperature, the reaction is not furnishing diene 335 at temperatures above -78 °C. It 
has been shown that the secondary amine, in this case HMDS, generated in situ from the 
enolisation of carbonyl compounds, has an effect upon the reactivity of the enolate 
formed.
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 This has been highlighted by the addition of a deuterating reagent to the 





Scheme 106 – Example of internal proton return (IPR) 





Instead of the desired α-deutero ester 347, the major reaction product is the re-
protonated ester 345. It is believed that the secondary amine generated in the reaction is 
responsible for the returned starting material, by a process termed “Internal Proton 
Return” (IPR). Work within the Carbery group, focussing on the enamido Ireland-
Claisen rearrangement, has also highlighted the importance of IPR within the Ireland-
Claisen rearrangement.
181
 It is believed that the observed return of 263 in our reaction, 
at temperatures exceeding -78 °C may be due to HMDS mediated IPR to the enolate, 
silylketene acetal or both. 
 
As starting material was still being isolated from the ynamido Ireland-Claisen 
rearrangement it was believed that increasing the equivalents of base used for the initial 
deprotonation of 263 would increase the yield of the reaction. 
  
Table 17 – Base screen 
 
Entry LiHMDS (equiv.) TMSCl (equiv.) Yield (%) Z:E 
1 5.2 5.2 0 n/a 
2 2.6 2.6 31 1:1 
3 2.3 2.3 40 3:1 
4 2 2 42 5:1 
5 1.8 1.8 83 8:1 
6 1.3 1.3 61 >99:1 
7 1.05 1.05 19 6:1 
 
It can be observed that when a large excess of base is used no product is obtained, and 
unlike all the other examples, no starting material can be recovered from this reaction. 
Lowering the equivalents of base increases the yield of diene 335, however, now the 
reaction provides a mixture of Z:E isomers. When 1.8 equivalents of base are used the 




maximum yield for the reaction is achieved with good selevtivity. As seen previously, 
the use of 1.3 equivalents of base provides the product as a single isomer in good yield. 
When near stiochiometric amounts of base are employed, the yield of 335 drops sharply 
to 19 % as well as the Z:E ratio decreasing. Interestingly, an alternative product can also 
be isolated from this rearrangement. 
 
 
Scheme 107 – Lactone 348 formation in the ynamido Ireland-Claisen rearrangement of 263 
 
The lactone 348 formed as part of this reaction has only been isolated when 1.05 
equivalents of base has been used for the rearrangement. It is believed that the lactone is 
formed through intermolecular attack of the carboxylic acid onto allene 336, mirroring 





















4.5 Ynamido ester scope 
 
With optimised conditions for the rearrangement of 263, it was decided to probe the 
scope of the reaction with regards to the substitution of the ester fragment of the 
substrate. In order to assess the generality of our ynamido Ireland-Claisen 
rearrangement, a range of ynamido esters, with varying electronic and steric demands, 
were first synthesised. 
 
Table 18 – Ynamido ester synthesis 
 
Entry R Product Yield [%] 
1 4-ClC6H4 349 84 
2 4-NO2C6H4 350 82 
3 3-MeC6H4 351 60 
4 2-MeC6H4 352 58 
5 CH2CH3 353 83 
 
Halogenated substrate 349 was prepared, along with electron-withdrawing ester 350 to 
explore the electronic demands of our rearrangement (Table 18, entries 1-2). To assess 
if alternate substitution patterns would be tolerated in the reaction, tolyl regioisomers 
351 and 352 were synthesised (entries 3-4). An alkyl variant 353 was also synthesised 
to determine if the reaction would tolerate alternate ester functionality (entry 5). Along 
with ynamido esters synthesised for our gold(I) catalysed rearrangement, these new 
esters were subjected to our optimised conditions. 
 
 




Table 19 – Substrate scope for ynamido Ireland-Claisen rearrangement 
 
Entry Substrate R Product Yield [%] Z:E 
1 289 4-NMe2C6H4 354 53 >95:5 
2 288 4-OMeC6H4 355    62
[a] 
9:1 
3 292 3,4-(O2CH2)C6H3 356 69 2:1 
4 290 4-FC6H4 357 67 3:1 
5 349 4-ClC6H4 358 65 4:1 
6 350 4-NO2C6H4 359 54 2:1 
7 287 4-MeC6H4 360 73 3:1 
8 351 3-MeC6H4 361 42 6:1 
9 352 2-MeC6H4 362 43 2:1 
10 353 CH2CH3 363    32
[a] 
>95:5 
[a] 1.3 equivalents of LiHMDS used 
 
Electron rich substrates 289 and 288 rearrange in good yields, providing high levels of 
Z:E selectivity in the diene products 354 and 355 respectively (Table 19, Entries 1 and 
2) with methoxyester 288 giving the best results when treated with 1.3 equivalents of 
base. Piperonylic ester 292 rearrangement proceeded in high yield, however Z:E 
selectivity was lower than that seen for the other electron-donating esters. Halogenated 
substrates 290 and 349 all rearrange smoothly providing the respective dienes, 357 and 
358, in good yield (entries 3-5). Interestingly, the Z:E ratios for these substrates are 
lower than that for the electron-rich substrates. Electron-poor ester 350 was shown to 
rearrange well, albeit with poor Z:E selectivity. Tolyl regioisomers all proceeded to give 
the respective diene products, however meta- and ortho-products, 361 and 362 
respectively, afforded poorer yields than the para-tolyl product 360. Pleasingly, alkyl 
ester 351 rearranged as a single isomer 363, however reaction yield is diminished 
compared to the aromatic analogues.  
 




A possible rationale for the observed reactivity may be due to the stability of the 
respective enolates formed from both the aromatic and alkyl ynamido esters.  
 
 
Figure 32 – Enolates generated from 263 and 353 respectively 
 
Enolate 364 may be more stable due to the ability to delocalise the negative charge 
throughout the aromatic system, which enolate 365 cannot do. The Ireland-Claisen 
rearrangement requires the silylation of the enolate intermediate, forming a silylketene 
acetal, to halt the degredation of the intermediate enolate. As enolate 364 is more stable 
than 365, it may be longer lived, thus allowing for a higher level of silylketene acetal 
formation, manifesting in an increased yield of the Ireland-Claisen rearrangement 
product. 
 
 4.5.1 Accounting for observed geometrical isomers 
 
In order to account for the formation of geometrical isomers during the ynamido 
Ireland-Claisen rearrangement, the following model is proposed. Starting from (R)
*
-
263, two possible silylketene acetals can be formed, with E-silylketene acetal 366 
leading to syn-368, and Z-silylketene acetal 367 affording anti-368. These 
diastereomers are each capable of adopting two conformations, minimising 1,2- and 
1,3-allylic strain respectively. Following decarboxylation, the intermediates generated 
from minimising 1,3-allylic strain afford the opposite enamide geometry to that 
observed in our reaction. This indicates that the reduction of 1,2-allylic strain is more 
important during this transformation. The diastereomers formed from both E- and Z- 
silylketene acetals may adopt the conformations seen in scheme 108, resulting from the 
minimisation of 1,2-allylic strain, which ultimately decarboxylate to afford the major 
and minor geometrical isomers of 335. The observed major product from our 




rearrangement can be seen to arise from the rearrangement and decarboxylation of the 
E-silylketene acetal 366.  
 
 
Scheme 108 – Potential intermediates in the ynamido Ireland-Claisen rearragement 
 
Studies within the Carbery group, following the formation of aryl-substituted 
silylketene acetals by 
1
H NMR, have shown that at low temperatures (-95 °C), E-
silylketene acetals are formed exclusively; however at this temperature conversion 
remains low. Upon warming, there is a significant degredation in the E/Z silylketene 




acetal ratio, along with a marked increase in the consumption of the starting material.
182
 
The temperature at which silylation of the enolate formed during the Ireland-Claisen 
rearrangement is therefore key to the E/Z silylketene acetal ratio, and the subsequent 
geometrical isomer ratio of the diene product 335. In addition to this, it was found that 
many other factors also affect the E/Z ratio of phenylacetate derived silylketene acetals, 
including the initiation temperature, nature of the ester alkoxy moiety and the loading of 
silylating agent.  
 
Although this model accounts for the formation of the major and minor geometrical 
isomers formed during the ynamido Ireland-Claisen rearrangement, additional studies 
would be necessary to be able to rationalise the observed Z/E ratios of the diene 
products fromed as part of the ynamido Ireland-Claisen rearrangement. 
 
4.6 Alternative N-protection in the ynamido Ireland-Claisen rearrangement 
 
With the aim of enhancing the synthetic utility of the ynamido Ireland-Claisen 
rearrangement, the synthesis of an alternative ynamido ester was investigated to probe 
the effect on reactivity of modulating the electronic donating ability of the ynamide 
nitrogen. To allow for the cleavage of the ynamide fragment post rearrangement, p-
tolylsulfonamide was selected (cleaved by Mg/MeOH).
183
 The other N-substituent could 
be fulfilled by an allyl group (cleaved by Wilkinson’s catalyst), allowing for orthogonal 









Scheme 109 – Synthesis of sulfonamide 373 
Utilising the procedure for the synthesis of our model ynamide substrate 263, 
sulfonamide 371 was prepared from bromoalkyne 271. The initial Ullman coupling 
proceeded in good yield, with subsequent deprotection and carbodiimide promoted 
esterification affording sulfonamide 373 in good yield. Having synthesised the required 
substrate, it was subjected to our optimised reaction conditions. 
 
 
Scheme 110 – Ireland-Claisen rearrangement of sulfonamide 373 
 
Although 373 rearranges with associated decarboxylation, the yield for this reaction is 
poor compared to those of oxazolidinone ynamides. A possible rational for such 
disparities in reactivity between the allylsulfonamide and oxazolidinone containing 
substrates could be attributed to the pKa of the respective parent amines. As previously 
discussed in the hypothesised mechanism of this reaction; the ability for the nitrogen 




lone-pair to be donated into the alkyne is key for the decarboxylation to occur. 
Allylsulfonamide 370 has a lower pKa (~16.1 in DMSO) than oxazolidinone 272 (~20.8 
in DMSO),
185
 implying that the nitrogen lone pair in the sulfonamide is less available, 
and therefore less able to be donated into the alkyne system.  
 
4.7 Diels-Alder reaction of Ireland-Claisen product 335 
 
To establish the synthetic utility of the products formed as part of this work, a Diels-
Alder reaction was attempted on the diene formed from the Ireland-Claisen 
rearrangement. Following the procedure developed by Hsung et al. for the Diels-Alder 






Scheme 111 – Attempted Diels-Alder reaction of 335 
 
Unfortunately, the cycloaddition failed to occur, with quantitative starting material 
being isolated from this reaction.  In order for this Diels-Alder reaction to proceed, the 
diene 335 must adopt the cis-conformation to allow for required interaction with the 















A novel ynamido variant of the Ireland-Claisen rearrangement has been reported, the 
products of which undergo facile decarboxylation at ambient temperature, which is 
unprecedented for systems of this type.  
 
An extensive programme of optimisation has been undertaken to increase the synthetic 
utility of this reaction, with good yield and high Z:E selectivities possible for ynamido 
ester 263. 
 
A range of electronically differentiated arylacetate ynamido esters have been 
synthesised and rearranged, showing our reaction protocol to be general with respect to 
the ester fragment of our ynamides. Attempts to alter the ynamide moiety have proved 
unsuccessful, with sulfonamide 373 rearranging in poor yield. 
 
Attempted Diels Alder cyclisation of our amino diene products has proved 






















4.9 Future work 
 
Although the ester fragment of our substrate has been explored, the ynamide fragment 
has received limited attention. To address this, a range of ynamides could be 




Figure 34 – Carbamate 377, acetamide 378 and imidazolidin-2-one 379 
 
Although a tentative mechanism has been provided for the ynamido Ireland-Claisen 
rearrangement, it may be possible to carry out in situ 
13
C NMR monitoring of the 
reaction to determine precisely when decarboxylation occurs. This would require the 
synthesis of a 
13
C enriched substrate to be synthesised. 
 
 
Figure 35 – Carbon labelled substrate for 13C NMR studies 
 
A possible method for confirming the presence of alleneamide 336 would involve 
trapping the intermediate with a suitable electrophile, potentially inhibiting 











5. EXPERIMENTAL  
 
5.1 General Information 
 
All reactions were carried out using anhydrous solvents and under an inert atmosphere 
of nitrogen.  All reaction vessels were flame dried before use.  Solvents were obtained 
by passing through anhydrous alumina columns using an Innovative Technology Inc. 
PS-400-7 solvent purification system.  All reagents were purchased from commercial 
suppliers: Acros Organics, Alfa Aesar, Sigma Aldrich or Novabiochem and used 
without further purification.  Triethylamine was freshly distilled prior to use and 
chlorotrimethylsilane was freshly distilled from 10 % quinoline.  All distilled materials 
were stored under nitrogen in a fridge.  All reactions were monitored by thin layer 
chromatography (TLC) using pre-coated MN Alugram Sil G/UV254 silica gel 60 
aluminium backed plates.  Plates were developed using standard techniques, UV light 
followed by a chemical dip, usually KMnO4 and gentle heating.  Flash chromatography 
was performed on chromatography grade, silica 60Å particle size 35-70 micron from 





C NMR was performed on Brüker Avance 250 (
1
H 250 MHz), Brüker Avance 
300 (
1
H 300 MHz and 
13
C 75 MHz), Brüker Avance 400 (
1
H 400 MHz and 
13
C 100 
MHz) and Brüker Avance 500 (
1
H 500 MHz and 
13
C 125 MHz) as stated.  Chemical 
shifts are reported in parts per million (ppm) relative to tetramethylsilane (TMS) ( = 
0.00). Coupling constants are reported in Hertz (Hz) and signal multiplicity is denoted 
as singlet (s), doublet (d), triplet (t), quartet (q), septet (sept), multiplet (m), and broad 
(br. s).  Mass spectroscopy was performed on a Brüker TOF using electrospray 
ionisation (ESI) in either positive or negative ionisation as stated.  Infra-red 
spectroscopy was carried out using a Perkin Elmer Spectrum RX FT-IR system with 
KBr plates, using a thin film.  Melting points were determined using a Bibby Scientific 
Melting point apparatus Stuart SMP10 digital. X-ray data was collected at 150 K on a 
Nonius KappaCCD area diffractometer using Mo-Kα radiation (l = 0.71073 Å) and all 
structures were solved by direct methods and refined on all F2 data using SHELXL-97 
suite of programs. Hydrogen atoms included in idealised positions and refined using the 
riding model. 




5.2 Chapter 2 
 






To a stirred solution of alkyne (1 equiv.) in THF (15 mL/mmol) at -78 ºC, was added 
n
BuLi (1.6 M in hex., 1.1 equiv.) dropwise and stirred for 10 minutes. The solution was 
warmed to room temperature, then stirred for 20 minutes before returning to -78 ºC. A 
solution of aldehyde (1 equiv.) in THF (5 mL) was added and the reaction warmed to 
room temperature and stirred for 4 hours. NH4Cl (sat.) (100 mL) was added and the 
product was extracted with EtOAc (3 × 100 mL), washed with brine (100 mL), dried 
over Na2SO4, filtered and concentrated in vacuo to afford a crude residue. The crude 
residue was then dissolved in DCM (15 mL/mmol), and treated with manganese dioxide 
(25 equiv.) and stirred for 24 hours. The mixture was filtered through celite then 
concentrated in vacuo. Purification was achieved by flash chromatography, eluting with 






Prepared according to general procedure A, using phenyl acetylene (1.07 mL, 9.79 
mmol, 1 equiv.), crotonaldehyde (800 µL, 9.79 mmol, 1 equiv.), 
n
BuLi (1.6M in Hex., 
6.70 mL, 10.7 mmol, 1.1 equiv.), THF (150 mL), manganese dioxide (19.3 g, 222 
mmol, 25 equiv.), DCM (150 mL). Purification was achieved by flash chromatography 
to afford 147 as a pale yellow oil (0.94 g, 64%). 
 





H NMR (CDCl3, 500 MHz) : 7.27–7.62 (6H, m), 6.28 (1H, dq, J = 15.6, 1.7 Hz), 
2.04 (3H, dd, J = 6.9, 1.7 Hz); 
13
C NMR (CDCl3, 125 MHz) C: 178.4, 149.5, 134.0, 
132.9, 130.5, 128.6, 120.2, 91.1, 86.2, 18.5.  








To indole (1.05 equiv.) in a round bottomed flask was added a solution of enynone (1 
equiv.) in acetonitrile (1 mL) followed by a solution of sodium tetrachloroaurate (III) 
hydrate (5 mol%) in acetonitrile (1 mL) and stirred at room temperature for 4 hours. The 
solution was filtered through celite and concentrated in vacuo. Subsequent purification 






To a solution of 147 (280 mg, 1.90 mmol, 1 equiv.) in acetonitrile (10 mL) at 0 °C was 
added DNsOH (23 mg, 0.10 mmol, 5 mol%) portionwise, then the reaction was allowed 
to stir for 40 minutes. Upon completion, the reaction was filtered through K2CO3 and 
concentrated in vacuo. Purification was achieved by flash chromatography to provide 
the title compound as a yellow oil (404 mg, 81%). 
 
FTIR (thin film) max: 3414, 3057, 2963, 2928, 2199, 1654; 
1
H NMR (500 MHz, 
CDCl3) : 7.95 (1H, br. s), 7.64 (1H, d, J = 7.5 Hz), 7.46–7.31 (3H, m), 7.30–7.19 (3H, 
m), 7.18–7.02 (2H, m), 6.91 (1H, d, J = 2.4 Hz), 3.84–3.69 (1H, m), 3.12 (1H, dd, J = 
15.5, 6.0 Hz), 2.86 (1H, dd, J = 15.5, 8.4 Hz), 1.40 (3H, d, J = 7.2 Hz); 
13
C NMR (125 
MHz, CDCl3) C: 187.7, 136.6, 133.1, 130.7, 128.6, 126.4, 122.1, 120.5, 120.4, 120.0, 




119.4, 119.1, 111.5, 91.2, 88.1, 53.2, 27.7, 21.1; HRMS (ESI, +ve) m/z: calcd.  for 








Prepared according to general procedure B (reaction time = 4 h), using indole (25 mg, 
0.21 mmol, 1.05 equiv.), diphenylpent-1-en-4-yn-3-one (34 mg, 0.2 mmol, 1 equiv.), 
sodium tetrachloroaurate (III) hydrate (4 mg, 0.01 mmol, 5 mol%), acetonitrile (2 mL). 
Purification was achieved by flash chromatography (8:1 Pet/EtOAc) afforded a yellow 
solid. Recrystallisation from petrol/DCM afforded 148 as a yellow solid (57 mg, 100%). 
 
MP: 170 – 171 °C. FTIR (thin film) max: 3057, 2956, 2924, 1707, 1623; 
1
H NMR (500 
MHz, CDCl3) H7.73 (1H, br. s), 7.70-7.17 (8H, m), 6.20 (1H, s), 3.61–3.38 (1H, m), 
3.19 (1H, dd, J = 14.4, 3.1 Hz), 2.97 (1H, dd, J = 14.4, 1.8 Hz), 1.37 (3H, d, J = 7.2 
Hz); 
13
C NMR (75 MHz, CDCl3) C: 199.9, 145.2, 139.7, 135.5, 129.9, 129.3, 129.0, 
128.9, 128.5, 126.8, 126.2, 124.7, 120.4, 119.5, 111.4, 48.2, 25.0, 17.1; HRMS (ESI, 








Prepared according to general procedure B (reaction time = 4 h), using 5-methoxyindole 
(31 mg, 0.21 mmol, 1.05 equiv.), 147 (34 mg, 0.20 mmol, 1 equiv.), sodium 
tetrachloroaurate (III) hydrate (4 mg 0.01 mmol, 5 mol%), acetonitrile (2 mL). 
Purification was achieved by flash chromatography to afford 157 as a yellow oil (57 
mg, 90%). 





FTIR (thin film) max: 2959, 2831, 1718, 1623, 1582, 1567, 1533; 
1
H NMR (500 MHz, 
CDCl3) H 7.63 (1H, br. s), 7.52–7.44 (5H, m), 7.20–7.16 (2H, m), 7.04 (1H, d, J = 2.3 
Hz), 6.94 (1H, dd, J = 8.8, 2.3 Hz), 6.17 (1H, d, J = 1.6 Hz), 3.90 (s, 3H), 3.61–3.55 
(1H, m), 3.20 (1H, dd, J = 14.7, 3.5 Hz), 2.96 (1H, dd, J = 14.7, 5.6 Hz), 1.36 (3H, d, J 
= 7.5 Hz); 
13
C NMR (75 MHz, CDCl3) C: 199.8, 154.6, 130.9, 129.2, 128.9, 128.5, 
128.2, 125.7, 122.3, 116.0, 99.8, 55.8, 48.2, 25.0, 17.0; HRMS (ESI, +ve) m/z: calcd. 









Prepared according to general procedure B (reaction time = 24 h), using methyl indole-
5-carboxylate (37 mg, 0.21 mmol, 1.05 equiv.), 147 (34 mg, 0.20 mmol, 1 equiv.), 
sodium tetrachloroaurate (III) hydrate (4 mg 0.01 mmol, 5 mol%), acetonitrile (2 mL). 
Purification was achieved by flash chromatography to afford 158 as a yellow oil (49 
mg, 71%). 
 
FTIR (thin film) max: 2956, 2897, 1711, 1625, 1541, 1512; 
1
H NMR (500 MHz, 
CDCl3) H8.46 (1H, br. s), 7.96–7.94 (2H, m), 7.53–7.44 (5H, m), 7.29–7.25 (2H, m), 
7.20–7.16 (1H, m), 6.24 (1H, d, J = 1.6 Hz), 3.97 (3H, s), 3.74–3.66 (1H, m), 3.18 (1H, 
dd, J = 14.7, 3.3 Hz), 2.98 (1H, dd, J = 14.7, 5.1 Hz), 1.38 (3H, d, J = 7.5 Hz); 
13
C 
NMR (75 MHz, CDCl3) C: 199.5, 167.7, 144.4, 139.3, 131.2, 129.7, 129.4, 129.0, 
128.5, 128.2, 127.2, 126.5, 125.6, 122.6, 122.5, 111.1, 52.0, 48.0, 24.9, 17.1; HRMS 
















Prepared according to general procedure B (reaction time = 4 h), using To 5-
chloroindole (32 mg, 0.21 mmol, 1.05 equiv.), 147 (34 mg, 0.20 mmol, 1 equiv.), 
sodium tetrachloroaurate (III) hydrate (4 mg, 0.01 mmol, 5 mol%), acetonitrile (2 mL). 
Purification was achieved by flash chromatography to afford 159 as a yellow oil (62 
mg, 96%). 
 
FTIR (thin film) max: 2963, 2925, 2849, 1734, 1630, 1535; 
1
H NMR (500 MHz, 
CDCl3) H 7.77 (1H, br. s), 7.65–7.63 (1H, m), 7.54–7.51 (3H, m), 7.48–7.44 (2H, m), 
7.20–7.19 (2H, m), 6.23 (1H, d, J = 1.6 Hz), 3.59–3.53 (1H, m), 3.16 (1H, dd, J = 14.6, 
3.2 Hz), 2.96 (1H, dd, J = 14.6, 5.3 Hz), 1.35 (3H, d, J = 7.3 Hz); 
13
C NMR (75 MHz, 
CDCl3) C: 199.5, 144.5, 139.4, 133.7, 131.1, 129.5, 129.4, 129.1, 128.5, 127.8, 126.1, 
125.3, 125.0, 118.8, 112.5, 48.1, 25.0, 17.1; HRMS (ESI, +ve) m/z: calcd. for 








Prepared according to general procedure B (reaction time = 4 h), using 4-chloro indole 
(32 mg, 0.21 mmol, 1.05 equiv.), 147 (34 mg, 0.20 mmol, 1 equiv.), sodium 
tetrachloroaurate (III) hydrate (4 mg 0.01 mmol, 5 mol%), acetonitrile (2 mL). 
Purification was achieved by flash chromatography  to afford 160 as a yellow oil (51 
mg, 80%). 
 




FTIR (thin film) max: 3060, 3028, 2922, 2865, 1734, 1651, 1537; 
1
H NMR (500 MHz, 
CDCl3) H: 7.82 (1H, br. s). 7.51–7.35 (3H, m), 7.45–7.42 (2H, m), 7.16–7.12 (3H, m), 
6.23 (1H, d, J = 2.0 Hz), 4.53–4.47 (1H, m), 3.20 (1H, dd, J = 14.7, 3.0 Hz), 2.95 (1H, 
dd, J = 14.7, 2.0 Hz), 1.38 (3H, d, J = 7.4 Hz); 
13
C NMR (75 MHz, CDCl3) C: 199.9, 
150.1, 144.7, 139.7, 136.7, 131.0, 129.8, 129.3, 129.1, 128.5, 127.2, 126.5, 124.8, 
121.9, 110.1, 47.9, 24.7, 17.1; HRMS (ESI, +ve) m/z: calcd. for C20H16ClNO 322.0999, 








Prepared according to general procedure B (reaction time = 4 h), using 5-methylindole 
(28 mg, 0.21 mmol, 1.05 equiv.), 147 (34 mg, 0.20 mmol, 1 equiv.), sodium 
tetrachloroaurate (III) hydrate (4 mg, 0.01 mmol, 5 mol%), acetonitrile (2 mL). 
Purification was achieved by flash chromatography to afford 161 as a yellow oil (58 
mg, 96%). 
 
FTIR (thin film) max: 2970, 2933, 2884, 1768, 1659; 
1
H NMR (500 MHz, CDCl3) 
H7.64 (1H, br. s), 7.52–7.45 (6H, m), 7.16 (1H, d, J = 8.5 Hz), 7.09 (1H, dd, J = 8.5, 
1.3 Hz), 6.17 (1H, d, J = 1.6 Hz), 3.64–3.58 (1H, m), 3.18 (1H, dd, J = 14.4, 3.3 Hz), 
2.95 (1H, dd, J = 14.4, 5.4 Hz), 2.48 (3H, s), 1.35 (3H, d, J = 7.2 Hz); 
13
C NMR (75 
MHz, CDCl3) : 199.9, 145.3, 129.8, 129.2, 128.9, 128.5, 126.6, 125.7, 118.8, 111.1, 
48.2, 29.7, 24.9, 21.6, 17.0; HRMS (ESI, +ve) m/z: calcd. for C21H20NO 302.1545, 












Prepared according to general procedure B (reaction time = 4 h), using 4-methylindole 
(27.5 mg, 0.21 mmol, 1.05 equiv.), 147 (34 mg, 0.20 mmol, 1 equiv.), sodium 
tetrachloroaurate (III) hydrate (4 mg, 0.01 mmol, 5 mol%), acetonitrile (2 mL). 
Purification was achieved by flash chromatography to afford 162 as a yellow oil (56 
mg, 93%). 
 
FTIR (thin film) max: 3056, 2965, 2864, 1729, 1625, 1570, 1523; 
1
H NMR (500 MHz, 
CDCl3) H7.72 (1H, br. s),7.52–7.43 (5H, m), 7.14–7.07 (2H, m), 6.89 (1H, dt, J = 
6.7, 1.2 Hz), 6.19 (1H, d, J = 1.8 Hz), 4.06–4.00 (1H, m), 3.23 (1H, dd, J = 14.8, 3.2 
Hz), 2.95 (1H, dd, J = 14.8, 5.5 Hz), 2.79 (3H, s), 1.38 (3H, d, J = 7.4 Hz); 
13
C NMR 
(75 MHz, CDCl3) C: 199.8, 145.6, 140.1, 135.8, 135.8, 131.8, 129.9, 129.2, 128.9, 
128.6, 127.8, 124.7, 122.5, 109.4, 48.2, 25.7, 20.9, 17.1; HRMS (ESI, +ve) m/z: calcd. 








Prepared according to general procedure B (reaction time = 4 h), using 6-methylindole 
(28 mg, 0.21 mmol, 1.05 equiv.), 147 (34 mg, 0.20 mmol, 1 equiv.), sodium 
tetrachloroaurate (III) hydrate (4 mg, 0.01 mmol, 5 mol%), acetonitrile (2 mL). 
Purification was achieved by flash chromatography to afford 163 as a yellow oil (57 
mg, 96%). 
 
FTIR (thin film) max:3054, 2965, 2867, 1735, 1625, 1570, 1523. 
1
H NMR (500 MHz, 
CDCl3) H 7.70 (1H, br. s), 7.56 (1H, d, J = 8.0 Hz), 7.52–7.44 (5H, m), 7.07–7.06 
(1H, m), 7.02 (1H, dd, J = 8.0, 1.2 Hz), 6.16 (1H, d, J = 1.6 Hz), 3.63–3.57 (1H, m), 
3.18 (1H, dd, J = 14.7, 3.9 Hz), 2.94 (1H, dd, J = 14.7, 5.4 Hz), 2.46 (3H, s), 1.35 (3H, 
d, J = 7.4 Hz); 
13
C NMR (75 MHz, CDCl3) C: 199.9, 145.4, 139.9, 136.1, 135.0, 129.4, 




129.2, 128.9, 128.5, 128.3, 126.4, 124.7, 122.4, 119.1, 111.1, 48.2, 25.0, 17.0; HRMS 








Prepared according to general procedure B (reaction time = 4 h), using 7-methylindole 
(28 mg, 0.21 mmol, 1.05 equiv.), 147 (34 mg, 0.20 mmol, 1 equiv.), sodium 
tetrachloroaurate (III) hydrate (4 mg, 0.01 mmol, 5 mol%), acetonitrile (2 mL). 
Purification was achieved by flash chromatography to afford 164 as a yellow oil (56 
mg, 95%). 
 
FTIR (thin film) max: 2965, 2928, 2864, 1732, 1626, 1571, 1524; 
1
H NMR (500 MHz, 
CDCl3) H 7.75 (1H, br. s), 7.52–7.42 (5H, m), 7.14–7.08 (2H, m), 6.89 (1H, dt, J = 
6.9, 1.0 Hz), 6.19 (1H, d, J = 1.9 Hz), 4.06–4.00 (1H, m),  3.23 (1H, dd, J = 14.7, 3.0 
Hz), 2.95 (1H, dd, J = 14.7, 5.7), 2.79 (3H, s), 1.39 (3H, d, J = 7.2 Hz); 
13
C NMR (75 
MHz, CDCl3) C: 199.8, 144.7, 140.1, 135.8, 131.8, 129.9, 129.2, 128.9, 128.6, 128.5, 
127.8, 125.3, 124.7, 122.5, 109.4, 48.2, 25.7, 20.9, 17.1; HRMS (ESI, +ve) m/z: calcd. 









Prepared according to general procedure B (reaction time = 4 h), using 5-indoleboronic 
acid pinacol ester (51 mg, 0.21 mmol, 1.05 equiv.), 147 (34 mg, 0.20 mmol, 1 equiv.), 




sodium tetrachloroaurate (III) hydrate (4 mg 0.01 mmol, 5 mol%), acetonitrile (2 mL). 
Purification was achieved by flash chromatography to afford 165 as an amorphous 
yellow solid (73 mg, 88%).  
 
FTIR (thin film) max: 2976, 2931, 1718, 1626, 1541, 1512; 
1
H NMR (500 MHz, 
CDCl3) H8.12 (1H, s), 7.72 (1H, br. s), 7.61 (1H, dd, J = 8.3, 0.9 Hz), 7.44–7.35 (5H, 
m), 7.16 (1H, dd, J = 8.3, 0.9 Hz), 6.10 (1H, d, J = 1.5 Hz), 3.68–3.58 (1H, m), 3.06 
(1H, dd, J = 14.7, 3.4 Hz), 2.85 (1H, dd, J = 14.7, 1.5 Hz), 1.31–1.25 (15H, m); 13C 
NMR (75 MHz, CDCl3) C: 199.8, 145.0, 139.6, 137.4, 130.6, 129.9, 129.3, 129.0, 
128.5, 127.4, 126.9, 126.5, 110.7, 83.7, 48.1, 25.0, 24.9, 24.7, 16.9; HRMS (ESI, +ve) 








Prepared according to general procedure B (reaction time = 4 h), using 5-iodoindole (51 
mg, 0.21 mmol, 1.05 equiv.), 147 (34 mg, 0.20 mmol, 1 equiv.), sodium 
tetrachloroaurate (III) hydrate (4 mg 0.01 mmol, 5 mol%), acetonitrile (2 mL). 
Purification by flash chromatography afforded 166 as an amorphous yellow solid (81 
mg, 98%).  
 
FTIR (thin film) max: 2960, 2928, 1720, 1626, 1582, 1535; 
1
H NMR (500 MHz, 
CDCl3) H 8.02 (1H, d, J = 8.5 Hz), 7.78 (1H, br. s), 7.54–7.43 (6H, m), 7.05 (1H, d, J 
= 8.5 Hz), 6.22 (1H, d, J = 1.8 Hz), 3.58–3.52 (1H, m), 3.15 (1H, dd, J = 14.9, 3.2 Hz), 
2.95 (1H, dd, J = 14.9, 5.4 Hz), 1.34 (3H, d, J = 7.5 Hz); 
13
C NMR (75 MHz, CDCl3) 
C: 199.5, 144.5, 139.3, 134.3, 132.8, 130.5, 129.6, 129.4, 129.3, 129.1, 128.5, 128.4, 
124.9, 113.3, 83.7, 48.0, 24.9, 17.1; HRMS (ESI, +ve) m/z: calcd. for C20H16INONa 













Prepared according to general procedure B (reaction time = 4 h), using 5-hydroxy 
indole (28 mg, 0.21 mmol, 1.05 equiv.), 147 (34 mg, 0.2 mmol, 1 equiv.), sodium 
tetrachloroaurate (III) hydrate (4 mg 0.01 mmol, 5 mol%), acetonitrile (2 mL). 
Purification was achieved by flash chromatography to afford 167 as a yellow solid (55 
mg, 92%). 
 
MP: 111 – 114 °C; FTIR (thin film) max: 3314, 2959, 1712, 1611, 1581; 
1
H NMR (500 
MHz, CDCl3) H7.62 (1H, br. s), 7.52–7.45 (5H, m), 7.14 (1H, d, J = 8.7 Hz), 7.05 
(1H, d, J = 2.3 Hz), 6.86 (1H, dd, J = 8.7, 2.3 Hz), 6.18 (1H, d, J = 1.6 Hz), 4.92 (1H, 
br. s), 3.53–3.48 (1H, m), 3.18 (1H, d, J = 14.9, 3.4 Hz), 2.95 (1H, dd, J = 14.9, 5.4 
Hz), 1.33 (3H, d, J = 7.4 Hz); 
13
C NMR (75 MHz, CDCl3) C: 200.0, 150.0, 145.2, 
139.7, 131.0, 130.9, 129.2, 128.9, 128.7, 128.5, 127.4, 125.3, 115.3, 112.3, 103.0, 48.2, 









Prepared according to general procedure B (reaction time = 4 h, RT), using 1-methyl-
1H-indole (41 μL, 0.32 mmol, 1.05 equiv.), 147 (50 mg, 0.29 mmol, 1 equiv.), sodium 
tetrachloroaurate (III) hydrate (6 mg, 0.015 mmol, 5 mol%), acetonitrile (2 mL). 
Purification by flash chromatography afforded 169 as a yellow oil (63 mg, 71%). 
 




FTIR (thin film) max: 2981, 2888, 1638, 1566, 1531; 
1
H NMR (500 MHz, CDCl3) H:  
7.80 (1H, app.d., J = 8.0 Hz), 7.55–7.44 (3H, m), 7.44–7.37 (2H, m), 7.35 (1H, app.d., J 
= 7.5 Hz), 7.33–7.28 (1H, m), 7.24 (1H, app.t., J = 7.5 Hz), 6.47 (1H, s), 3.74–3.61 
(1H, m), 3.13 (3H, s), 3.09 (1H, app.d., J = 17.5 Hz), 3.00 (1H, dd, J = 17.5, 6.1 Hz), 
1.59 (3H, d, J = 7.2 Hz); 
13
C NMR (125 MHz, CDCl3) C: 201.2, 144.9, 141.6, 138.9, 
133.5, 130.8, 129.0, 128.8, 127.6, 125.9, 125.2, 123.9, 119.9, 119.6, 109.9, 52.4, 32.9, 









Prepared according to general procedure B (reaction time = 16 h, reflux), using 2,5-
dimethylpyrrole (31 μL, 0.31 mmol, 1.05 equiv.), 147 (50 mg, 0.29 mmol, 1 equiv.), 
sodium tetrachloroaurate (III) hydrate (6 mg, 0.015 mmol, 5 mol%), acetonitrile (2 mL). 
Purification by flash chromatography afforded 173 as a yellow oil (38 mg, 49%, 69% 
BRSM). 
 
FTIR (thin film) max: 3655, 3365, 2980, 2871, 2889, 2200, 1655, 1604; 
1
H NMR (500 
MHz, CDCl3) H: 7.58–7.53 (2H, m), 7.47–7.42 (1H, m), 7.41–7.36 (2H, m), 5.72 (1H, 
d, J = 2.5 Hz), 3.39 (1H, app. sex, J = 6.7 Hz), 2.87 (1H, dd, J = 15.3, 6.7 Hz), 2.81 
(1H, dd, J = 15.3, 7.9 Hz), 2.20 (3H, s), 2.19 (3H, s), 1.25 (3H, d, J = 6.7 Hz); 
13
C NMR 
(125 MHz, CDCl3) : 187.8, 133.0, 130.6, 128.6, 125.3, 123.1, 121.0, 120.2, 103.7, 
90.5, 88.2, 54.3, 27.5, 22.2, 13.0, 11.1; HRMS (ESI, +ve) m/z: calcd. for C18H19NONa: 














In a two-necked flask, a solution of 1-bromo-4-(trifluoromethyl)benzene (900 mg, 4.00 
mmol, 1 equiv.), bis(triphenylphosphine)palladium(II) dichloride (84 mg, 0.12 mmol, 3 
mol%), copper(I) iodide (46 mg, 0.24 mmol, 6 mol%), triphenylphosphine (63 mg, 0.24 
mmol, 6 mol%) in pyridine (15 mL) was heated to 80 °C. Ethynyltrimethylsilane (737 
µL, 5.33 mmol, 1.33 equiv.) was added dropwise under a positive pressure of nitrogen 
and the reaction was allowed to stir for 24 hours. Upon completion the reaction was 
cooled to RT, quenched with NH4Cl (sat) (50mL) and extracted with DCM (3 × 50 mL). 
The organic extracts are then washed with water (3 × 50 mL), dried over Na2SO4 and 
concentrated in vacuo. The crude material was subjected to flash chromatography, 
eluting with 100% Pet, to give 176 as a pale yellow oil (871 mg, 90%). 
 
1
H NMR (CDCl3, 300 MHz) δ: 7.36 (4H, s), 0.07 (9H, s); 13C NMR (CDCl3, 75 MHz) 
δ: 132.4, 130.4 (q, J = 32.8 Hz), 127.2 (m), 125.3 (q, J = 3.8 Hz), 124.1 (q, J = 272.4 
Hz), 103.6, 97.4, 0.0.  










To 175 (1.95 g, 8.08 mmol, 1 equiv.) in a round-bottomed flask was added MeOH (20 
mL) and NaOH solution (1.43 M, 20 mL). The reaction was allowed to stir for 24 hours 
at room temperature. Upon completion, pentane (20 mL) was added to the reaction 
mixture and organics extracted. The organic extract was then washed with water (20 
mL), dried over MgSO4 and concentrated in vacuo. The crude product was distilled 




H NMR (CDCl3, 500 MHz) δH: 7.61 (4H, s), 3.21 (1H, s); 13C NMR (CDCl3, 125 
MHz) δC: 132.4, 130.6 (q, J = 32.4), 125.9 (m), 125.3 (q, J = 3.5 Hz), 123.8 (q, J = 
272.6 Hz), 82.2, 79.6. 














2-bromonaphthalene (2.00 g, 9.66 mmol, 1 equiv.), 
bis(triphenylphosphine)palladium(II) dichloride (302 mg, 0.43 mmol, 4.5 mol%) and 
copper(I) iodide (91 mg, 0.48 mmol, 5 mol%) were added to a round-bottomed flask 
and purged with nitrogen. Distilled triethylamine (40 mL) was added, followed by the 
dropwise addition of ethynyltrimethylsilane (2.00  mL, 14.49 mmol, 1.5 equiv.). The 
reaction was stirred at RT for 16 hours, then quenched with NH4Cl (sat) (40 mL) and 
extracted with hexane (3 × 40 mL). The organic extracts were combined and dried over 
Na2SO4 and concentrated in vacuo. The crude product was subjected to flash 
chromatography, eluting with 100% Pet, to afford 179 as a clear oil (1.38 g, 64%). 
 
1
H NMR (CDCl3, 300 MHz) δH: 7.91 (1H, app.s), 7.76–7.62 (3H, m), 7.46–7.33 (3H, 
m), 0.20 (9H, s); 13C NMR (CDCl3, 75 MHz) δC: 132.9, 132.8, 132.0, 128.6, 127.8, 
127.8, 127.7, 126.7, 126.5, 120.4, 105.4, 94.5, 0.0. 










To a degassed solution of potassium hydroxide (375 mg, 6.70 mmol, 2 equiv.) in MeOH 
(12.5 mL) was added a solution of 179 (750 mg, 3.35 mmol, 1 equiv.) in DCM (12.5 
mL) dropwise. The reaction was allowed to stir for 2 hours, then quenched with water 
(10 mL) and the organic layer extracted. The organic extract was dried over Na2SO4 and 
concentrated in vacuo before being subjected to flash chromatography, eluting with 
100% Pet, to afford 180 as a clear oil (296 mg, 58%).   
 





H NMR (CDCl3, 300 MHz) δ: 7.87 (1H, app.s), 7.70–7.57 (3H, m), 7.41–7.29 (3H, m), 
2.98 (1H, s); 13C NMR (CDCl3, 75 MHz) δ: 133.1, 132.8, 132.3, 128.6, 128.0, 127.8, 
127.8, 126.9, 126.6, 119.4, 84.0, 77.2. 










To a solution of propargylic alcohol (1.00 mL, 17.80 mmol, 1 equiv.) in THF (35 mL) 
was added triethylamine (4.90 mL, 35.60 mmol, 2 equiv.), TBSCl (2.68 g, 17.80 mmol, 
1 equiv.) and DMAP (110 mg, 0.90 mmol, 20 mol %). The resultant mixture was stirred 
at rt for 18 h, diluted with hexane (150 mL) and washed with NH4Cl (sat) (150 mL) and 
brine (150 mL) and dried over MgSO4, filtered and concentrated in vacuo. Purification 




H NMR (500 MHz, CDCl3) δH: 4.33 (2H, d, J = 2.5 Hz), 2.40 (1H, t, J = 2.5 Hz), 0.93 
(9H, s), 0.14 (6H, s); 
13
C NMR (125 MHz, CDCl3) δC: 82.4, 72.8, 51.5, 25.8, 18.3, -5.2. 








Prepared according to general procedure A, using 1-ethynyl-4-methylbenzene (1.02 mL, 
8.00 mmol, 1 equiv.), crotonaldehyde (663 μL, 8.00 mmol, 1 equiv.), nBuLi (1.6 M in 
Hex., 5.50 mL, 8.80 mmol, 1.1 equiv.), manganese dioxide (17.39 g, 200 mmol, 25 
equiv.). Purified by flash chromatography to afford 183 as a yellow oil (893 mg, 60 %). 
 




FTIR (thin film) υmaz: 3035, 2964, 2909, 2203, 1641, 1615, 1603, 1509; 
1
H NMR (300 
MHz, CDCl3) δH: 7.41 (2H, app.d, J = 8.2 Hz), 7.28–7.14 (1H, m), 7.11 (2H, app.d, J = 
8.2 Hz), 6.18 (1H, dq, J = 15.7, 1.6 Hz), 2.31 (3H, s), 1.94 (3H, dd, J = 6.9, 1.6 Hz); 
13
C NMR (75 MHz) δ: 178.5, 149.2, 141.2, 134.0, 132.9, 129.4, 117.1, 91.7, 86.1, 21.7, 









Prepared according to general procedure A, using 4-ethynylanisole (0.98 mL, 7.56 
mmol, 1 equiv.), crotonaldehyde (0.62 mL, 7.56 mmol, 1 equiv.), 
n
BuLi (1.6M in Hex., 
5.20 mL, 8.32 mmol, 1.1 equiv.), THF (50 mL), manganese dioxide (13.0 g, 150 mmol, 
25 equiv.), DCM (50 mL). Purification was achieved by flash chromatography to afford 
184 as a yellow oil (0.62 g, 52%). 
 
FTIR (thin film) max: 2938, 2841, 2201, 1735, 1643, 1619, 1599, 1568; 
1
H NMR (500 
MHz, CDCl3) :  7.57 (1H, app. d, J = 8.8 Hz), 7.31–7.24 (1H, m), 6.92 (2H, app. d, J 
= 8.8 Hz), 6.27 (1H, d, J = 15.5 Hz), 3.86 (3H, s), 2.03 (3H, d, J = 6.9 Hz); 
13
C NMR 
(125 MHz, CDCl3) : 178.5, 161.5, 148.8, 134.9, 134.0, 114.3, 112.0, 92.1, 86.1, 55.4, 













Prepared according to general procedure A, using 1-ethynyl-4-(trifluoromethyl)benzene 
(1.36 g, 8.00 mmol, 1 equiv.), crotonaldehyde (663 μL, 8.00 mmol, 1 equiv.), nBuLi 
(1.6 M in Hex., 5.50 mL, 8.80 mmol, 1.1 equiv.), manganese dioxide (17.39 g, 200 
mmol, 25 equiv.). Crude residue purified by washing with petroleum ether (5 mL) to 
afford 185 as a light yellow solid (302 mg, 16 %). 
 
FTIR (thin film) υmaz: 2981, 2212, 1644, 1621; 
1
H NMR (500 MHz, CDCl3) δH: 7.71 
(2H, app.d., J = 8.2 Hz), 7.66 (2H, app.d., J = 8.2 Hz), 7.31 (1H, dq, J = 15.9, 6.9 Hz), 
6.29 (1H, dq, J = 15.9, 1.6 Hz), 2.05 (3H, dd, J = 6.9, 1.6 Hz); 
13
C NMR (100 MHz) δC: 
177.9, 150.3, 133.8, 133.0, 132.0 (q, J = 32.9), 125.6 (q, J = 3.7 Hz), 124.1, 123.6 (q, J 
= 272.9 Hz), 88.6, 87.5, 18.6; HRMS (ESI, +ve) m/z: calcd. for C13H9F3ONa: 261.0503, 








Prepared according to general procedure A, using 2-ethynylnaphthalene (272 mg, 1.80 
mmol, 1 equiv.), crotonaldehyde (148 μL, 1.80 mmol, 1 equiv.), nBuLi (1.6 M in Hex., 
1.23 mL, 2.00 mmol, 1.1 equiv.), manganese dioxide (3.89 g, 44.8 mmol, 25 equiv.). 
Purified by flash chromatography to afford 186 as a yellow oil (220 mg, 56%). 
 
FTIR (thin film) υmax: 2981, 2889, 2188, 1645, 1618; 
1
H NMR (400 MHz, CDCl3) δH: 
8.22 (1H, s), 7.94–7.85 (3H, m), 7.67–7.54 (3H, m), 7.41 (1H, dq, J = 15.7, 6.8 Hz), 
6.36 (1H, dq, J = 15.7, 1.6 Hz), 2.11 (3H, dd, J = 6.8, 1.6 Hz); 
13
C NMR (100 MHz) δ: 
178.4, 149.5, 134.1, 133.8, 132.8, 129.0, 128.5, 128.4, 127.9, 127.9, 127.0, 117.4, 91.6, 
















Prepared according to general procedure A, using 1-hexyne (1.12 mL, 9.79 mmol, 1 
equiv.), crotonaldehyde (0.80 mL, 9.79 mmol, 1 equiv.), 
n
BuLi (1.6 M in Hex., 6.70 
mL, 10.7 mmol, 1.1 equiv.), THF (150 mL), manganese dioxide (10.1 g, 115.9 mmol, 
25 equiv.), DCM (150 mL). Purification was achieved by flash chromatography to 
afford 187 as a pale yellow oil (0.70 g, 48%). 
 
1
H NMR (400 MHz, CDCl3) H 7.20 (1H, dq, J = 15.8, 6.9 Hz), 7.15 (1H, dq, J = 15.8, 
6.9 Hz), 6.17 (1H, d, J = 15.8 Hz), 2.41 (2H, t, J = 7.3 Hz), 1.99 (3H, d, J = 6.9 Hz), 
1.63–1.43 (4H, m), 0.95 (3H, t, J = 7.3 Hz); 13C NMR (100 MHz, CDCl3) : 178.8, 
145.0, 134.0, 94.5, 79.0, 29.9, 22.0, 18.7, 18.3, 13.5. 








Prepared according to general procedure A, using tert-butyldimethyl(prop-2-yn-1-
yloxy)silane (0.69g, 4.10 mmol, 1 equiv.), crotonaldehyde (0.38 mL,  4.10 mmol, 1 
equiv.), 
n
BuLi (1.6 M in Hex., 2.5 mL, 4.50 mmol, 1.1 equiv.), THF (45 mL), 
manganese dioxide (7.20 g, 83.0 mmol, 25 equiv.), DCM (20 mL). Purification was 
achieved by flash chromatography to afford 188 as a yellow oil (0.51 g, 65%). 
 
FTIR (thin film) υmax: 2956, 2930, 2858, 2217, 1647, 1630; 
1
H NMR (400 MHz, 
CDCl3) δH: 7.16 (1H, dq, J = 15.4, 7.1 Hz), 6.13 (1H, d, J = 15.4 Hz), 4.46 (2H, s), 1.94 
(3H, d, J = 7.1 Hz), 0.88 (9H, s); 
13C NMR (100 MHz) δC: 177.8, 149.9, 133.6, 90.6, 




82.0, 51.5, 25.6, 18.3, 18.2, -5.3; HRMS (ESI, +ve) m/z: calcd. for C13H22O2SiNa: 









Prepared according to general procedure A, using ethynyltrimethylsilane (1.38 mL, 9.79 
mmol, 1 equiv.), crotonaldehyde (800 μL, 9.79 mmol, 1 equiv.), nBuLi (1.6 M in Hex., 
6.70 mL, 10.7 mmol, 1.1 equiv.), manganese dioxide (21.2 g, 244 mmol, 25 equiv.). 
Purified by flash chromatography to afford 189 as a pale yellow oil (830 mg, 51%). 
 
FTIR (thin film) υmaz: 2962, 2903, 2159, 1639, 1626; 
1
H NMR (300 MHz, CDCl3) δH: 
7.20 (1H, dq, J = 15.7, 6.9 Hz), 6.18 (1H, dq, J = 15.7, 1.7 Hz), 1.96 (3H, dd, J = 6.9, 
1.7 Hz), 0.26 (9H, s); 
13
C NMR (125 MHz) δC: 178.1, 150.0, 133.7, 100.3, 98.1, 18.5, -








Prepared according to general procedure A, using phenylacetylene (653 μL, 5.94 mmol, 
1 equiv.), (E)-2-methylbut-2-enal (574 μL, 5.94 mmol, 1 equiv.), nBuLi (1.6 M in Hex., 
4.01 mL, 6.53 mmol, 1.1 equiv.), manganese dioxide (12.9 g, 149 mmol, 25 equiv.). 
Purified by flash chromatography to afford 190 as a yellow oil (623 mg, 57%). 
 
FTIR (thin film) υmaz: 2980, 2194, 1622, 1578; 
1
H NMR (500 MHz, CDCl3) δH: 7.60 
(2H, app. d, J = 8.4 Hz), 7.47–7.42 (1H, m), 7.41–7.30 (3H, m), 1.99 (3H, d, J = 7.2 
Hz), 1.87 (3H, s); 
13
C NMR (125 MHz) δC: 180.2, 145.2, 139.5, 132.7, 130.3, 128.6, 




120.5, 90.9, 86.1, 15.2, 10.3; HRMS (ESI, +ve) m/z: calcd. for C13H12ONa: 207.0786, 








Prepared according to general procedure A, using phenyl acetylene (1.07 mL, 9.79 
mmol, 1 equiv.), 4-methyl-2-pentenal (1.14 mL, 9.79 mmol, 1 equiv.), 
n
BuLi (1.6M in 
Hex., 6.7 mL, 10.7 mmol, 1.1 equiv.), THF (150 mL), manganese dioxide (18.0 g, 208.0 
mmol, 25 equiv.), DCM (150 mL). Purification was achieved by flash chromatography 
to afford 191 as a pale yellow oil (1.31 g, 58%). 
 
FTIR (thin film) max: 2964, 2871, 2210, 1642, 1620; 
1
H NMR (400 MHz, CDCl3) H: 
7.64–7.61 (2H, m), 7.48–7.39 (3H, m), 7.24 (1H, dd, J = 15.9, 6.7 Hz), 6.22 (1H, dd, J 
= 15.9, 1.5 Hz), 2.61 (1H, doct, J = 6.9, 1.5 Hz), 1.16 (6H, d, J = 6.9 Hz); 
13
C NMR 
(100 MHz, CDCl3) C: 178.9, 160.1, 132.9, 130.5, 129.7, 128.6, 120.3, 91.1, 86.4, 31.4, 








Prepared according to general procedure A, using phenyl acetylene (1.07 mL, 9.79 
mmol, 1 equiv.), cinamaldehyde (1.23 mL, 9.79 mmol, 1 equiv.), 
n
BuLi (1.6M in Hex., 
6.70 mL, 10.7 mmol, 1.1 equiv.), THF (150 mL), manganese dioxide (11.3 g, 130 
mmol, 25 equiv.), DCM (150 mL). Purification was achieved by flash chromatography 
(8:1 Pet/EtOAc) to afford a pale yellow solid. Recrystallisation (Pet.) afforded 192 as 
colourless needles (1.31 g, 58%). 
 




MP: 75–77 °C. 1H NMR (400 MHz, CDCl3) H 7.92 (1H, d, J = 16.1 Hz), 7.67–7.59 
(4H, m), 7.50–7.41 (6H, m), 6.88 (1H, d, J = 16.1 Hz); 13C NMR (100 MHz, CDCl3) 
C: 178.2, 148.3, 134.1, 132.9, 131.2, 130.6, 129.1, 128.7, 128.7, 128.6, 120.3, 91.6, 
86.7. 








Prepared according to general procedure A, using 2-ethynylnaphthalene (146 mg, 0.96 
mmol, 1 equiv.), cinnamaldehyde (121 μL, 0.96 mmol, 1 equiv.), nBuLi (1.6 M in Hex., 
661 μL, 1.06 mmol, 1.1 equiv.), manganese dioxide (2.01 g, 24.0 mmol, 25 equiv.). 
Purified by flash chromatography to afford 193 as a yellow oil (147 mg, 54%). 
 
FTIR (thin film) υmaz: 3057, 2186, 1626, 1593, 1575; 
1
H NMR (500 MHz, CDCl3) δH: 
8.24 (1H, s), 7.99 (1H, d, J = 16.1 Hz), 7.93–7.85 (3H, m), 7.69–7.63 (3H, m), 7.60–
7.57 (2H, m), 7.50–7.44 (3H, m), 6.93 (1H, d, J = 16.1 Hz); 13C NMR (125 MHz) δC: 
178.2, 148.3, 134.1, 133.9, 132.7, 131.2, 130.3, 129.1, 128.7, 128.6, 128.5, 128.4, 
128.2, 128.0, 127.9, 127.0, 117.4, 92.1, 86.9; HRMS (ESI, +ve) m/z: calcd. for 








Prepared according to general procedure A, using 1-hexyne (1.12 mL, 9.79 mmol, 1 
equiv.), cinnamaldehyde (1.23 mL, 9.79 mmol, 1 equiv.), 
n
BuLi (1.6M in Hex., 6.7 mL, 
10.7 mmol, 1.1 equiv.), THF (150 mL), manganese dioxide (8.93 g, 102.8 mmol, 25 




equiv.), DCM (150 mL). Purification was achieved by flash chromatography to afford 
194 as a pale yellow oil (0.88 g, 42%).  
 
FTIR (thin film) max: 2959, 2933, 2873, 2210, 1628;  
1
H NMR (300 MHz, CDCl3) H: 
7.70 (1H, d, J = 16.3 Hz), 7.50–7.41 (2H, m), 7.36–7.26 (3H, m), 6.66 (1H, d, J = 16.3 
Hz), 2.37 (2H, t, J = 6.9 Hz), 1.62–1.49 (2H, m), 1.48–1.34 (2H, m), 0.88 (3H, t, J = 
6.9 Hz); 
13
C NMR (75 MHz, CDCl3) C: 178.6, 148.1, 134.2, 131.0, 129.1, 128.7, 
128.6, 95.0, 79.3, 29.9, 22.0, 18.7, 13.6; HRMS (ESI, +ve) m/z: calcd. for C15H17O 
213.1279 found 213.1253 [M + H]
+
.  







Prepared according to general procedure A, using hexyne (540 µL, 4.90 mmol, 1 
equiv.), acrolein (330 µL, 4.90 mmol, 1 equiv.), 
n
BuLi (1.6M in Hex., 3.35 mL, 5.35 
mmol, 1.1 equiv.), THF (50 mL), manganese dioxide (10.1 g, 116 mmol, 25 equiv.), 
DCM (50 mL). Purification was achieved by flash chromatography to afford 195 as a 
pale yellow oil (0.30 g, 44%).  
 
FTIR (thin film) max: 2960, 2933, 2874, 2216, 1646, 1611; 
1
H NMR (500 MHz, 
CDCl3) H6.53 (1H, app. d, J = 16.8 Hz), 6.39 (1H, dd, J = 16.8, 10.5 Hz), 6.16 (1H, 
d, J = 10.5 Hz), 2.43 (2H, t, J = 7.1 Hz), 1.64–1.59 (2H, m), 1.51–1.44 (2H, m), 0.95 
(3H, t, J = 7.4 Hz); 
13
C NMR (125 MHz, CDCl3) C: 179.2, 138.1, 133.2, 95.7, 78.6, 
29.8, 22.0, 18.7, 13.5; HRMS (ESI, +ve) m/z: calcd. for C9H13O 137.0966 found 












Prepared according to general procedure A, using phenyl acetylene (540 µL, 4.90 
mmol, 1 equiv.), acrolein (330 µL, 4.90 mmol, 1 equiv.), 
n
BuLi (1.6M in Hex., 3.35 
mL, 5.35 mmol, 1.1 equiv.), THF (50 mL), manganese dioxide (10.1 g, 116.4 mmol, 25 
equiv.), DCM (50 mL). Purification was achieved by flash chromatography to afford 
196 as a pale yellow oil (0.36 g, 48%). 
 
FTIR (thin film) max: 3061, 2202, 1638, 1607; 
1
H NMR (500 MHz, CDCl3) H7.62 
(2H, d, J = 7.7 Hz), 7.48 (1H, app. t, J = 7.7 Hz), 7.41 (2H, t, J = 7.7 Hz), 6.67 (1H, d, 
J = 17.4 Hz), 6.50 (1H, dd, J = 17.4, 10.1 Hz), 6.24 (1H, d, J = 10.1 Hz); 
13
C NMR 
(125 MHz, CDCl3) C: 178.8, 138.0, 133.5, 133.0, 130.8, 128.7, 119.7, 92.1, 85.8; 








Prepared according to general procedure A, using phenylacetylene (653 μL, 5.90 mmol, 
1 equiv.), methacrolein (490 μL, 5.90 mmol, 1 equiv.), nBuLi (1.6 M in Hex., 4.01 mL, 
6.50 mmol, 1.1 equiv.), manganese dioxide (12.9 g, 149 mmol, 25 equiv.). Purification 
by flash chromatography afforded 197 as an amorphous white solid (552 mg, 55 %). 
 
FTIR (thin film) υmaz: 2981, 2921, 2205, 1632, 1593; 
1
H NMR (500 MHz, CDCl3) δH: 
7.60 (2H, app. d, J = 7.6 Hz), 7.45 (1H, app. t, J = 7.6 Hz), 7.39 (2H, app. t, J = 7.6 
Hz), 6.55 (1H, s), 6.08 (1H, s), 1.97 (3H, s); 
13
C NMR (125 MHz) δC: 180.1, 145.3, 
132.9, 130.7, 130.5, 128.6, 120.3, 91.4, 86.0, 16.2; HRMS (ESI, +ve) m/z: calcd. for 
















Prepared according to general procedure B (reaction time = 6 h), using indole (33 mg, 
0.28 mmol, 1.05 equiv.), 183 (50 mg, 0.27 mmol, 1 equiv.), sodium tetrachloroaurate 
(III) hydrate (5 mg, 0.01 mmol, 5 mol%), acetonitrile (2 mL). Purification was achieved 
by flash chromatography to afford 198 as a yellow oil (79 mg, 98 %). 
 
FTIR (thin film) υmaz: 3058, 3022, 2946, 2926, 1718, 1615, 1529. 
1
H NMR (500 MHz, 
CDCl3) δH: 7.89 (1H, s), 7.69 (1H, app.d., J = 8.1 Hz), 7.37 (2H, app.d., J = 8.8 Hz), 
7.32 (2H, app.d., J = 8.8 Hz), 7.30–7.23 (2H, m), 7.23–7.12 (1H, m), 6.19 (1H, s), 
3.70–3.57 (1H, m), 3.18 (1H, dd, J = 14.9, 3.1 Hz), 2.95 (1H, dd, J = 14.9, 5.2 Hz), 
2.47 (3H, s), 1.37 (3H, d, J = 7.4 Hz); 
13
C NMR (125 MHz) δC: 199.9, 145.3, 139.4, 
136.8, 135.5, 130.0, 129.6, 128.6, 28.5, 126.8, 126.0, 124.6, 120.3, 199.4, 111.4, 48.3, 
25.0, 21.3, 17.0; HRMS (ESI, +ve) m/z: calcd. for C21H20NO: 302.1545, found: 








Prepared according to general procedure B (reaction time = 24 h), using indole (43 mg, 
0.42 mmol, 1.05 equiv.), 184 (80 mg, 0.40 mmol, 1 equiv.), sodium tetrachloroaurate 
(III) hydrate (8 mg, 0.02 mmol, 5 mol%), acetonitrile (2 mL). Purification was achieved 
by flash chromatography to afford a yellow solid. Recrystalization from DCM/Pet. 
afforded 199 as yellow needles (111 mg, 82%). 





MP: 166–167 °C; FTIR (thin film) max: 2956, 2928, 2835, 1636, 1604; 
1
H NMR (500 
MHz, CDCl3) H: 7.78 (1H, br. s), 7.68 (1H, d, J = 8.1 Hz), 7.41 (2H, app. d, J = 8.5 
Hz), 7.29–7.16 (3H, m), 7.03 (2H, app. d, J = 8.5 Hz), 6.20 (1H, s), 3.67–3.59 (1H, m), 
3.17 (1H, dd, J = 14.6, 2.9 Hz), 2.95 (1H, dd, J = 14.6, 4.9 Hz), 1.37 (3H, d, J = 7.4 
Hz); 
13
C NMR (125 MHz, CDCl3) C: 199.9, 160.5, 144.9, 135.4, 131.9, 130.2, 130.1, 
128.5, 126.8, 126.0, 124.6, 120.4, 119.4, 114.4, 111.3, 55.5, 48.4, 24.9, 16.9; HRMS 









Prepared according to general procedure B (reaction time = 16 h), using indole (26 mg, 
0.22 mmol, 1.05 equiv.), 185 (50mg, 0.21 mmol, 1 equiv.), acetonitrile (2 mL). 
Purification was achieved by flash chromatography to afford 200 as a yellow solid (54 
mg, 73 %). 
 
MP: 216–217 °C; FTIR (thin film) υmaz: 3361, 2981, 2972, 1890, 1638, 1580, 1532; 
1
H 
NMR (400 MHz, CDCl3) δH: 7.83 (2H, app.d., J = 8.1 Hz), 7.73 (2H, app.d., J = 7.6 
Hz), 7.65 (2H, app.d., J = 8.1 Hz), 7.37–7.29 (2H, m), 7.28–7.18 (1H, m), 6.20 (1H, s), 
3.76–3.62 (1H, m), 3.23 (1H, dd, J = 14.7, 2.9 Hz), 3.01 (1H, dd, J = 14.7, 5.2 Hz), 
1.40 (3H, d, J = 7.5 Hz); 
13
C NMR (100 MHz) δ: 199.5, 143.7, 143.3, 135.8, 131.4 (q, J 
= 32.7 Hz), 129.3, 129.1, 129.0, 126.8, 126.8, 126.1 (q, J = 3.3 Hz), 125.1, 123.9 (q, J 
= 272.2), 120.7, 119.6, 111.5, 48.1, 25.0, 17.1; HRMS (ESI, +ve) m/z: calcd. for 














Prepared according to general procedure B (reaction time = 8 h, RT), using indole (22 
mg, 0.19 mmol, 1.05 equiv.), 186 (40 mg, 0.18 mmol, 1 equiv.), sodium 
tetrachloroaurate (III) hydrate (3.6 mg, 0.01 mmol, 5 mol%), acetonitrile (2 mL). 
Purification was achieved by flash chromatography afforded 201 as a yellow oil (50 mg, 
81%).  
 
FTIR (thin film) max: 3319, 3056, 2957, 2924, 2855, 1623, 1567, 1536; 
1
H NMR (300 
MHz, CDCl3) H: 7.91–7.72 (5H, m), 7.60 (1H, app.d., J = 7.9 Hz), 7.55–7.41 (3H, m), 
7.22–7.03 (3H, m), 6.18 (1H, d, J = 1.5 Hz), 3.64–3.48 (1H, m), 3.11 (1H, dd, J = 14.6, 
3.3 Hz), 2.87 (1H, ddd, J = 14.6, 5.4, 1.5 Hz), 1.29 (3H, d, J = 7.4 Hz); 
13
C NMR (75 
MHz, CDCl3) C: 199.9, 145.3, 137.1, 135.6, 133.4, 133.1, 130.1, 129.1, 128.8, 128.4, 
128.0, 127.9, 127.2, 127.0, 126.8, 126.3, 126.1, 124.7, 120.5, 119.5, 111.5, 48.3, 25.0, 









Prepared according to general procedure B (reaction time = 24 h, reflux), using indole 
(43 mg, 0.42 mmol, 1.05 equiv.), 187 (60 mg, 0.4 mmol, 1 equiv.), sodium 
tetrachloroaurate (III) hydrate (8 mg, 0.02 mmol, 5 mol%) in acetonitrile (2 mL). 
Purification was achieved by flash chromatography to afford 202 a yellow oil (85 mg, 
79%). 





FTIR (thin film) max: 2915, 2843, 1704, 1692, 1622, 1602; 
1
H NMR (500 MHz, 
CDCl3) H: 8.15 (1H, br. s), 7.64 (1H, d, J = 8.3 Hz), 7.42–7.40 (1H, m), 7.32–7.28 
(1H, m), 7.18 (1H, t, J = 7.3 Hz), 6.15 (1H, s), 3.07 (1H, dd, J = 14.2, 3.1 Hz), 2.87 
(1H, dd, J = 14.2, 5.5 Hz), 2.74–2.58 (2H, m), 1.67 (2H, pent, J = 7.2 Hz), 1.47 (2H, 
sext, J = 7.2 Hz), 1.23 (3H, d, J = 7.2 Hz), 0.98 (3H, t, J = 7.2 Hz); 
13
C NMR (125 
MHz, CDCl3) : 200.2, 144.7, 141.3, 127.8, 126.8, 125.7, 124.6, 120.4, 119.4, 111.2, 
47.7, 36.2, 31.3, 22.5, 16.6, 13.9; HRMS (ESI, +ve) m/z: calcd. for C18H21ONNa 








Prepared according to general procedure B (reaction time = 48 h, reflux), using indole 
(43 μL, 0.42 mmol, 1.05 equiv.), 189 (66 mg, 0.40 mmol, 1 equiv.), sodium 
tetrachloroaurate (III) hydrate (8 mg, 0.020 mmol, 5 mol%), acetonitrile (2 mL). 
Purification by flash chromatography afforded 204 as a yellow oil (111 mg, 98%). 
 
FTIR (thin film) max: 3058, 2961, 2149, 1665, 1620. 
1
H NMR (400 MHz, CDCl3) H: 
8.08 (1H, br.s), 7.74–7.71 (1H, m), 7.41 (1H, dt, J = 8.2, 0.9 Hz), 7.28–7.17 (2H, m), 
7.03 (1H, d, J = 2.2 Hz), 3.87–3.79 (1H, m), 3.14 (1H, dd, J = 16.0, 5.7 Hz), 2.88 (1H, 
dd, J = 16.0, 8.9 Hz), 1.48 (3H, d, J = 7.1 Hz), 0.28 (9H, s);  
13
C NMR (125 MHz, 
CDCl3) C: 187.3, 136.6, 126.3, 122.1, 120.6, 120.3, 119.3, 119.1, 111.3, 102.2, 98.2, 
53.1, 27.3, 21.0, -0.75; HRMS (ESI, +ve) m/z: calcd. for C25H20NO: 284.1471, found: 












Prepared according to general procedure B (reaction time = 8 h, reflux), using indole 
(31 mg, 0.27 mmol, 1 equiv.), 191 (58 mg, 0.29, 1 equiv.), sodium tetrachloroaurate 
(III) hydrate (11 mg, 0.03 mmol, 0.1 equiv.), acetonitrile (2 mL). Purification was 
achieved by flash chromatography to afford 205 as a yellow oil (60 mg, 72 %). 
 
FTIR (thin film) υmaz: 3335.4, 3059.2, 2958.1, 1626.1, 1583.9, 1566.8, 1535.0. 
1
H NMR 
(500 MHz, CDCl3) δ: 7.84 (1H, s), 7.67 (1H, d, J = 8.1 Hz), 7.55–7.43 (5H, m), 7.30–
7.22 (2H, m), 7.20–7.14 (1H, m), 6.19 (1H, s), 3.21 (1H, dd, J = 15.2, 5.1 Hz), 3.12–
3.00 (2H, m), 2.22–2.10 (1H, m), 1.12 (3H, d, J = 6.6 Hz), 0.91 (3H, d, J = 6.6 Hz); 
13C NMR (125 MHz) δ: 199.9, 145.6, 139.8, 135.4, 129.9, 129.4, 128.9, 128.7, 128.3, 
125.5, 124.5, 120.4, 120.2, 111.3, 45.8, 37.5, 28.8, 22.7, 20.4; HRMS (ESI, +ve) m/z: 








Prepared according to general procedure B (reaction time = 18 h, RT), using indole (69 
mg, 0.60 mmol, 1.05 equiv.), 190 (100 mg, 0.54 mmol, 1 equiv.), sodium 
tetrachloroaurate (III) hydrate (11 mg, 0.03 mmol, 5 mol%), acetonitrile (4 mL). 
Purification by flash chromatography afforded 206 as a yellow solid (119 mg, 73%). 
 
FTIR (thin film) max: 3335, 2057, 2971, 2932, 1634, 1584, 1568, 1538; 
1
H NMR (500 
MHz, CDCl3)  (Major):  7.79 (1H, br. s), 7.67 (1H, app.d., J = 8.06 Hz), 7.56–7.42 (5H, 
m), 7.31–7.24 (2H, m), 7.23–7.15 (1H, m), 6.11 (1H, s), 3.46–3.37 (1H, m), 3.02–2.93 
(1H, m), 1.35 (3H, d, J = 7.5 Hz), 1.14 (3H, d, J = 7.5 Hz);  (Minor): 7.79 (1H, br. s), 
7.67 (1H, app.d., J = 8.06 Hz), 7.56–7.42 (5H, m), 7.31–7.24 (2H, m), 7.23–7.15 (1H, 
m), 6.07 (1H, d, J = 1.5 Hz), 3.34–3.23 (1H, m), 3.02–2.93 (1H, m), 1.18 (3H, d, J = 
7.4 Hz), 1.10 (3H, d, J = 7.5 Hz); 
13
C NMR (125 MHz, CDCl3) : 203.4, 144.3, 139.6, 
135.8, 129.7, 129.2, 129.0, 128.5, 128.3, 127.2, 124.7, 123.1, 120.3, 119.4, 111.4, 51.5, 




31.6, 18.3, 16.0; HRMS (ESI, +ve) m/z: calcd. for C21H20NO: 302.1545, found: 









Prepared according to general procedure B (reaction time = 3 h, reflux), using indole 
(43 mg, 0.42 mmol, 1.05 equiv.), 192 (94 mg, 0.40 mmol, 1 equiv.), sodium 
tetrachloroaurate (III) hydrate (8 mg, 0.02 mmol, 5 mol%), acetonitrile (2 mL). 
Purification by flash chromatography afforded 207 as a yellow solid (140 mg, 100%).   
 
MP: 125–126 °C; FTIR (thin film) max: 3057, 2952, 1624, 1536; 
1
H NMR (500 MHz, 
CDCl3) H: 7.90 (1H, br. s), 7.53–7.46 (6H, m), 7.32–7.11 (8H, m), 6.12 (1H, d, J = 1.3 
Hz), 4.86–4.84 (1H, m), 3.52 (1H, dd, J = 14.9, 6.0 Hz), 3.43 (1H, dd, J = 14.9, 3.4 
Hz); 
13
C NMR (125 MHz, CDCl3) C: 198.9, 145.0, 139.8, 139.6, 135.6, 131.2, 
129.4(x2), 129.0, 128.6(x2), 127.4(x2), 126.8, 124.8, 122.9, 120.7, 119.8, 111.4, 48.7, 








Prepared according to general procedure B (reaction time = 24 h, RT), using indole (22 
mg, 0.19 mmol, 1.05 equiv.), 193 (50 mg, 0.18 mmol, 1 equiv.), sodium 
tetrachloroaurate (III) hydrate (4 mg, 0.01 mmol, 5 mol%), acetonitrile (2 mL). 
Purification by flash chromatography afforded 208 as a yellow oil (68 mg, 97%).  





FTIR (thin film) max: 3333, 3058, 2981, 2889, 1626, 1581, 1538; 
1
H NMR (400 MHz, 
CDCl3) H:  8.01–7.90 (5H, m), 7.64–7.58 (2H, m), 7.55 (1H, app.dd., J = 8.4, 1.7 Hz) 
7.50 (1H, app.dd., J = 8.4, 0.6 Hz), 7.33–7.29 (3H, m), 7.27–7.23 (2H, m), 7.21 (1H, tt, 
J = 7.0, 1.7 Hz),  7.15–7.11 (1H, m), 6.23 (1H, d, J = 1.4 Hz), 4.88 (1H, dd, J = 6.0, 3.7 
Hz), 3.55 (1H, ddd, J = 15.0, 6.0, 1.4 Hz), 3.47 (1H, dd, J = 15.0, 3.7 Hz); 
13
C NMR 
(125 MHz, CDCl3) C: 199.0, 145.3, 139.9, 137.0, 135.7, 133.5, 133.1, 129.6, 128.8, 
128.7, 128.4, 128.1, 127.9, 127.6, 127.5, 127.2, 127.1, 126.9, 126.1, 124.8, 123.0, 
120.7, 119.8, 111.6, 48.8, 35.4; HRMS (ESI, +ve) m/z: calcd. for C29H21NONa: 








Prepared according to general procedure B (reaction time = 36 h, reflux), using indole 
(43 mg, 0.42 mmol, 1.05 equiv.), 194 (85 mg, 0.40 mmol, 1 equiv.), sodium 
tetrachloroaurate (III) hydrate (8 mg, 0.02 mmol, 5 mol%), acetonitrile (2 mL). 
Purification by flash chromatography affordef 209 as a yellow oil (88 mg, 67%).  
 
FTIR (thin film) max: 3060, 3024, 2956, 2929, 2871, 1715, 1620, 1530; 
1
H NMR (400 
MHz, CDCl3) H: 8.28 (1H, br. s), 7.45–7.10 (9H, m), 6.05 (1H, s), 4.77–4.72 (1H, m), 
3.42 (1H, dd, J = 14.7, 5.6 Hz), 3.31 (1H, dd, J = 14.7, 3.7 Hz), 2.76–2.56 (2H, m), 
1.71–1.37 (4H, m), 0.95 (3H, t, J = 7.2 Hz); 13C NMR (100 MHz, CDCl3) C: 199.2, 
144.9, 139.7, 135.6, 132.0, 128.5, 128.4, 128.2, 127.6, 127.4, 124.7, 122.4, 120.6, 
119.7, 111.3, 48.2, 36.3, 35.1, 31.2, 22.3, 12.9; HRMS (ESI, +ve) m/z: calcd. for 















Prepared according to general procedure B (reaction time = 12 h), using indole (43 mg, 
0.42 mmol, 1.05 equiv.), 195 (63 mg, 0.40 mmol, 1 equiv.), sodium tetrachloroaurate 
(III) hydrate (8 mg, 0.02 mmol, 5 mol%), acetonitrile (2 mL). Purification by flash 
chromatography afforded 210 as a yellow oil (108 mg, 99%). 
 
FTIR (thin film) max: 3058, 2927, 1723, 1624, 1538; 
1
H NMR (500 MHz, CDCl3) H: 
7.78 (1H, br. s), 7.67 (1H, d, J = 8.3 Hz), 7.53–7.46 (5H, m), 7.30–7.25 (2H, m), 7.21–
7.17 (1H, m), 6.24 (1H, s), 3.23–3.20 (2H, m), 2.97–2.94 (2H, m); 13C NMR (125 MHz, 
CDCl3) C: 200.6, 145.2, 139.7, 135.7, 131.4, 129.4, 129.0, 128.7, 128.4, 127.0, 124.6, 
121.3, 120.4, 119.6, 111.4, 42.5, 18.2; HRMS (ESI, +ve) m/z: calcd. for C19H16NO 








Prepared according to general procedure B (reaction time = 96 h, reflux), using indole 
(43 mg, 0.42 mmol, 1.05 equiv.), 196 (54 mg, 0.4 mmol, 1 equiv.), sodium 
tetrachloroaurate (III) hydrate (8 mg, 0.02 mmol, 5 mol%), acetonitrile (2 mL). 
Purification by flash chromatography afforded 211 as a yellow oil (61 mg, 60%). 
 
FTIR (thin film) max: 3058, 2955, 2927, 2869, 1718, 1616, 1589, 1574; 
1
H NMR (500 
MHz, CDCl3) H:  8.16 (1H, br. s), 7.63 (1H, app. d, J = 7.2 Hz), 7.40 (1H, app. d, J = 
7.2 Hz), 7.31–7.28 (1H, m), 7.18 (1H, app. t, J = 7.2 Hz), 6.15 (1H, s), 3.08–3.05 (2H, 
m), 2.85–2.83 (2H, m), 2.64 (2H, app. t, J = 7.8 Hz), 1.69–1.62 (2H, m), 1.46 (1H, sext, 
J = 7.2 Hz), 0.98 (3H, t, J = 7.2 Hz); 
13
C NMR (125 MHz, CDCl3) C: 200.8, 145.3, 




135.7, 132.2, 127.4, 127.1, 124.4, 120.8, 120.4, 119.5, 111.3, 41.9, 36.3, 31.3, 22.5, 









Prepared according to general procedure B (reaction time = 8 h, RT), using indole (36 
mg, 0.31 mmol, 1.05 equiv.), 197 (50 mg, 0.29, 1 equiv.), sodium tetrachloroaurate (III) 
hydrate (6 mg, 0.015 mmol, 5 mol%), acetonitrile (2 mL). Purification by flash 
chromatography afforded 212 as a yellow oil (64 mg, 76 %). 
 
FTIR (thin film) max: 3324, 2981, 1629, 1540; 
1
H NMR (300 MHz, CDCl3) H: 7.79 
(1H, br. s), 7.58 (1H, app.d., J = 7.7 Hz), 7.48–7.28 (5H, m), 7.22–6.98 (3H, m), 6.10 
(1H, s), 3.12 (1H, dd, J = 15.4, 2.0 Hz), 3.04–2.74 (2H, m), 1.15 (3H, d, J = 6.7 Hz); 
13
C NMR (75 MHz, CDCl3) C: 201.7, 143.1, 138.5, 134.7, 130.2, 128.3, 127.9, 127.7, 
126.9, 126.6, 123.4, 119.3, 118.5, 118.3, 110.4, 43.9, 24.8, 14.8; HRMS (ESI, +ve) m/z: 










To a microwave vial was added 166 (62 mg, 0.15 mmol, 1 equiv.), phenylboronic acid 
(18 mg, 0.15 mmol, 1 equiv.), K2CO3 (31 mg, 0.23 mmol, 1.5 equiv.) and Pd(PPh3)4 (7 
mg, 0.006 mmol, 4 mol%). Acetonitrile (3 mL) and water (1 mL) were added and the 
vessel was sealed, followed by sonication and purging with nitrogen concurrently for 10 




minutes. The reaction mixture was then subjected to microwave irradiation at 120 °C 
for 30 minutes. The reaction mixture was then passed through a plug of silica gel before 
concentration in vacuo. Purification was achieved by flash chromatography, eluting 
with 8:1 Pet/EtOAc, affording 214 as a yellow oil (50 mg, 92%). 
 
FTIR (thin film) max: 3317, 2956, 2922, 2854; 
1
H NMR (500 MHz, CDCl3) :  7.87 
(1H, s), 7.82 (1H, br. s), 7.69–7.65 (2H, m), 7.55–7.45 (8H, m), 7.39–7.32 (2H, m), 6.21 
(1H, d, J = 1.3 Hz), 3.77–3.66 (1H, m), 3.21 (1H, dd, J = 14.6, 3.3 Hz), 2.98 (1H, dd, J 
= 14.6, 1.3 Hz), 1.39 (1H, d, J = 7.5 Hz); 
13
C NMR (125 MHz, CDCl3) C: 199.8, 
145.0, 142.0, 139.7, 138.2, 135.0, 134.1, 130.6, 129.3, 129.0, 128.8, 128.5, 127.3, 
126.8, 126.4, 124.7, 117.7, 111.7, 48.2, 25.0, 17.1; HRMS (ESI, +ve) m/z: calcd. for 




To a microwave vial was added 165 (62mg, 0.15 mmol, 1 equiv.), iodobenzene (17 µL, 
0.15 mmol, 1 equiv.), K2CO3 (31 mg, 0.225 mmol, 1.5 equiv.) and Pd(PPh3)4 (7 mg, 
0.006 mmol, 4 mol%). Acetonitrile (3 mL) and water (1 mL) were added and the vessel 
was sealed, followed by sonication and purging with nitrogen concurrently for 10 
minutes. The reaction mixture was then subjected to microwave irradiation at 120 °C 
for 30 minutes. The reaction mixture was then passed through a plug of silica gel before 
concentration in vacuo. Purification was achieved by flash chromatography (8:1 
Pet/EtOAc) affording 214 as a yellow oil (54 mg, 99%). 













To a microwave vial was added 165 (62mg, 0.15 mmol, 1 equiv.), 166 (62 mg, 0.15 
mmol, 1 equiv.), K2CO3 (31 mg, 0.225 mmol, 1.5 equiv.) and Pd(PPh3)4 (7 mg, 0.006 
mmol, 4 mol%). Acetonitrile (3 mL) and water (1 mL) were added and the vessel was 
sealed, followed by sonication and purging with nitrogen concurrently for 10 minutes. 
The reaction mixture was then subjected to microwave irradiation at 120 °C for 30 
minutes. The reaction mixture was then passed through a plug of silica gel before 
concentration in vacuo. Purification was achieved by flash chromatography, eluting 
with 8:1 Pet/EtOAc, affording 216 as a yellow oil (75 mg, 87%). 
 
FTIR (thin film) max: 3353, 2960, 1630, 1583, 1565, 1531; 
1
H NMR (500 MHz, 
CDCl3) H:  7.93–7.87 (2H, m), 7.79 (2H, s), 7.63–7.57 (10H, m), 7.36 (2H, app.d., J = 
8.5 Hz), 6.22 (2H, d = 1.5 Hz), 3.80 (2H, m), 3.23 (2H, dt, J = 14.5, 2.9 Hz), 3.00 (2H, 
ddd, J = 14.5, 6.5, 1.1 Hz), 1.41 (3H, d, J = 7.3 Hz), 1.40 (3H, d, J = 7.3 Hz); 
13
C NMR 
(125 MHz, CDCl3) C: 199.8, 145.0, 139.7, 134.9, 134.8, 130.6, 129.3, 129.0(x2), 
128.5, 127.4, 126.4, 125.1, 117.6, 111.7, 48.2, 25.0, 17.1; HRMS (ESI, +ve) m/z: calcd. 










To indole (27 mg, 0.23 mmol, 1 equiv.) in a round bottomed flask, was added a solution 
of 190 (42 mg, 0.23 mmol, 1 equiv.) in acetonitrile (1 mL) at 0 °C. A solution of 2,4-
dinitrobenzenesulfonic acid (3 mg, 0.01 mmol, 5 mol%) in acetonitrile (1 mL) was 
added and stirred at room temperature for 2 hours. The solution was filtered through 
celtie and concentrated in vacuo. 2:1 dr as determined by 
1




H NMR (500 MHz, CDCl3) H (Major): 8.06 (1H, br. s), 7.71 (1H, app. d, J = 7.9 Hz), 
7.61–7.54 (2H, m), 7.55–7.38 (4H, m), 7.29–7.15 (2H, m), 7.11–7.08 (1H, m), 3.59– 
3.49 (1H, m), 3.21–3.11 (1H, m), 1.51 (3H, d, J = 7.0 Hz), 1.20 (3H, d, J = 6.9 Hz); H 
(Minor): 8.06 (1H, br. s), 7.82 (1H, app. d, J = 7.9 Hz), 7.61–7.54 (2H, m), 7.55–7.38 (4H, 




m), 7.29–7.15 (2H, m), 7.11–7.08 (1H, m), 4.02–3.93 (1H, m), 3.32–3.23 (1H, m), 1.40 











A flask was charged with freshly distilled 1-methylindole (1.56 mL, 13.2 mmol) and 
then flushed with argon. To this was added D2O (4 mL), and the mixture heated to 105 
C overnight with very vigorous stirring. Upon cooling, the solution was extracted with 
hexanes (3 × 5 mL), and dried over Na2SO4. The solvent was removed and the final 
product was purified by distillation from molecular sieves. The product was 94 % 
enriched with deuterium in the 3-position, as determined by 
1









To a solution of 187 (280 mg, 1.90 mmol, 1 equiv.) in acetonitrile (10 mL) at 0 °C was 
added DNsOH (23 mg, 0.10 mmol, 5 mol%) portionwise, the reaction was then allowed 
to stir for 40 minutes. Upon completion, the reaction was filtered through K2CO3 and 
concentrated in vacuo. Purification was achieved by flash chromatography, eluting with 
8:1 Pet/EtOAc, to provide 219 as a yellow oil (404 mg, 81%). 
 
FTIR (thin film) max: 3414, 2959, 2933, 2872, 2208, 1659; 
1
H NMR (500 MHz, 
CDCl3) :  8.03 (1H, br. s), 7.68 (1H, app. d, J = 8.0 Hz), 7.36 (1H, app. d, J = 8.0 
Hz), 7.21 (1 H, app. t, J = 7.5 Hz), 7.14 (1H, app. t, J = 7.5 Hz), 6.98 (1H, d, J = 1.6 
Hz), 3.85–3.72 (1H, m), 3.08 (1H, dd, J = 15.7, 5.8 Hz), 2.81 (1H, dd, J = 15.7, 8.7 




Hz), 2.35 (2H, t, J = 6.8 Hz), 1.61–1.49 (2H, m), 1.48–1.37 (5H, m), 0.93 (3H, t, J = 
7.4 Hz); 
13
C NMR (125 MHz, CDCl3) C: 187.9, 136.6, 126.4, 122.1, 120.7, 120.3, 
119.3, 119.1, 111.4, 94.9, 81.1, 53.2, 29.7, 27.4, 22.0, 21.0, 18.7, 13.5; HRMS (ESI, 












A flame dried flask was charged with freshly distilled 1-methylindole (1.56 mL, 13.2 
mmol) and purged with nitrogen. Anhydrous THF (20 mL) was added and the solution 
cooled to 0 C. n-BuLi (1.6 M in hexanes, 14.9 mL, 23.8 mmol) was added drop wise, 
and the resulting solution warmed to rt and stirred for an additional 20 minutes. Very 
slowly, D2O (1 mL) was added drop wise. After the solution was fully quenched, it was 
extracted with hexanes (3 × 5 mL). The organic solution was dried over Na2SO4 and 
concentrated in vacuo. The final product was purified by distillation from molecular 
sieves. The product was 98 % enriched with deuterium in the 2-position, as determined 
by 
1






To a solution of C-3-
2
H-168 (65 µL, 0.51 mmol, 1 equiv.) in MeCN (1 mL) was added 
3-penten-2-one (50 µL, 0.51 mmol, 1 equiv.). A solution of AuCl3 (8 mg, 5 mol%) in 
MeCN (1 mL) was added and the reaction allowed to stir for 40 mins.  The reaction 
mixture was then filtered through a pad of celite and concentrated in vacuo. The crude 
residue was subjected to flash chromatography, eluting with 8:1 Pet/EtOAc, affording 
221 as a light yellow oil (76 mg, 69%). The product was 72 % enriched with deuterium 
in the 2-position, as determined by 
1
H NMR (See appendix 6.3.3) 





FTIR (thin film) max: 2060, 2927, 2882, 1709; 
1
H NMR (300 MHz, CD3CN) H: 7.67–
7.61 (1H, m), 7.38–7.33 (1H, m), 7.24–7.17 (1H, m), 7.11–7.04 (1H, m), 6.97 (1H, s, 
70% D incorporation), 3.74 (3H, s), 3.63–3.51 (1H, m), 2.92 (1H, dd, J = 16.5, 7.0 Hz), 
2.73 (1H, dd, J = 16.5, 7.0 Hz), 2.08 (3H, s), 1.33 (3H, d, J = 7.0 Hz); 
13
C NMR (75 
MHz, CD3CN) C: 207.6, 136.9, 126.4, 124.9, 121.0, 120.9, 118.7, 118.1, 109.1, 50.5, 
31.6, 29.1, 26.2, 20.7; HRMS (ESI, +ve) m/z: calcd. for C14H16DNONa, 239.1271 found 












To a solution of 3-butyn-2-ol (900 µL, 11.4 mmol, 1 equiv.) in THF (35 mL) was added 
triethylamine (3.30 mL, 22.7 mmol, 2 equiv.), TBDPSCl (3.20 mL, 12.5 mmol, 1.1 
equiv.) and DMAP (140m g, 1.14 mmol, 10 mol%). The resultant mixture was stirred at 
rt for 18 h, diluted with hexane (150 mL) and washed with NH4Cl (sat) (150 mL) and 
brine (150 mL) and dried over MgSO4, filtered and concentrated in vacuo. Purification 
via flash chromatography, eluting with 100 % Pet, afforded 271 as a clear oil (3.27 g, 94 
%). 
 
FTIR (thin film) max: 3306, 3072, 3050, 2983, 2960, 2932, 2891, 2858;  
1
H NMR (250 
MHz, CDCl3) δH: 7.71–7.57 (4H, m), 7.40–7.24 (6H, m), 4.38 (1H, dq, J = 6.5, 2.1 Hz), 
2.25 (1H, d, J = 2.1 Hz), 1.31 (3H, d, J = 6.5 Hz), 1.00 (9H, s); 
13
C NMR (75 MHz, 
CDCl3) δC 136.4, 136.2, 134.1, 133.8, 130.2, 130.1, 128.0, 127.9, 86.5, 71.0, 31.3, 27.3, 















To a solution of the silyl ether 271 (10.0 g, 33.0 mmol, 1 equiv.) in acetone (180 mL) 
was added N-bromosuccinimide (6.46 g, 36.3 mmol, 1.1 equiv.) and AgNO3 (560 mg, 
3.30 mmol, 10 mol%). The resultant mixture was stirred at rt for 3 h, diluted with 
CHCl3 (180 mL), filtered through a pad of celite and concentrated in vacuo. Purification 
via flash chromatography, eluting with 100 % Pet, afforded the title product (11.25 g, 
88 %) as a light yellow oil. 
 
FTIR (film/cm
-1) υmax: 3076, 2985, 2964, 2932, 2894, 2864; 
1
H NMR (250 MHz, 
CDCl3) δH: 7.68–7.56 (4H, m), 7.39–7.25 (6H, m), 4.37 (1H, q, J = 6.5 Hz), 1.31 (3H, 
d, J = 6.5Hz) 0.99 (9H, s); 
13
C NMR (75 MHz, CDCl3) δC: 136.3, 136.2, 134.0, 133.8, 
130.2, 130.1, 128.0, 127.9, 82.7, 61.2, 44.3, 27.2, 25.4, 19.6; MS (ESI:+ve) m/z: calcd 










To a solution of 272 (1.50 g, 3.80 mmol, 1.1 equiv.) and oxazolidinone (300 mg, 3.50 
mmol, 1 equiv.) in toluene (50 mL) was added CuSO4.5H2O (175 mg, 0.70 mmol, 20 
mol%), 1,10-phenanthroline (250 mg, 1.40 mmol, 40 mol%) and K3PO4 (1.50 g, 7.00 
mmol, 2 equiv.). The suspension was then refluxed for 48 h, filtered through celite and 
concentrated in vacuo. Purification via flash chromatography, eluting with 4:1 




Pet/EtOAc, afforded ynamide 274 as a white powder (0.88g, 64%). Recrysallisation 
(Pet/DCM) afforded the title compound as colourless crystals.  
 
MP: 110–112; FTIR (film/cm-1) υmax: 2929, 2856, 2262, 1777; 
1
H NMR (250 MHz, 
CDCl3) δH:  7.71–7.59 (4H, m), 7.36–7.26 (6H, m), 4.58 (1H, q, J = 6.5), 4.25 (2H, t, J 
= 8.0 Hz), 3.51 (2H, m), 1.37 (3H, d, J = 6.5 Hz), 0.99 (9H, s); 
13
C NMR (75 MHz, 
CDCl3) δC: 156.2, 136.4, 136.2, 134.3, 134.1, 130.1, 129.9, 128.0, 127.8, 74.6, 73.9, 
63.2, 60.5, 47.0, 27.3, 25.5, 19.5; MS (ESI:+ve) m/z: calcd for C23H28NO3Si: 394.1838, 










To a solution of the protected ynamide 274 (3.00g, 7.60 mmol, 1 equiv.) in THF (175 
mL) was added TBAF (1M in THF, 15.2 mL, 15.2 mmol, 2 equiv.) at 0 
o
C. The 
resultant solution was then warmed to rt, after 40 min the reaction mixture was 
hydrolysed with NH4Cl (sat) (25 mL) and extracted with EtOAc (3 × 25 mL). The 
combined extracts were dried over MgSO4, filtered and concentrated in vacuo. The 
crude material was purified by rapid filtration through silica gel, eluting with 100% 




) υmax: 3245, 2924, 2854, 1765; 
1
H NMR (250 MHz, CDCl3) δH:  4.68 
(1H, q, J = 6.6 Hz), 4.48–4.26 (2H, m), 3.94–3.87 (2H, m), 2.49 (1H, br s), 1.47 (3H, d, 
J = 6.6Hz); 
13
C NMR (75 MHz, CDCl3) δC: 156.3, 74.1, 73.4, 63.1, 58.3, 46.8, 24.2; 


















To a solution of EDCi (2 equiv.) in DCM was successively added triethylamine (2 
equiv.), DMAP (20 mol%), phenylacetic acid (2 equiv.) and propargylic alcohol (1 
equiv.). After 3 hours at room temperature the resultant solution was washed with 10% 
citric acid (3 x 10 ml), NaHCO3 (sat) (3 x 10 ml) and brine (10 ml). The organic extract 
was then dried over MgSO4 and concentrated in vacuo. The crude mixture was then 
subjected to column chromatography for purification, eluting with 4:1 Pet/EtOAc. 
 




Prepared according to general procedure C using; propargyl alcohol 266 (290 mg, 1.89 
mmol, 1 equiv.), phenylacetic acid (510 mg, 3.78 mmol, 2 equiv.), EDCi (720 mg, 3.78 
mmol, 2 equiv.), triethylamine (550 µL, 3.78 mmol, 2 equiv.), DMAP (50 mg, 0.76 
mmol, 20 mol%) and DCM (30 mL). Purification was achieved by recrystallization 
from DCM/hexane to afford 264 as colourless crystals (0.45 g, 88 %). 
 
MP: 115–116; FTIR (film/cm-1) υmax: 3031, 2991, 2915, 2262, 1760, 1733; 
1
H NMR 
(250 MHz, CDCl3) δH: 7.40-7.30 (5H, m), 5.64 (1H, q, J = 6.8 Hz) 4.46 (2H, m), 3.92 
(2H, m), 3.66 (2H, s), 1.55 (3H, d, J = 6.8 Hz); 
13
C NMR (75 MHz, CDCl3) δC: 170.5, 
155.9, 133.7, 129.3, 128.6, 127.1, 75.1, 70.1, 63.1, 61.0, 46.7, 41.2, 21.3; MS (ESI:+ve) 













To a solution of indole (1 equiv.) and ynamido ester (1 equiv.) in DCM at -30 °C was 
added PPh3AuCl (5 mol%) and AgPF6 (5mol%) portion-wise over 45 mins. Upon 
consumption of starting material, the reaction was filtered through a pad of silica and 







To a solution of 264 (50 mg, 0.18 mmol, 1 equiv.) in DCM (2 mL) was added 
AuCl(PPh3) (4.5 mg, 0.01 mmol, 5 mol%) and AgSbF6 (3.4 mg, 0.01 mmol, 5 mol%). 
The reaction mixture was allowed to stir at room temperature for 5 minutes before being 
filitered through a pad of silica. Purification by flash chromatography afforded 275 as a 
light yellow oil (1 mg, 4%). 
 
FTIR (film/cm
-1) υmax: 2981, 2920, 1770, 1679, 1628; 
1
H NMR (500 MHz, CDCl3) δH: 
7.03 (1H, dq, J = 11.7, 1.8 Hz), 6.49 (1H, dq, J = 11.7, 7.3 Hz), 4.42 (2H, app. t, J = 8.0 
Hz), 4.07 (2H, app. t, J = 8.0 Hz), 2.16 (3H, dd, J = 7.3, 1.8 Hz); 
13
C NMR (75 MHz, 
CDCl3) δC: 165.2, 153.5, 146.8, 119.7, 62.0, 42.5, 16.2; MS (ESI:+ve) m/z: calcd for 















Prepared according to general procedure D using, indole (21 mg, 0.18 mmol, 1 equiv.), 
264 (50 mg, 0.18 mmol, 1 equiv.), AuCl(PPh3) (4.5 mg, 0.01 mmol, 5 mol%), AgPF6 
(2.3 mg, 0.01 mmol, 5 mol%) and DCM (2 mL). Purification by flash chromatography 
afforded enamide 279 as a light yellow oil (65 mg, 93%). 
 
FTIR (thin film) max: 3659, 3408, 2981, 2972, 2889, 1758, 1686, 1621; 
1
H NMR (500 
MHz, CDCl3) H: 8.06 (1H, br.s), 7.55 (1H, d, J = 7.8 Hz), 7.35–7.32 (5H, m), 7.19 
(1H, app.t, J = 7.8 Hz), 7.10 (1H, app.t, J = 7.8 Hz), 6.93 (1H, d, J = 2.3 Hz), 5.23 (1H, 
d, J = 9.6 Hz), 4.26 (2H, app.t, J = 8.1Hz), 3.80 (2H, s), 3.77–3.71 (1H, m), 3.69–3.63 
(2H, m), 1.42 (3H, d, J = 6.8 Hz); 
13
C NMR (125 MHz, CDCl3) C: 169.4, 154.4, 136.5, 
136.3, 133.0, 129.5, 128.8, 127.5, 126.5, 122.0, 120.4, 119.7, 119.3, 119.3, 114.6, 
111.2, 61.7, 45.3, 40.7, 27.7, 20.8; HRMS (ESI, +ve) m/z: calcd. for C23H22N2O4Na: 









Prepared according to general procedure D using, 5-methyl indole (24 mg, 0.18 mmol, 1 
equiv.), 264 (50 mg, 0.18 mmol, 1 equiv.), AuCl(PPh3) (4.5 mg, 0.01 mmol, 5 mol%), 




AgPF6 (2.3 mg, 0.01 mmol, 5 mol%) and DCM (2 mL). Purification by flash 
chromatography afforded enamide 280 as a light yellow oil (65 mg, 89%). 
 
FTIR (thin film) max: 3659, 3407, 2981, 2972, 2889, 1755, 1689, 1627; 
1
H NMR (400 
MHz, CDCl3) H: 7.95 (1H, br.s), 7.63–7.50 (1H, m), 7.40–7.32 (5H, m), 7.27 (1H, d, J 
= 8.3 Hz), 7.06 (1H, dd, J = 8.3, 1.6 Hz), 6.93 (1H, dd, J = 2.6, 0.7 Hz), 5.29 (1H, d, J 
= 9.6 Hz), 4.31 (2H, app.t, J = 8.1 Hz), 3.86 (2H, s), 3.79–3.66 (3H, m), 2.51 (3H, s), 
1.44 (3H, d, J = 6.9 Hz); 
13
C NMR (100 MHz, CDCl3) C: 169.4, 154.5, 136.3, 134.9, 
133.1, 129.5, 128.8, 128.4, 127.5, 126.7, 123.6, 120.5, 119.2, 119.0, 114.9, 110.9, 61.7, 
45.4, 40.7, 27.7, 21.6, 21.0; HRMS (ESI, +ve) m/z: calcd. for C24H24N2O4Na: 427.1634, 









Prepared according to general procedure D using, 5-iodoindole (45 mg, 0.18 mmol, 1 
equiv.), 264 (50 mg, 0.18 mmol, 1 equiv.), AuCl(PPh3) (4.5 mg, 0.01 mmol, 5 mol%), 
AgPF6 (2.3 mg, 0.01 mmol, 5 mol%) and DCM (2 mL). Purification by flash 
chromatography afforded enamide 281 as a orange solid (87 mg, 92%). 
Recrystallisation (Pet/DCM) afforded the title compound as orange crystals. 
 
MP: 135–136 °C; FTIR (thin film) max: 3261, 2970, 2911, 1772, 1720, 1683; 
1
H NMR 
(400 MHz, CDCl3) H: 8.15 (1H, br. s), 7.91–7.87 (1H, m), 7.46 (1H, dd, J = 8.5, 1.7 
Hz), 7.42–7.33 (5H, m), 7.15 (1H, d, J = 8.5 Hz), 6.94–6.91 (1H, m), 5.32 (1H, d, J = 
9.7 Hz), 4.36–4.30 (2H, m), 3.84 (2H, s), 3.75–3.69 (2H, m), 3.68–3.57 (1H, m), 1.38 
(3H, d, J = 7.0 Hz); 
13
C NMR (100 MHz, CDCl3) C: 169.3, 154.7, 136.3, 135.6, 133.0, 
130.3, 129.4, 129.1, 128.9, 128.1, 127.7, 121.3, 119.2, 114.6, 113.3, 82.8, 61.8, 45.2, 




40.9, 27.5, 21.2; HRMS (ESI, +ve) m/z: calcd. for C23H21N2O4INa: 539.0444, found: 









Prepared according to general procedure D using, 5-fluoroindole (25 mg, 0.18 mmol, 1 
equiv.), 264 (50 mg, 0.18 mmol, 1 equiv.), AuCl(PPh3) (4.5 mg, 0.01 mmol, 5 mol%), 
AgPF6 (2.3 mg, 0.01 mmol, 5 mol%) and DCM (2 mL). Purification by flash 
chromatography afforded enamide 282 as a pink oil (74 mg, 99%). 
 
FTIR (thin film) max: 3359, 2959, 2924, 1754, 1697; 
1
H NMR (400 MHz, (CD3)2CO) 
H: 10.07 (1H, br. s), 7.43–7.39 (2H, m), 7.38–7.32 (3H, m), 7.32–7.22 (2H, m), 7.21–
7.18 (1H, m), 6.89 (1H, td, J = 9.2, 2.6 Hz), 5.29 (1H, d, J = 9.9 Hz), 4.39–4.32 (2H, 
m), 3.94 (2H, s), 3.88–3.76 (2H, m), 3.75–3.66 (1H, m), 1.37 (3H, d, J = 7.0 Hz); 13C 
NMR (100 MHz, (CD3)2CO) C: 168.9, 157.3 (d, J = 231.6 Hz), 154.0, 136.9, 133.9, 
133.6, 129.6, 128.5, 127.2, 127.0 (d, J = 8.8 Hz), 122.9, 119.4 (d, J = 4.6 Hz), 112.4, 
112.1 (d, J = 8.8 Hz), 109.3 (d, J = 24.6 Hz), 103.8 (d, J = 24.6 Hz), 61.7, 45.0, 40.1, 
27.4, 20.5; HRMS (ESI, +ve) m/z: calcd. for C23H21N2O4FNa: 431.1383, found: 



















Prepared according to general procedure D using, indole (32 mg, 0.18 mmol, 1 equiv.), 
264 (50 mg, 0.18 mmol, 1 equiv.), AuCl(PPh3) (4.5 mg, 0.01 mmol, 5 mol%), AgPF6 
(2.3 mg, 0.01 mmol, 5 mol%) and DCM (2 mL). Purification by flash chromatography 
afforded enamide 283 as an orange oil (43 mg, 53%). 
 
FTIR (thin film) max: 3383, 2957, 2923, 2854, 1760, 1703, 1617; 
1
H NMR (400 MHz, 
CDCl3) H: 8.46 (1H, br. s), 8.42–8.39 (1H, m), 7.92 (1H, dd, J = 7.0, 1.5 Hz), 7.38–
7.29 (6H, m), 7.02–7.00 (1H, m), 5.39 (1H, d, J = 9.7 Hz), 4.34–4.28 (2H, m), 4.00 
(3H, s), 3.84 (2H, s), 3.80–3.67 (3H, m), 1.43 (1H, d, J = 7.0 Hz); 13C NMR (100 MHz, 
CDCl3) C: 169.3, 168.3, 154.7, 139.2, 136.3, 133.0, 129.4, 128.8, 127.6, 126.0, 123.3, 
122.4, 121.9, 121.3, 121.1, 114.7, 111.0, 61.8, 51.9, 45.2, 40.8, 27.9, 21.4; HRMS (ESI, 









Prepared according to general procedure D using, 6-methoxy indole (27 mg, 0.18 mmol, 
1 equiv.), 264 (50 mg, 0.18 mmol, 1 equiv.), AuCl(PPh3) (4.5 mg, 0.01 mmol, 5 mol%), 




AgPF6 (2.3 mg, 0.01 mmol, 5 mol%) and DCM (2 mL). Purification by flash 
chromatography afforded enamide 284 as a light brown oil (70 mg, 92%). 
 
FTIR (thin film) max: 3401, 2981, 1754, 1684, 1628, 1628; 
1
H NMR (400 MHz, 
CDCl3) H: 7.96 (1H, s), 7.40 (1H, d, J = 8.6 Hz), 7.39–7.32 (5H, m), 6.88–6.84 (2H, 
m), 6.80 (1H, dd, J = 8.6, 2.2 Hz), 5.23 (1H, d, J = 9.6 Hz), 3.88 (3H, s), 3.86 (2H, s), 
3.74–3.66 (3H, m), 1.43 (3H, d, J = 7.0 Hz); 13C NMR (100 MHz, CDCl3) C: 169.4, 
156.5, 154.5, 137.3, 136.3, 133.1, 129.5, 128.8, 127.5, 121.0, 120.0, 119.7, 119.1, 
114.7, 109.3, 94.7, 61.7, 55.7, 45.4, 40.7, 27.7, 20.8; HRMS (ESI, +ve) m/z: calcd. for 








Prepared according to general procedure C using; propargyl alcohol 266 (331 mg, 2.14 
mmol, 1 equiv.), 2-(p-tolyl)acetic acid (643 mg, 4.28 mmol, 2 equiv.), EDCi (821 mg, 
4.28 mmol, 2 equiv.), NEt3 (591 µL, 4.28 mmol, 2 equiv.), DMAP (53 mg, 0.43 mmol, 
20 mol%) and DCM (40 mL). Purification was achieved by flash chromatography 
affording ester 288 as an orange solid (0.64 g, 99%). Recrystallisation (Pet/DCM) 
afforded the title compound as yellow crystals. 
 
MP: 103–105 °C; FTIR (film/cm-1) υmax: 2986, 2264, 1768, 1735, 1520; 
1
H NMR (300 
MHz, CDCl3) δH: 7.20 – 7.17 (2H, m), 7.16 – 7.13 (2H, m), 5.62 (1H, q, J = 6.7 Hz), 
4.46 – 4.41 (2H, m), 3.93 – 3.88 (2H, m), 3.60 (2H, s), 2.35 (3H, s), 1.53 (3H, d, J = 6.7 
Hz); 
13
C NMR (75 MHz, CDCl3) δC: 171.1, 155.9, 137.1, 130.7, 129.2, 129.1, 77.2, 
70.2, 63.0, 61.0, 46.7, 40.8, 21.3, 21.1; MS (ESI:+ve) m/z: calcd for C16H17NO4Na: 













Prepared according to general procedure C using; propargyl alcohol 266 (343 mg, 1.89 
mmol, 1 equiv.), 2-(4-methoxyphenyl)acetic acid (732 mg, 3.78 mmol, 2 equiv.), EDCi 
(844 mg, 4.36 mmol, 2 equiv.), triethylamine (603 µL, 4.36 mmol, 2 equiv.), DMAP 
(0.03g, 0.22 mmol, 20 mol%) and DCM (35 mL). Purification was achieved by flash 
chromatography yielding ester 289 as a yellow solid (0.53g, 79%). Recrystallisation 
(Pet/DCM) afforded the title compound as yellow crystals. 
 
MP: 74–76 °C; FTIR (film/cm-1) υmax: 2941, 2838, 2264, 1769, 1735, 1612, 1512; 
1
H 
NMR (300 MHz, CDCl3) δH: 7.24–7.16 (2H, m), 6.91–6.82 (2H, m), 5.61 (1H, q, J = 
6.8 Hz), 4.47–4.38 (2H, m), 3.93–3.84 (2H, m), 3.80 (3H, s), 3.57 (2H, s), 1.52 (3H, d, J 
= 6.8 Hz);  
13
C NMR (75 MHz, CDCl3) δC: 171.2, 159.1, 138.0, 130.7, 126.1, 114.4, 
77.6, 70.6, 63.4, 61.4, 55.7, 47.1, 40.8, 21.7; MS (ESI:+ve) m/z: calcd for C16H18NO5: 









Prepared according to general procedure C using; propargyl alcohol 266 (674 mg, 4.40 
mmol, 1 equiv.), 2-(4-(dimethylamino)phenyl)acetic acid (1.57 g, 8.80 mmol, 2 equiv.), 
EDCi (1.73 g, 8.8 mmol, 2 equiv.), triethylamine (1.21 mL, 8.80 mmol, 2 equiv.), 
DMAP (106 mg, 0.88 mmol, 20 mol%) and DCM (60 mL). Purification was achieved 




by flash chromatography yielding ester 290 as a yellow solid (0.93 g, 68%). 
Recrystallisation (Pet/DCM) afforded the title compound as yellow crystals. 
 
MP: 133–135 °C; FTIR (film/cm-1) υmax: 2982, 2890, 2268, 1773, 1735, 1615; 
1
H NMR 
(250 MHz, CDCl3) δH:7.18-7.11 (2H, m), 6.73-6.65 (2H, m), 5.60 (1H, q, J = 6.7 Hz), 
4.40 (2H, dd, J = 7.6, 6.6 Hz), 3.87 (2H, dd, J = 7.6, 6.6Hz), 3.52 (2H, s), 2.92 (6H, s), 
1.51 (3H, d, J = 6.7 Hz); 
13
C NMR (75 MHz, CDCl3) δC: 171.2, 155.9, 129.9, 121.5, 
122.8, 75.0, 70.3, 63.0, 60.8, 46.7, 40.7, 40.2, 21.4; MS (ESI:+ve) m/z: calcd for 








Prepared according to general procedure C using; propargyl alcohol 266 (674 g, 4.40 
mmol, 1 equiv.), 2-(4-fluorophenyl)acetic acid (1.35 g, 8.80 mmol, 2 equiv.), EDCi 
(1.73 g, 8.80 mmol, 2 equiv.), triethylamine (1.21 mL, 8.80 mmol, 2 equiv.), DMAP 
(106 mg, 0.88 mmol, 20 mol%) and DCM (60 mL). Purification was achieved by flash 
chromatography yielding ester 291 as an amorphous yellow solid (0.72g, 57%). 
 
FTIR (film/cm
-1) υmax: 2982, 2890, 2267, 1769, 1734, 1603; 
1
H NMR (250 MHz, 
CDCl3) δH: 7.30-7.17 (2H, m), 7.05-6.94 (2H, m), 6.60 (1H, q, J = 6.7 Hz), 4.42 (2H, 
dd, J = 8.0, 6.7 Hz), 3.87 (2H, dd, J = 8.0, 6.7 Hz), 3.59 (2H, s), 1.51 (3H, d, J = 6.7 
Hz); 
13
C NMR (75 MHz, CDCl3) δC: 170.4, 162.0 (d, J = 245.8 Hz), 155.8, 130.9, 130.8, 
129.4 (d J = 4.6 Hz), 115.4 (d, J = 22.1 Hz), 75.2, 70.0, 63.1, 61.2, 46.7, 40.4, 21.4; MS 
















Prepared according to general procedure C using; propargyl alcohol 266 (342 mg, 2.21 
mmol, 1 equiv.), 2-(4-iodophenyl)acetic acid (904 mg, 3.42 mmol, 2 equiv.), EDCi (843 
mg, 3.42 mmol, 2 equiv.), triethylamine (598 mL, 3.42 mmol, 2 equiv.), DMAP (27 mg, 
0.22 mmol, 20 mol%) and DCM (30 mL). Purification was achieved by flash 
chromatography yielding ester 292 as a yellow solid (0.62g, 71%). Recrystallisation 
(Pet/DCM) afforded the title compound as yellow crystals. 
 
MP: 92–94 °C; FTIR (film/cm-1) υmax: 2988, 2263, 1766, 1732, 1589; 
1
H NMR (300 
MHz, CDCl3) δH: 7.65 (2H, app.d, J = 8.5 Hz), 7.04 (2H, app. d, J = 8.5 Hz), 5.60 (1H, 
q, J = 6.9 Hz), 4.45 (1H, d, J = 7.8 Hz), 4.42 (1H, d, J = 6.6 Hz), 3.90 (1H, d, J = 6.6 
Hz), 3.87 (1H, d, J = 7.8 Hz), 3.57 (2H, s), 1.51 (3H, d, J = 6.9 Hz); 
13
C NMR (75 
MHz, CDCl3) δC: 169.9, 155.9, 137.6, 133.3, 131.4, 92.7, 75.5, 69.9, 63.1, 61.3, 46.7, 









Prepared according to general procedure C using; propargyl alcohol 266 (671 g, 4.40 
mmol, 1 equiv.), 2-(benzo[d][1,3]dioxol-5-yl)acetic acid (1.58 g, 8.80 mmol, 2 equiv.), 
EDCi (1.72 g, 8.80 mmol, 2 equiv.), triethylamine (1.21 mL, 8.80 mmol, 2 equiv.), 
DMAP (106 mg, 0.88 mmol, 20 mol%) and DCM (60 mL). Purification was achieved 




by flash chromatography yielding ester 293 as a yellow solid (0.81 g, 60%). 
Recrystallisation (Pet/DCM) afforded the title compound as yellow crystals. 
 
MP: 107–109 °C; FTIR (film/cm-1) υmax: 2982, 2890, 2267, 1768, 1733, 1613; 
1
H NMR 
(250 MHz, CDCl3) δH: 6.79-6.67 (3H, m), 5.93 (2H, s), 5.59 (1H, q, J = 6.7 Hz), 4.41 
(2H, dd, J = 7.8, 6.7 Hz), 3.88 (2H, dd, J = 7.8, 6.7 Hz), 3.52 (2H, s), 1.51 (3H, d, J = 
6.7 Hz); 
13
C NMR (75 MHz, CDCl3) δC: 170.6, 155.9, 147.2, 146.8, 127.2, 122.5, 109.7, 
108.3, 101.0, 75.2, 70.1, 63.0, 61.1, 46.7, 40.8, 21.4; MS (ESI:+ve) m/z: calcd for 








Acetic anhydride (356 μL, 3.77 mmol, 1.1 equiv.), Et3N (715 μL, 5.15 mmol, 1.75 
equiv.) and DMAP (42 mg, 0.34 mmol, 10 mol%) were added to a round bottomed flask 
containing DCM (20 mL). 266 (531mg, 3.43 mmol, 1 equiv.) in DCM (5 mL) was 
added and the reaction was allowed to stir at room temperature for 3 hours. Upon 
completion, the reaction was concentrated in vacuo and subjected to column 
chromatography, eluting with 2:1 Pet/EtOAc, affording 295 as a clear oil (603 mg, 89 
%). 
 
FTIR (thin film) max: 2968, 2938, 2877, 2267, 1770, 1712; 
1
H NMR (500 MHz, 
CDCl3) H: 5.59 (1H, q, J = 6.7 Hz), 4.46–4.42 (2H, m), 3.94–3.90 (2H, m), 2.07 (3H, 
s), 1.53 (3H, d, J = 6.7 Hz); 
13
C NMR (125 MHz, CDCl3) C: 169.9, 155.9, 74.9, 70.2, 
63.0, 60.6, 46.7, 21.4, 21.1; HRMS (ESI, +ve) m/z: calcd. for C9H11NO4Na: 220.0586, 






(Z)-3-(1H-Indol-3-yl)-1-(2-oxooxazolidin-3-yl)but-1-en-1-yl 2-(p-tolyl)acetate (296) 







Prepared according to general procedure D using, indole (20 mg, 0.17 mmol, 1 equiv.), 
288 (50 mg, 0.17 mmol, 1 equiv.), AuCl(PPh3) (4.3 mg, 0.01 mmol, 5 mol%), AgPF6 
(2.2 mg, 0.01 mmol, 5 mol%) and DCM (2 mL). Purification by flash chromatography 
afforded enamide 296 as a light yellow oil (60 mg, 85%). 
 
FTIR (thin film) max: 3414, 2980, 2890, 1760, 1685; 
1
H NMR (400 MHz, CDCl3) H: 
7.95 (1H, br. s), 7.53 (1H, d, J = 7.9 Hz), 7.35 (1H, d, J = 7.9 Hz), 7.23–7.16 (3H, m), 
7.15–7.06 (3H, m), 6.96 (1H, d, J = 1.9 Hz), 5.25 (1H, d, J = 9.7 Hz), 4.33–4.25 (2H, 
m), 3.77 (2H, s), 3.76–3.66 (3H, m), 2.33 (3H, s), 1.41 (3H, d, J = 7.1 Hz); 13C NMR 
(100 MHz, CDCl3) C: 169.6, 154.5, 137.2, 136.5, 136.3, 129.9, 1295, 129.3, 126.6, 
122.1, 1203, 119.9, 119.4, 119.3, 114.7, 111.1, 61.7, 45.4, 40.3, 27.7, 21.1, 20.9; HRMS 









Prepared according to general procedure D using, indole (19 mg, 0.17 mmol, 1 equiv.), 
289 (50 mg, 0.17 mmol, 1 equiv.), AuCl(PPh3) (4.1 mg, 0.01 mmol, 5 mol%), AgPF6 
(2.1 mg, 0.01 mmol, 5 mol%) and DCM (2 mL). Purification by flash chromatography 
afforded enamide 297 as a light brown oil (51 mg, 74%). 
 




FTIR (thin film) max: 3384, 2959, 2927, 1756, 1691, 1612; 
1
H NMR (400 MHz, 
CDCl3) H: 8.08 (1H, br. s), 7.59 (1H, app. d, J = 7.9 Hz), 7.38 (1H, app. d, J = 7.9 Hz), 
7.30–7.19 (2H, m), 7.16–7.11 (1H, m), 7.01–6.97 (1H, m), 6.95–6.85 (2H, m), 5.28 
(1H, d, J = 9.6 Hz), 4.31 (2H, app. t, J = 8.2 Hz), 3.89–3.63 (8H, m), 1.46 (3H, d, J = 
7.0 Hz); 
13
C NMR (100 MHz, CDCl3) C: 169.8, 159.0, 154.6, 136.5, 136.3, 130.6, 
126.5, 125.1, 122.0, 120.4, 119.8, 119.4, 119.3, 114.7, 114.2, 111.2, 61.8, 55.3, 45.4, 
39.8, 27.7, 20.9; HRMS (ESI, +ve) m/z: calcd. for: C24H24N2O5Na, 443.1583 found: 









Prepared according to general procedure D using, indole (37 mg, 0.32 mmol, 1 equiv.), 
290 (100 mg, 0.32 mmol, 1 equiv.), AuCl(PPh3) (7.8 mg, 0.02 mmol, 5 mol%), AgPF6 
(4.0 mg, 0.02 mmol, 5 mol%) and DCM (4 mL). Purification by flash chromatography 
afforded enamide 298 as a light yellow oil (119 mg, 87%). 
 
FTIR (thin film) max: 3406, 2981, 2980, 1751, 1683, 1614, 1522; 
1
H NMR (400 MHz, 
CDCl3) H: 8.01 (1H, br. s), 7.56 (1H, app. d, J = 8.0 Hz), 7.33 (1H, app. d, J = 8.0 Hz), 
7.23–7.12 (3H, m), 7.08 (1H, app. t, J = 7.5 Hz), 6.95 (1H, d, J = 1.8 Hz), 6.68 (2H, 
app. d, J = 8.6 Hz), 5.30 (1H, d, J = 9.7 Hz), 4.26 (2H, app. t, J = 8.1 Hz), 3.80–3.61 
(5H, m), 2.92 (6H, s), 1.41 (3H, d, J = 7.0 Hz); 
13
C NMR (100 MHz, CDCl3) C: 170.1, 
154.6, 149.8, 136.6, 136.2, 130.1, 126.5, 121.9, 120.9, 120.4, 119.8, 119.5, 119.3, 
115.0, 113.0, 111.2, 61.8, 45.3, 40.8, 39.8, 27.7, 21.0; HRMS (ESI, +ve) m/z: calcd. for 













Prepared according to general procedure D using, indole (21 mg, 0.18 mmol, 1 equiv.), 
291 (50 mg, 0.18 mmol, 1 equiv.), AuCl(PPh3) (4.5 mg, 0.01 mmol, 5 mol%), AgPF6 
(2.3 mg, 0.01 mmol, 5 mol%) and DCM (2 mL). Purification by flash chromatography 
afforded enamide 299 as a light pink oil (55 mg, 79%). 
 
FTIR (thin film) max: 3383, 2959, 1924, 2854, 1754, 1696; 
1
H NMR (400 MHz, 
CDCl3) H: 8.07 (1H, br. s), 7.60–7.56 (2H, m), 7.42–7.37 (1H, m), 7.33–7.27 (2H, m), 
7.27–7.20 (1H, m), 7.17–7.12 (1H, m), 7.07–7.00 (2H, m), 7.00–6.99 (1H, m), 5.22 
(1H, d, J = 9.1 Hz), 4.38–4.31 (2H, m), 3.83 (2H, s), 3.82–3.72 (3H, m), 1.46 (3H, d, J 
= 7.3 Hz); 
13
C NMR (100 MHz, CDCl3) C:169.2, 154.3 (d, J = 245.4 Hz), 136.5 (d, J = 
6.1 Hz), 134.2, (d, J = 15.3 Hz), 131.1 (d, J = 7.6 Hz), 128.8, 126.5, 122.1, 120.3, 
119.7, 119.4, 119.3, 115.7, 115.5, 114.1, 111.2, 61.7, 45.5, 39.7, 27.7, 20.7; HRMS 









Prepared according to general procedure D using, indole (15 mg, 0.13 mmol, 1 equiv.), 
292 (50 mg, 0.13 mmol, 1 equiv.), AuCl(PPh3) (3 mg, 0.006 mmol, 5 mol%), AgPF6 




(1.6 mg, 0.006 mmol, 5 mol%) and DCM (2 mL). Purification by flash chromatography 
afforded enamide 300 as an orange solid (60 mg, 92%). Recrystallisation (Pet/DCM) 
afforded the title compound as orange crystals. 
 
MP: 127–129 °C; FTIR (thin film) max: 3261, 2971, 2911, 1772, 1720, 1683; 
1
H NMR 
(400 MHz, CDCl3) H: 8.07 (1H, br. s), 7.67 (2H, app. d, J = 8.4 Hz), 7.59–7.55 (1H, 
m), 7.42–7.37 (1H, m), 7.27–7.22 (1H, m), 7.19–7.14 (1H, m), 7.07 (2H, app. d, J = 8.4 
Hz), 7.01–7.00 (1H, m), 5.21 (1H, d, J = 9.6 Hz), 4.40-4.36 (2H, m), 3.79 (2H, s), 3.79–
3.72 (3H, m), 1.47 (3H, d, J = 7.0 Hz); 
13
C NMR (100 MHz, CDCl3) C: 168.8, 154.3, 
137.8, 136.5, 134.3, 134.1, 132.6, 131.5, 129.4, 126.5, 122.1, 120.4, 119.7, 119.5, 
119.3, 114.1, 111.3, 93.1, 61.7, 45.6, 40.1, 27.7, 21.1; HRMS (ESI, +ve) m/z: calcd. for 









Prepared according to general procedure D using, indole (18 mg, 0.16 mmol, 1 equiv.), 
293 (50 mg, 0.16 mmol, 1 equiv.), AuCl(PPh3) (4.0 mg, 0.01 mmol, 5 mol%), AgPF6 
(2.0 mg, 0.01 mmol, 5 mol%) and DCM (2 mL). Purification by flash chromatography 
afforded enamide 301 as a light brown oil (26 mg, 38%). 
 
FTIR (thin film) max: 3385, 2966, 1770, 1706; 
1
H NMR (400 MHz, CDCl3) H: 8.03 
(1H, br. s), 7.64–7.49 (2H, m), 7.39 (1H, app.d, J = 8.0 Hz), 7.26–7.18 (1H, m), 7.17–
7.11 (1H, m), 7.01 (1H, app. d, J = 1.8 Hz), 6.85 (1H, s), 6.79 (1H, s), 5.98–5.94 (2H, 
m), 5.26 (1H, d, J = 9.6 Hz), 4.34 (2H, t, J = 8.1 Hz), 3.84–3.69 (5H, m), 1.47 (3H, d, J 
= 7.0 Hz); 
13
C NMR (100 MHz, CDCl3) C: 169.6, 154.5, 147.9, 136.5, 136.4, 126.5, 
122.7, 122.1, 120.4, 119.8, 119.3, 114.6, 111.2, 110.0, 108.5, 101.1, 61.7, 45.5, 40.3, 













Prepared according to general procedure D using, indole (30 mg, 0.25 mmol, 1 equiv.), 
295 (50 mg, 0.25 mmol, 1 equiv.), AuCl(PPh3) (6.0 mg, 0.013 mmol, 5 mol%), AgPF6 
(5.0 mg, 0.013 mmol, 5 mol%) and DCM (2 mL). Purification by flash chromatography 
afforded enamide 302 as a brown oil (70 mg, 89%). 
 
FTIR (thin film) max: 3658, 3407, 2981, 2972, 2889, 1754, 1685, 1621; 
1
H NMR (500 
MHz, CDCl3) H: 8.14 (1H, br.s), 7.69 (1H, d, J = 7.7 Hz), 7.36 (1H, d, J = 7.7 Hz), 
7.20 (1H, app.t, J = 7.5 Hz), 7.13 (1H, app.t, J = 7.5 Hz), 7.01 (1H, d, J = 1.6 Hz), 5.19 
(1H, d, J = 9.6 Hz), 4.31 (2H, app.t, J = 8.3 Hz), 3.95–3.86 (1H, m), 3.78–3.73 (2H, m), 
2.27 (3H, s), 1.51 (3H, d, J = 6.8 Hz); 
13
C NMR (125 MHz, CDCl3) C: 167.8, 154.4, 
136.6, 136.4, 134.3, 126.6, 122.0, 120.4, 119.7, 119.3, 114.1, 111.3, 61.7, 45.5, 27.8, 









To a solution of (S)-3-butyn-2-ol (15.0 g, 214 mmol, 1 equiv.) in THF (200 mL) was 
added triethylamine (59.1 mL, 428 mmol, 2 equiv.), TBDPSCl (64.7g, 235 mmol, 1.1 
equiv.) and DMAP (2.61 g, 21.4 mmol, 10 mol%). The resultant mixture was stirred at 




rt for 18 h, diluted with hexane (300 mL) and washed with NH4Cl (sat) (250 mL) and 
brine (250 mL) and dried over MgSO4, filtered and concentrated in vacuo. Purification 
via flash chromatography, eluting with 100 % Pet, afforded (S)-267 as a clear oil (66.0 




= +65 .0 (c 1, DCM) 






To a solution of the silyl ether (S)-267 (66.0 g, 214 mmol, 1 equiv.) in acetone (250 
mL) was added N-bromosuccinimide (41.6 g, 235 mmol, 1.1 equiv.) and AgNO3 (3.63 
g, 21.4 mmol, 10 mol%). The resultant mixture was stirred at rt for 3 h, diluted with 
CHCl3 (250 mL), filtered through a pad of celite and concentrated in vacuo. Purification 
via flash chromatography, eluting with 100 % Pet, afforded the title compound as a light 




= +10.3 (c 1, CH2Cl2) 










To a solution of the bromo-alkyne (S)-271 (5.00 g, 12.9 mmol, 1.1 equiv.) and 
oxazolidinone (1.02 g, 11.8 mmol, 1 equiv.) in toluene (250 mL) was added 
CuSO4.5H2O (586 mg, 2.35 mmol, 20 mol%), 1,10-phenanthroline (847 mg, 4.70 
mmol, 40 mol%) and K3PO4 (4.99 g, 23.5 mmol, 2 equiv.). The suspension was then 
refluxed for 48 h, filtered through celite and concentrated in vacuo. Purification via 
flash chromatography, eluting with 4:1 Pet/EtOAc, afforded ynamide (S)-274 as a white 




= -115.5 (c 2, CHCl3) 
All other data as previously stated. 
 




To a solution of the protected ynamide (S)-274 (3.00g, 7.60 mmol, 1 equiv.) in THF 
(175 mL) was added TBAF (1M in THF, 15.2 mL, 15.2 mmol, 2 equiv.) at 0 
o
C. The 
resultant solution was then warmed to rt, after 40 min the reaction mixture was 
hydrolysed with NH4Cl (sat) (25 mL) and extracted with EtOAc (3 × 25 mL). The 
combined extracts were dried over MgSO4, filtered and concentrated in vacuo. The 
crude material was passed through silica gel, eluting with 100% EtOAc, and used 
without further purification. To a solution of EDCi (1.80g, 9.43 mmol, 2 equiv.) in 
DCM (70 mL) was successively added triethylamine (1.31 mL, 9.43 mmol, 2 equiv.), 
DMAP (115 mg, 0.94 mmol, 20 mol%), phenylacetic acid (1.28g, 9.43 mmol, 2 equiv.) 
and crude propargylic alcohol (S)-266. After 3 hours at room temperature the resultant 
solution was washed with 10% citric acid (3 x 10 ml), NaHCO3 (sat) (3 x 10 ml) and 
brine (10 ml). The organic extract was then dried over MgSO4 and concentrated in 
vacuo. The crude mixture was then subjected to column chromatography, eluting with 
4:1 Pet/EtOAc, to afford the title compound as a white solid (888 mg, 43% over two 
steps). 






= -122 (c 1, CHCl3) 








To benzylamine (10.4 mL, 96 mmol, 1 equiv.) and triethylamine (20 mL, 143 mmol, 1.5 
equiv.) in DCM (500 mL), was added 4-methylbenzene-1-sulfonyl chloride (18.2 g, 96 
mmol, 1 equiv.) in small portions. The reaction was allowed to stir at room temperature 
for 1 hour before being quenched by water (300 mL). The aqueous layer was extracted 
with dichloromethane (3 x 200 mL), then the organic extracts were combined, dried 
over Na2SO4 and concentrated in vacuo. The residue was recrystallised 
(DCM/Petroleum ether) to afford 268 as a colourless crystals (25.0g, 99%).  
 
1
H NMR (300 MHz, (CD3)2CO) δH: 7.67 (2H, app. d, J = 8.4 Hz), 7.29 (2H, app. d, J = 
8.4 Hz), 7.21–7.07 (5H, m), 6.76 (1H, br. t, J = 6.5 Hz), 4.00 (2H, d, J = 6.5 Hz), 2.32 
(3H, s); 
13
C NMR (75 MHz, CDCl3) δC: 144.2, 139.2, 139.0, 130.8, 129.6, 129.1, 128.5, 
128.3, 48.1, 21.8. 












To a solution of 268 (962 mg, 3.68 mmol, 1 equiv.) in pyridine (16 mL) at 0 °C was 
added KHMDS (1M in THF, 3.68 mL, 3.68 mmol, 1 equiv.) over 4 minutes. The 
reaction was allowed to stir for 10 minutes before a solution of CuI (702 mg, 3.68 
mmol, 1 equiv.) in pyridine (8 mL) was added. The reaction mixture was allowed to 
warm to room temperature and stirred for 2 hours. A solution of 272 (2.85 g, 7.37 
mmol, 2 equiv.) in toluene (12 mL) was then added over 1 hour, with the resultant 
mixture being allowed to stir for 20 hours. The reaction was then diluted with Et2O (50 
mL) and washed with 2:1 brine/concentrated NH4OH (3 x 50 mL). The combined 
aquesous washings were then extracted with Et2O (50 mL). The organic extracts were 
combined, dried with MgSO4, filtered and concentrated in vacuo. Purification was 
achieved by flash chromatography (8:1 Pet/EtOAc) to afford the title compound as a 
yellow oil (1.51g, 72%).   
 
FTIR (thin film) max: 3071, 2956, 2930, 2890, 2857, 2246, 1597; 
1
H NMR (300 MHz, 
CDCl3) H: 7.72–7.50 (6H, m), 7.41–7.04 (13H, m), 4.45 (1H, q, J = 6.5 Hz), 4.32 (1H, 
d, J = 13.6 Hz), 4.20 (1H, d, J = 13.6 Hz), 2.35 (3H, s), 1.25 (3H, d, J = 6.5 Hz), 0.96 
(9H, s); 
13
C NMR (75 MHz, CDCl3) C: 144.5, 136.0, 135.8, 134.9, 133.8, 129.7, 128.7, 
128.5, 128.2, 127.8, 127.7, 127.6, 77.6, 73.7, 60.2, 55.4, 26.9, 25.2, 21.7, 19.3; HRMS 








To a solution of 313 (1.51 g, 2.67 mmol, 1 equiv.) in THF (75 mL) was added TBAF 
(1M in THF, 5.34 mL, 5.34 mmol, 2 equiv.) at 0 
o
C. The resultant solution was then 
warmed to rt, after 40 min the reaction mixture was hydrolysed with NH4Cl (sat) (25 
mL) and extracted with EtOAc (3 x 25 mL). The combined extracts were dried over 
MgSO4, filtered and concentrated in vacuo. The crude material was purified by rapid 




filtration through silica gel, eluting with 2:1 Pet/EtOAc, to give alcohol 314 as a yellow 
oil (527 mg, 60%). 
 
FTIR (film/cm
-1) υmax: 3375, 3035, 2983, 2930, 2245, 1596; 
1
H NMR (300 MHz, 
CDCl3) δH: 7.70–7.64 (2H, m), 7.35–7.15 (7H, m), 4.51–4.36 (3H, m), 2.36 (3H, s), 
1.24 (3H, d, J = 6.7 Hz); 
13
C NMR (75 MHz, CDCl3) δC: 144.7, 134.8, 134.6, 124.4, 
129.7, 128.9, 128.5, 128.4, 127.7, 77.8, 73.5, 58.4, 55.4, 24.2, 21.6, 19.0; MS (ESI:+ve) 








Prepared according to general procedure C, using 314 (527 mg, 1.60 mmol, 1 equiv.), 
phenylacetic acid (435 mg, 3.20 mmol, 2 equiv.), EDCi (613 mg, 3.20 mmol, 2 equiv.), 
NEt3 (445 µL, 3.20 mmol, 2 equiv.), DMAP (39 mg, 0.32 mmol, 20 mol%), DCM (75 
mL). Purification was achieved by flash chromatography, eluting with 8:1 Pet/EtOAc, 
affording the title compound as a yellow oil (489 mg, 68%). 
 
FTIR (film/cm
-1) υmax: 3030, 2990, 2246, 1736, 1597; 
1
H NMR (300 MHz, CDCl3) δH: 
7.72 (2H, app. d, J = 8.5 Hz), 7.36–7.17 (12H, m), 5.47 (1H, q, J = 6.6 Hz), 4.51 (1H, 
d, J = 14.3 Hz), 4.40 (1H, d, J = 14.3 Hz), 3.57 (2H, s), 2.43 (3H, s), 1.36 (3H, d, J = 
6.6 Hz); 
13
C NMR (75 MHz, CDCl3) δC: 170.4, 144.6, 134.5, 134.3, 133.8, 129.7, 
129.2, 128.9, 128.6, 128.5, 128.3, 127.8, 127.1, 78.8, 70.6, 61.2, 55.4, 41.2, 21.7, 21.1; 














Prepared according to general procedure D, using 315 (100 mg, 0.22 mmol, 1 equiv.), 
AuCl(PPh3) (5.4 mg, 0.01 mmol, 5 mol%), AgPF6 (2.8 mg, 0.01 mmol, 5 mol%) and 
DCM (4 mL). Purification by flash chromatography afforded 316 as a light orange oil 
(70 mg, 95%, 6:1 E/Z). 
 
FTIR (film/cm
-1) υmax: 3031, 2974, 1708, 1683, 1635, 1597; 
1
H NMR (500 MHz, 
CDCl3) δH Major isomer: 7.70–7.65 (2H, m), 7.44–7.28 (7H, m), 7.00 (1H, dq, J = 15.0, 7.0 
Hz), 6.63 (1H, dq, J = 15.0, 7.0 Hz), 5.13 (2H, s), 2.44 (3H, s), 1.85 (3H, dd, J = 7.0, 
1.7 Hz); δH Minor isomer 7.70–7.65 (2H, m), 7.44–7.28 (7H, m), 6.40 (1H, dq, J = 11.6, 7.0 
Hz), 6.21 (1H, dq, J = 11.6, 7.0 Hz), 5.13 (2H, s), 2.44 (3H, s), 1.90 (3H, dd, J = 7.0, 
1.7 Hz); 
13
C NMR (75 MHz, CDCl3) δC Major isomer 177.6, 166.0, 146.7, 144.7, 136.8, 
133.7, 129.6, 129.4, 128.7, 127.8, 122.9, 41.1, 21.5 18.5; δC Minor isomer 177.6, 166.0, 
146.5, 144.7, 136.8, 133.7, 129.6, 129.3, 128.7, 127.8, 122.0, 41.1, 21.6, 15.8; MS 




5.4 Chapter 4 
 




To a roundbottomed flask was added LiHMDS (1.3 equiv.) and TMSCl (1.3 equiv.). 
The mixture was allowed to stir at -95 
o
C for 15 min before the dropwise addition of 




ynamido ester (0.37 mmol) in THF (2 ml). After 30 min at -95 
o
C, the reaction mixture 
was allowed to warm to rt after which it was allowed to stir for 24 hours. The reaction 
was then quenched with 1:1 1M HCl/Brine solution (5 ml) and extracted with EtOAc (3 
x 10 ml), with the combined organic extracts being dried over Na2SO4, filtered and 
concentrated in vacuo. Purification via flash chromatography (petroleum ether: ethyl 






Prepared according to general procedure E using; ynamido ester 263 (100 mg, 0.37 
mmol, 1 equiv.), LiHMDS (1 M in THF, 480 µL, 0.48 mmol, 1.3 equiv.), TMSCl (41 
µL, 0.48 mmol, 1.3 equiv.) and THF (2mL). Purification was achieved by flash 




) υmax: 3025, 2916, 1744, 1620; 
1
H NMR (250 MHz, CDCl3) δH 7.32–
7.07 (5H, m), 6.48 (1H, s), 6.03 (1H, dqd, J = 11.5, 1.7, 0.4 Hz), 5.74 (1H, dqd, J = 
11.5, 7.2, 0.4 Hz), 4.36–4.31 (2H, m), 3.78–3.73 (2H, m), 1.50 (3H, dd, J = 7.2, 1.7 
Hz); 
13
C NMR (75 MHz, CDCl3) δC 156.1, 136.3, 132.5, 132.1, 129.3, 128.5, 127.3, 
123.5, 123.1, 61.9, 46.3, 15.2; MS (ESI:+ve) m/z: calcd for C14H16NO2 : 230.1181, 








Prepared according to general procedure E using; ynamido ester 263 (100 mg, 0.38 
mmol), LiHMDS (1M in THF, 0.40 mL, 0.40 mmol, 1.05 equiv.), TMSCl (51 μL, 0.40 




mmol, 1.05 equiv.) and THF (2 mL). Purification by flash chromatography afforded the 




) υmax: 2980, 2918, 1760, 1710, 1629; 
1
H NMR (500 MHz, CDCl3) δH 
7.42–7.30 (5H, m), 5.80 (1H, d, J = 2.0 Hz), 5.31 (1H, d, J = 2.0 Hz), 5.20 (1H, qd, J = 
6.9, 2.0 Hz), 4.34–4.29 (2H, m), 3.80–3.73 (1H, m), 3.73–3.65 (1H, m), 1.52 (3H, d, J = 
6.9 Hz); 
13
C NMR (125 MHz, CDCl3) δC 169.2, 154.3, 133.6, 129.2, 128.3, 127.7, 
126.2, 111.3, 73.5, 61.4, 46.1, 44.5, 22.1; MS (ESI:+ve) m/z: calcd for C15H16NO4: 








Prepared according to general procedure C using; propargyl alcohol 265 (540 mg, 3.61 
mmol, 1 equiv.), 2-(4-chlorophenyl)acetic acid (1.21 g, 7.11 mmol, 2 equiv.), EDCi 
(1.36 g, 7.1 mmol, 2 equiv.), NEt3 (988 µL, 7.1 mmol, 2 equiv.), DMAP (87 mg, 0.71 
mmol, 20 mol%) and DCM (50 mL). Purification was achieved by flash 




) υmax: 2989, 2921, 2264, 1769, 1734; 
1
H NMR (300 MHz, CDCl3) δH 
7.25–7.12 (4H, m), 5.53 (1H, q, J = 6.7 Hz), 4.38–4.32 (2H, m), 3.81–3.77 (2H, m), 
3.52 (2H, s), 1.44 (3H, d, J = 6.7 Hz); 
13
C NMR (75 MHz, CDCl3) δC 170.5, 156.2, 
133.5, 132.5, 131.1, 129.1, 75.6, 70.4, 63.4, 61.7, 47.1, 40.9, 21.7; MS (ESI:+ve) m/z: 

















Prepared according to general procedure C using; propargyl alcohol 265 (540 mg, 3.61 
mmol, 1 equiv.), 2-(4-nitrophenyl)acetic acid (1.28 g, 7.11 mmol, 2 equiv.), EDCi (1.36 
g, 7.11 mmol, 2 equiv.), NEt3 (988 µL, 7.11 mmol, 2 equiv.), DMAP (87 mg, 0.71 
mmol, 20 mol%) and DCM (50 mL). Purification was achieved by flash 




) υmax: 2985, 2265, 1768, 1736, 1606; 
1
H NMR (300 MHz, CDCl3) δH 
8.16–8.13 (2H, m), 7.42–7.38 (2H, m), 5.56 (1H, q, J = 6.7 Hz), 4.39–4.34 (2H, m), 
3.86–3.82 (2H, m), 3.49 (2H, s), 1.46 (3H, d, J = 6.7 Hz); 13C NMR (75 MHz, CDCl3) 
δC 169.5, 156.2, 147.7, 141.4, 130.7, 124.2, 75.9, 70.2, 63.4, 62.1, 47.0, 41.3, 21.7; MS 








Prepared according to general procedure C using; propargyl alcohol 265 (733 mg, 4.69 
mmol, 1 equiv.), 2-(m-tolyl)acetic acid (1.41 g, 9.39 mmol, 2 equiv.), EDCi (1.79 g, 
9.39 mmol, 2 equiv.), NEt3 (1.31 mL, 9.39 mmol, 2 equiv.), DMAP (115 mg, 0.94 
mmol, 20 mol%) and DCM (100 mL). Purification was achieved by flash 




) υmax: 3022, 2921, 2266, 1769, 1733, 1608; 
1
H NMR (300 MHz, 
CDCl3) δH: 7.25–7.19 (1H, m), 7.13–7.06 (3H, m), 5.62 (1H, q, J = 6.8 Hz), 4.46–4.39 




(2H, m), 3.92–3.86 (2H, m), 3.60 (2H, s), 2.35 (3H, s), 1.53 (3H, d, J= 6.8 Hz); 13C 
NMR (75 MHz, CDCl3) δC: 170.7, 155.9, 138.2, 133.6, 130.1, 128.5, 127.9, 126.3, 75.1, 
70.2, 63.1, 46.7, 41.2, 21.4; MS (ESI:+ve) m/z: calcd for C16H17NO4Na: 310.1055, 








Prepared according to general procedure C using; propargyl alcohol 265 (0.733 g, 4.69 
mmol, 1 equiv.), 2-(o-tolyl)acetic acid (1.41 g, 9.39 mmol, 2 equiv.), EDCi (1.79 g, 9.39 
mmol, 2 equiv.), NEt3 (1.31 mL, 9.39 mmol, 2 equiv.), DMAP (115 mg, 0.94 mmol, 20 
mol%) and DCM (100 mL). Purification was achieved by flash chromatography 




) υmax: 3020, 2916, 2264, 1762, 1735, 1607; 
1
H NMR (300 MHz, 
CDCl3) δH: 7.23–7.14 (4H, m), 5.63 (1H, q, J = 6.8 Hz), 4.42 (2H, app. t, J = 7.9 Hz), 
3.88 (2H, app. t, J = 7.9 Hz), 3.66 (2H, s), 2.33 (3H, s), 1.53 (3H, d, J = 6.8 Hz); 
13
C 
NMR (75 MHz, CDCl3) δC: 170.6, 156.0, 136.9, 132.5, 130.3, 130.2, 127.5, 126.2, 75.1, 
70.2, 63.0, 61.0, 46.7, 39.2, 21.3, 19.5; MS (ESI:+ve) m/z: calcd for: 310.1055, found: 








Prepared according to general procedure C using; propargyl alcohol 265 (872 mg, 5.80 
mmol, 1 equiv.), butyric acid (1.12 mL, 11.5 mmol, 2 equiv.), EDCi (2.22 g, 11.5 




mmol, 2 equiv.), triethylamine (1.61 mL, 11.5 mmol, 2 equiv.), DMAP (146 mg, 1.20 
mmol, 20 mol%) and DCM (60 mL). Purification was achieved by flash 




) υmax: 2968, 2938, 2878, 2268, 1770, 1733, 1712; 
1
H NMR (250 MHz, 
CDCl3) δH 5.60 (1H, q, J = 6.7 Hz), 4.49–4.43 (2H, m), 3.93–3.88 (2H, m), 2.28 (2H, t, 
J = 7.5 Hz), 1.65 (2H, sx, J = 7.5 Hz), 1.51 (3H, d, J = 6.7 Hz), 0.94 (3H, t, J = 7.5 
Hz); 
13
C NMR (75 MHz, CDCl3) δC 172.9, 156.3, 75.2, 70.7, 63.5, 60.6, 47.1, 36.5, 










Prepared according to general procedure E using; ynamido ester 289 (100 mg, 0.35 
mmol, 1 equiv.), LiHMDS (1 M in THF, 570 µL, 0.57 mmol, 1.8 equiv.), TMSCl (73 
µL, 0.57 mmol, 1.8 equiv.) and THF (2mL). Purification was achieved by flash 




) υmax: 2903, 2798, 1741, 1604, 1519; 
1
H NMR (500 MHz, CDCl3) δH: 
7.29 (2H, app. d, J = 8.5 Hz), 6.65 (2H, app. d, J = 8.5 Hz), 6.48 (1H, s), 6.17–6.08 
(1H, m), 5.79 (1H, dqd, J = 11.4, 7.2, 0.8 Hz), 4.42–4.34 (2H, m), 3.82–3.75 (2H, m), 
2.96 (6H, s), 1.66 (3H, dd,J = 7.2, 1.8 Hz); 
13
C NMR (75 MHz, CDCl3) δC : 156.1, 
149.5, 146.8, 130.3, 130.2, 128.5, 125.2, 123.8, 111.9, 61.6, 46.2, 40.4, 14.7; MS 













Prepared according to general procedure E using; ynamido ester 288 (100 mg, 0.33 
mmol, 1 equiv.), LiHMDS (1 M in THF, 602 µL, 0.60 mmol, 1.8 equiv.), TMSCl (76 
µL, 0.60 mmol, 1.8 equiv.) and THF (2mL). Purification was achieved by flash 




) υmax: 2980, 2905, 2836, 1747, 1604, 1571; 
1
H NMR (500 MHz, 
CDCl3) δH (Z isomer): 7.31 (2H, app. d, J = 8.5 Hz), 6.82 (2H, app. d, J = 8.5 Hz), 6.52 
(1H, s), 6.13–6.04 (1H, m), 5.87–5.74 (1H, m), 4.42–4.35 (2H, m), 3.83–3.80 (4H, m), 
3.78 (1H, d, J = 7.8 Hz), 1.61 (3H, dd, J = 7.1, 1.9 Hz); δH (E isomer): 7.31 (2H, app. d, J 
= 8.5 Hz), 6.82 (2H, app. d, J = 8.5 Hz), 6.35 (1H, s), 6.28–6.17 (1H, m), 5.85–5.69 
(1H, m), 4.36–4.27 (2H, m), 3.72–3.67 (5H, m), 1.73 (3H, dd, J = 6.8, 1.7 Hz); 13C 
NMR (75 MHz, CDCl3) δC: 158.6, 155.9, 131.3, 130.4, 130.3, 128.4, 123.4, 123.3, 
113.6, 61.5, 55.2, 46.0, 14.7; MS (ESI:+ve) m/z: calcd for C15H18NO3: 260.1287, found: 








Prepared according to general procedure E using; ynamido ester 292 (100 mg, 0.35 
mmol, 1 equiv.), LiHMDS (1 M in THF, 572 µL, 0.57 mmol, 1.8 equiv.), TMSCl (73 
µL, 0.57 mmol, 1.8 equiv.) and THF (2mL). Purification was achieved by flash 
chromatography to give diene 356 as a yellow oil (64 mg, 69 %, 2:1 E/Z).  
 






) υmax: 2907, 1741, 1604; 
1
H NMR (500 MHz, CDCl3) δH (Z isomer): 6.97–
6.92 (1H, m), 6.91–6.71 (2H, m), 6.49 (1H, app. s), 6.11–6.03 (1H, m), 5.95 (2H, s), 
5.89–5.76 (1H, m), 4.40–4.35 (2H, m), 3.82–3.75 (2H, m), 1.62 (3H, dd, J = 7.1, 1.8 
Hz); δH (E isomer): 6.97–6.92 (1H, m), 6.91–6.71 (2H, m), 6.36 (1H, s), 6.31 δH (E isomer): 
6.97–6.92 (1H, m), 6.91–6.71 (2H, m),6.22 (1H, m), 5.90 (2H, s), 5.86–5.76 (1H, m), 
4.41–4.33 (2H, m), 3.80–3.73 (2H, m), 1.78 (3H, dd, J = 6.8, 1.7 Hz); 13C NMR (75 
MHz, CDCl3) δC 155,8, 147.4, 146.6, 131.7, 130.8, 129.9, 123.4, 123.3, 123.2, 108.8, 
108.1, 101.0, 61.5, 45.9, 14.7; MS (ESI:+ve) m/z: calcd for C15H16NO4: 274.1079, 








Prepared according to general procedure E using; ynamido ester 290 (100 mg, 0.35 
mmol, 1 equiv.), LiHMDS (1 M in THF, 632 µL, 0.63 mmol, 1.8 equiv.), TMSCl (79 
µL, 0.63 mmol, 1.8 equiv.) and THF (2mL). Purification was achieved by flash 
chromatography to give diene 357 as a yellow oil (62 mg, 67 %, 3:1 E/Z).  
 
FTIR (film/cm
-1) υmax: : 2964, 2934, 2874, 1746, 1643; 
1
H NMR (500 MHz, CDCl3) δH 
(Z isomer): 7.34–7.19 (2H, m), 6.96–6.83 (2H, m), 6.47 (1H, app. s), 5.98 (1H, app. d, J = 
11.4 Hz), 5.75 (1H, dq, J = 11.4, 7.0 Hz), 4.38–4.25 (2H, m), 3.79–3.69 (2H, m), 1.49 
(3H, dd, J = 7.0, 1.6 Hz); δH (E isomer): 7.34–7.19 (2H, m), 6.96–6.83 (2H, m), 6.54 (1H, 
s), 6.29 (1H, app. d, J = 15.4 Hz), 6.02–5.86 (1H, m), 4.51–4.41 (2H, m), 3.90–3.81 
(2H, m), 1.83 (3H, dd, J = 6.8, 1.7 Hz); 
13
C NMR (75 MHz, CDCl3) δC: 161.6 (d, J = 
245.9 Hz), 155.8, 132.1, 132.0, 131.9, 130.5 (d, J = 9.0 Hz), 122.9, 121.6, 115.1 (d, J = 
21.5 Hz), 61.5, 45.9, 14.7; MS (ESI:+ve) m/z: calcd for: C14H14NO2F, 248.1087 found: 














Prepared according to general procedure E using; ynamido ester 349 (100 mg, 0.35 
mmol, 1 equiv.), LiHMDS (1 M in THF, 591 µL, 0.59 mmol, 1.8 equiv.), TMSCl (75 
µL, 0.59 mmol, 1.8 equiv.) and THF (2mL). Purification was achieved by flash 
chromatography to give diene 358 as a yellow oil (53 mg, 56 %, 4:1 E/Z).  
 
FTIR (film/cm
-1) υmax: 2906, 1738, 1607, 1517; 
1
H NMR (500 MHz, CDCl3) δH: 7.33–
7.19 (4H, m), 6.52 (1H, s), 6.10–6.02 (1H, m), 5.83 (1H, app. dq, J = 11.4, 7.1 Hz), 
4.41 (1H, d, J = 7.8 Hz), 4.38 (1H, d, J = 6.6 Hz), 3.83 (1H, d, J = 6.6 Hz), 3.80 (1H, d, 
J = 7.8 Hz), 1.56 (3H, dd, J = 7.1, 1.7 Hz); 
13
C NMR (75 MHz, CDCl3) δC: 155.6, 
134.6, 132.6, 132.4, 132.3, 130.1, 128.3, 122.7, 120.9, 61.5, 45.8, 14.8; MS (ESI:+ve) 








Prepared according to general procedure E using; ynamido ester 350 (100 µg, 0.32 
mmol, 1 equiv.), LiHMDS (1 M in THF, 573 µL, 0.57 mmol, 1.8 equiv.), TMSCl (73 
µL, 0.57 mmol, 1.8 equiv.) and THF (2mL). Purification was achieved by flash 
chromatography to give diene 359 as a yellow oil (54 mg, 54 %, 2:1 E/Z).  
 
FTIR (film/cm
-1) υmax: 2986, 2954, 2870, 1746, 1643, 1532; 
1
H NMR (500 MHz, 
CDCl3) δH: 8.06–8.02 (2H, m), 7.45–7.41 (2H, m), 6.58 (1H, s), 6.08–6.03 (1H, m), 
5.87–5.79 (1H, m), 4.42–4.31 (2H, m), 3.85–3.77 (2H, m), 1.46 (3H, d, J = 6.7 Hz); 13C 




NMR (75 MHz, CDCl3) δC 169.1, 155.8, 145.8, 135.7, 133.6, 129.9, 129.2, 123.6, 
122.7, 69.8, 46.6, 18.4; MS (ESI:+ve) m/z: calcd for C14H14N2O4Na: 297.0852, found: 








Prepared according to general procedure E using; ynamido ester 287 (100 mg, 0.35 
mmol, 1 equiv.), LiHMDS (1 M in THF, 633 µL, 0.63 mmol, 1.8 equiv.), TMSCl (80 
µL, 0.63 mmol, 1.8 equiv.) and THF (2mL). Purification was achieved by flash 




) υmax: 3022, 2920, 1744, 1624; 
1
H NMR (300 MHz, CDCl3) δH (Z isomer): 
7.26 (2H, app. d, J = 8.2 Hz), 7.09 (2H, app. d, J = 8.2 Hz), 6.53 (1H, app. s), 6.14–
6.06 (1H, m), 5.87–5.74 (1H, m), 4.40 (1H, d, J = 7.7 Hz), 4.37 (1H, d, J = 6.7 Hz), 
3.83 (1H, d J = 6.7 Hz), 3.80 (1H, d, J = 7.7 Hz), 2.33 (3H, s), 1.60 (3H, dd, J = 7.1, 
1.9 Hz); δH (E isomer): 7.26 (2H, app. d, J = 8.2 Hz), 7.09 (2H, app. d, J = 8.2 Hz), 6.43 
(1H, app. s), 6.29 (1H, app. d, J = 15.8 Hz), 5.92–5.74 (1H, m), 4.42–4.32 (2H, m), 
3.83–3.73 (2H, m), 2.28 (3H, s), 1.77 (3H, dd, J = 6.7, 1.8 Hz); 13C NMR (75 MHz, 
CDCl3) δC: 155.8, 136.8, 133.0, 131.4, 128.9, 128.8, 128.3, 123.3, 123.2, 61.6, 46.0, 













Prepared according to general procedure E using; ynamido ester 351 (100 mg, 0.35 
mmol, 1 equiv.), LiHMDS (1 M in THF, 631 µL, 0.63 mmol, 1.8 equiv.), TMSCl (80 
µL, 0.63 mmol, 1.8 equiv.) and THF (2mL). Purification was achieved by flash 
chromatography to give diene 361 as a yellow oil (36 mg, 42 %, 6:1 E/Z).  
 
FTIR (film/cm
-1) υmax: 2981, 2889, 1746, 1622; 
1
H NMR (500 MHz, CDCl3) δH (Z isomer): 
7.21–7.13 (3H, m), 7.04–6.98 (1H, m), 6.52 (1H, app. s), 6.15–6.07 (1H, m), 5.81 (1H, 
dqd, J = 11.5, 7.1, 0.6 Hz), 4.41 (1H, d, J = 7.9 Hz), 4.38 (1H, d, J = 6.6 Hz), 3.83 (1H, 
d, J = 6.6 Hz), 3.80 (1H, d, J = 7.9 Hz), 2.32 (3H, s), 1.60 (3H, dd, J = 7.1, 1.8 Hz); δH 
(E isomer): 7.21–7.13 (3H, m), 7.04–6.98 (1H, m), 6.38 (1H, app. s), 6.23 (1H, app. d, J = 
16.5 Hz), 5.86–5.72 (1H, m), 4.36–4.29 (2H, m), 3.76–3.70 (2H, m), 2.22 (3H, s), 1.73 
(3H, dd, J = 6.8, 1.6 Hz); 
13
C NMR (75 MHz, CDCl3) δC: 155.8, 137.6, 135.8, 131.9, 
131.5, 129.8, 128.0, 127.7, 126.0, 123.2, 123.2, 61.6, 46.0, 21.4, 14.8; MS (ESI:+ve) 








Prepared according to general procedure E using; ynamido ester 352 (100 mg, 0.35 
mmol, 1 equiv.), LiHMDS (1 M in THF, 0.631 µL, 0.63 mmol, 1.8 equiv.), TMSCl (80 
µL, 0.63 mmol, 1.8 equiv.) and THF (2mL). Purification was achieved by flash 
chromatography to give diene 362 as a yellow oil (37 mg, 43 %, 2:1 E/Z).  
 
FTIR (film/cm
-1) υmax: 2998, 2890, 1753, 1621; 
1
H NMR (500 MHz, CDCl3) δH (Z isomer): 
7.22–7.05 (4H, m), 6.59 (1H, app. s), 6.04–5.96 (1H, m), 5.75–5.62 (1H, m), 4.43 (1H, 
d, J = 7.7 Hz), 4.40 (1H, d, J = 6.7 Hz), 3.87 (1H, d, J = 6.7 Hz), 3.84 (1H, d, J = 7.7 
Hz), 2.30 (3H, s), 1.47 (3H, dd, J = 7.1, 1.8 Hz); δH (E isomer): 7.22–7.05 (4H, m), 6.41 
(1H, s), 6.01 (1H, dq, J = 15.6, 1.6 Hz), 5.74 (1H, dq, J = 15.6, 6.6 Hz), 4.37–4.29 (2H, 
m), 3.77–3.70 (2H, m), 2.13 (3H, s), 1.65 (3H, dd, J = 6.6, 1.6 Hz); 13C NMR (75 MHz, 
CDCl3) δC: 155.6, 139.2, 135.9, 133.6, 133.3, 129.2, 129.1, 128.8, 128.7, 124.4, 111.2, 




61.4, 46.2, 22.1, 21.5; MS (ESI:+ve) m/z: calcd for C15H17NO2Na: 266.1157, found: 









Prepared according to general procedure E using; ynamido ester 353 (100 mg, 0.44 
mmol, 1 equiv.), LiHMDS (1 M in THF, 573 µL, 0.57 mmol, 1.3 equiv.), TMSCl (72 
µL, 0.57 mmol, 1.3 equiv.) and THF (2mL). Purification was achieved by flash 




) υmax: 2963, 2935, 2876, 1748, 1643; 
1
H NMR (500 MHz, CDCl3) δH: 
5.82 (1H, d, J = 11.4 Hz), 5.72–5.68 (1H, m), 5.38 (1H, t, J = 7.8 Hz), 4.26–4.21 (2H, 
m), 3.64–3.60 (2H, m), 1.96 (2H, m), 1.58 (3H, dd, J = 7.5, 1.5 Hz), 0.92 (3H, t, J = 7.8 
Hz); 
13
C NMR (75 MHz, CDCl3) δC: 156.2, 136.5, 130.4, 125.0, 122.7, 61.4, 46.0, 21.3, 











To a solution of allylamine (6.6 ml, 87.5 mmol) and triethylamine (11.0 ml, 79.6 mmol) 
in CH2Cl2 (250 mL) at reflux, was added slowly p-TsCl (15.2 g, 79.6 mmol). After 1 
hour at reflux and 30 in at room temperature, the crude reaction mixture was added to a 
saturated aqueous solution of NaHCO3 (120 mL). The product was extracted with 
CH2Cl2 (150 mL), washed with brine (2 x 100 mL) and dried over Na2SO4, filtered and 




evaporated in vacuo. The allyl sulfonamide was then recrystallised (CH2Cl2/Petroleum 
ether) affording clear crystals (16.0 g, 95 %). 
 
1
H NMR (250 MHz, CDCl3) δH: 7.69 (2H, app. d, J = 8.0 Hz), 7.25 (2H, app. d, J = 8.0 
Hz), 5.65 (1H, ddt, J = 17.1, 10.2, 5.8 Hz), 5.10 (1H, dq, J = 17.1, 1.4 Hz), 5.04 (1H, 
dq, J = 10.2, 1.4 Hz), 4.34 (1H, brs), 3.52 (2H, tt, J = 5.8, 1.4 Hz), 2.37 (3H, s); 
13
C 
NMR (75 MHz, CDCl3) δC: 143.9, 137.3, 133.4, 130.2, 127.6, 118.2, 46.2, 22.0. 









To a solution of bromo-alkyne 271 (5.0 g, 12.9 mmol, 1.1 equiv.) and N-allyl-4-
methylbenzenesulfonamide (2.48 g, 11.8 mmol, 1 equiv.) in toluene (250 mL) was 
added CuSO4.5H2O (586 mg, 2.36 mmol, 20 mol%), 1,10-phenanthroline (847 mg, 4.72 
mmol, 40 mol%) and K3PO4 (4.99 g, 23.5 mmol, 2 equiv.). The suspension was heated 
to 65 °C and stirred for 48 h, filtered through celite and concentrated in vacuo. 
Purification via flash chromatography, eluting with 8:1 Pet/EtOAc, afforded ynamide 
371 as a yellow  oil (4.70g, 78%). 
 
1
H NMR (250 MHz, CDCl3) δH: 7.70-7.56 (4H, m), 7.36–7.17 (10H, m), 5.53 (1H, m), 
5.05 (2H, m), 4.53 (1H, q, J = 6.5 Hz), 3.74 (2H, m), 2.36 (3H, s), 1.32 (3H, d, J = 6.5 
H), 0.97 (9H, s); 
13
C NMR (75 MHz, CDCl3) δC: 144.8, 136.3, 136.1, 135.6, 135.2, 
134.2, 131.4, 130.0, 129.9, 128.1, 128.0, 127.8, 120.0, 77.6, 73.6, 60.6, 54.5, 27.2, 25.7, 
22.0, 19.6.  
 









To a solution of the protected ynamide 371 (5.0g, 9.7 mmol, 1 equiv.) in THF (200 mL) 
was added TBAF (1M in THF, 19 mL, 19.3 mmol, 2 equiv.) at 0 
o
C. The resultant 
solution was then warmed to rt, after 40 min the reaction mixture was hydrolysed with 
NH4Cl (sat) (25 mL) and extracted with EtOAc (3 x 25 mL). The combined extracts 
were dried over MgSO4, filtered and concentrated in vacuo. The crude material was 
purified by rapid filtration through silica gel (EtOAc) to give alcohol 372 as a clear oil 
(1.78 g, 70%). 
 
1
H NMR (250 MHz, CDCl3) δH 7.78–7.70 (2H, m), 7.31–7.26 (2H, m), 5.68–5.59 (1H, 
m), 5.19–5.11 (2H, m), 4.56 (1H, q, J = 6.4 Hz), 3.90–3.83 (2H, m), 2.38 (3H, s), 1.96 
(1H, brs), 1.36 (3H, d, J = 6.5 Hz); 
13
C NMR (75 MHz, CDCl3) δC 145.1, 135.0, 131.2, 
130.1, 128.1, 120.4, 77.6, 73.5, 58.9, 54.5, 24.8, 22.0. 












Prepared according to general procedure C using; propargyl alcohol 372 (1.66 g, 5.96 
mmol, 1 equiv.), phenylacetic acid (1.62 g, 11.9 mmol, 2 equiv.), EDCi (2.3 g, 11.9 
mmol, 2 equiv.), triethylamine (1.7 mL, 11.9 mmol, 2 equiv.), DMAP (147 mg, 1.2 
mmol, 20 mol%) and DCM (100 mL). Purification was achieved by flash 




) υmax: 3032, 2986, 2934, 2247, 1735 1597; 
1
H NMR (250 MHz, 
CDCl3) δH 7.73–7.66 (2H, m), 7.28–7.13 (7H, m), 5.60 (1H, m), 5.47 (1H, q, J = 6.7), 
5.14–5.09 (2H, m), 3.88–3.82 (2H, m), 3.53 (2H, s), 2.37 (3H, s), 1.39 (3H, d, J = 6.7 
Hz); 
13
C NMR (75 MHz, CDCl3) δC 170.8, 145.1, 135.0, 134.2, 131.0, 130.1, 129.9, 
129.6, 129.1, 128.9, 128.2, 127.5, 120.5, 78.88, 77.65, 70.5, 61.6, 54.5, 49.5, 41.6, 22.1, 









Prepared according to general procedure E using; ynamido ester 373 (0.10 g, 0.25 
mmol, 1 equiv.), LiHMDS (1 M in THF, 0.33 mL, 0.33 mmol, 1.3 equiv.), TMSCl (41 
µL, 0.33 mmol, 1.3 equiv.) and THF (2mL). Purification was achieved by flash 




) υmax: 2937, 2917, 1734, 1597; 
1
H NMR (500 MHz, CDCl3) δH 7.78–
7.74 (2H, m), 7.36–7.25 (7H, m), 6.50 (1H, s), 6.36 (1H, app. d, J = 15.2 Hz), 6.10 (1H, 
dq, J = 15.2, 7.1 Hz), 5.63–5.57 (1H, m), 5.12–5.07 (2H, m), 3.97–3.92 (2H, m,), 2.19 
(3H, s), 1.28 (3H, t, J = 7.1 Hz); 
13
C NMR (75 MHz, CDCl3) δC 143.4, 137.3, 134.7, 
133.0, 131.5, 131.1, 129.7, 129.5, 129.2, 129.1, 128.8, 128.5, 118.4, 110.2, 49.1, 20.5, 










6.1 Crystal data for 206 
 
Table 1.  Crystal data and structure refinement for 206. 
                                                        
 Identification code k11dc1 
 Empirical formula C22 H20.83 N1.17 O1.33 
 Formula weight 322.91 
 Temperature 150(2) K 
 Wavelength 0.71073 Å 
 Crystal system Trigonal 
 Space group R-3 
 Unit cell dimensions a = 22.3950(6)Å alpha = 90
o
 
       b = 22.3950(6)Å beta = 90
o
 
       c = 22.7710(8)Å gamma = 120
o
 
 Volume 9890.4(5) Å
3
 
 Z 18 
 Density (calculated) 0.976 Mg/m
3
 
 Absorption coefficient 0.060 mm
-1
 
 F(000) 3090 
 Crystal size 0.50 x 0.40 x 0.13 mm 
 Theta range for data collection 3.73 to 24.87
o
 
 Index ranges -26<=h<=26; -26<=k<=25; -26<=l<=26 
 Reflections collected 51664 
 Independent reflections 3812 [R(int) = 0.1439] 
  3063 
 Data Completeness 0.996 
 Absorption correction Semi-empirical from equivalents 
 Max. and min. transmission 1.232 and 0.473 
 Refinement method Full-matrix least-squares on F
2
 
 Data / restraints / parameters 3812 / 0 / 213 
 Goodness-of-fit on F
2
 1.107 
  R1 = 0.1333   wR2 = 0.3400 
 R indices (all data) R1 = 0.1570  wR2 = 0.3587 






The crystals were visually beautiful for this sample – so it was quite a surprise to 
see minimal diffraction intensity beyond a Bragg angle of approximately 21
o
. Thus, 
in the refinement, data were truncated to a max theta value of 25
o
. The larger than 
desirable Rint value purely reflects this facet of the data set. 
 
The reason for this diffraction fall-off became obvious when the structure was 
solved and refined. Analysis revealed that almost 33% of the unit cell volume is 
composed of a diffuse/disordered solvent, which did not lend itself to modelling. 




Thus, PLATON SQUEEZE was employed to estimate the contribution of the latter 
to diffraction and to generate a data set of solvent-free diffraction intensities. 
SQUEEZE suggested a total count of 207 electrons in accessible unit cell ‘voids’, 
which were assigned as 3 molecules of acetonitrile plus 3 molecules of ethyl acetate 
per unit cell. The final formula presented herein includes this level of solvent. 
 
Intermolecular N-H…O bonds serve to generate hydrogen-bonded chains along c 
in the gross structure. 
   
 Table 2.  Atomic coordinates ( x 10
4





) for 206.U(equiv.) is defined as one third of the trace of the orthogonalized 
Uij tensor. 
                                                             
                                                             
Atom x y z U(equiv.) 
O(1) 782(2) 3929(2) -1068(2) 132(2) 
N(1) 285(2) 2534(2) 1134(1) 63(1) 
C(1) 427(2) 2012(2) 1158(2) 63(1) 
C(2) 328(2) 1545(2) 1620(2) 69(1) 
C(3) 549(3) 1090(3) 1532(2) 78(1) 
C(4) 850(3) 1052(3) 995(2) 85(1) 
C(5) 944(2) 1503(3) 551(2) 74(1) 
C(6) 745(2) 1999(2) 631(2) 64(1) 
C(7) 777(2) 2539(2) 277(2) 68(1) 
C(8) 1077(2) 2710(3) -335(2) 81(2) 
C(9) 595(3) 2843(3) -753(2) 92(2) 
C(10) 643(3) 3538(3) -646(3) 97(2) 
C(11) 529(3) 3747(3) -89(2) 90(2) 
C(12) 444(2) 3475(3) 464(2) 81(1) 
C(13) 502(2) 2867(2) 596(2) 66(1) 
C(14) 1822(3) 3327(3) -333(2) 99(2) 
C(15) 704(4) 2712(4) -1394(2) 131(3) 
C(16) 325(3) 3847(3) 960(2) 86(2) 
C(17) -168(3) 4061(4) 888(3) 114(2) 
C(18) -259(4) 4427(4) 1340(4) 133(3) 
C(19) 83(4) 4557(4) 1858(4) 123(2) 
C(20) 558(4) 4342(3) 1926(3) 108(2) 
C(21) 677(3) 3988(3) 1478(2) 87(2) 
                                   
   




   
 Table 3.   Bond lengths [Å] and angles [
o
] for 206. 
  
O(1)-C(10) 1.231(6) N(1)-C(1) 1.359(6) 
N(1)-C(13) 1.389(5) N(1)-H(1) 0.8800 
C(1)-C(6) 1.402(6) C(1)-C(2) 1.419(6) 
C(2)-C(3) 1.351(7) C(2)-H(2) 0.9500 
C(3)-C(4) 1.419(7) C(3)-H(3) 0.9500 
C(4)-C(5) 1.367(7) C(4)-H(4) 0.9500 
C(5)-C(6) 1.401(6) C(5)-H(5) 0.9500 
C(6)-C(7) 1.425(6) C(7)-C(13) 1.377(6) 
C(7)-C(8) 1.512(6) C(8)-C(14) 1.546(7) 
C(8)-C(9) 1.575(7) C(8)-H(8) 1.0000 
C(9)-C(10) 1.523(9) C(9)-C(15) 1.535(7) 
C(9)-H(9) 1.0000 C(10)-C(11) 1.421(8) 
C(11)-C(12) 1.370(7) C(11)-H(11) 0.9500 
C(12)-C(13) 1.463(7) C(12)-C(16) 1.504(7) 
C(14)-H(14A) 0.9800 C(14)-H(14B) 0.9800 
C(14)-H(14C) 0.9800 C(15)-H(15A) 0.9800 
C(15)-H(15B) 0.9800 C(15)-H(15C) 0.9800 
C(16)-C(21) 1.366(8) C(16)-C(17) 1.415(8) 
C(17)-C(18) 1.394(10) C(17)-H(17) 0.9500 
C(18)-C(19) 1.355(10) C(18)-H(18) 0.9500 
C(19)-C(20) 1.378(10) C(19)-H(19) 0.9500 
C(20)-C(21) 1.396(8) C(20)-H(20) 0.9500 
C(21)-H(21) 0.9500   
C(1)-N(1)-C(13) 109.1(3) C(1)-N(1)-H(1) 125.4 
C(13)-N(1)-H(1) 125.4 N(1)-C(1)-C(6) 108.8(4) 
N(1)-C(1)-C(2) 130.3(4) C(6)-C(1)-C(2) 120.8(4) 
C(3)-C(2)-C(1) 117.7(4) C(3)-C(2)-H(2) 121.2 
C(1)-C(2)-H(2) 121.2 C(2)-C(3)-C(4) 122.4(4) 
C(2)-C(3)-H(3) 118.8 C(4)-C(3)-H(3) 118.8 
C(5)-C(4)-C(3) 119.7(5) C(5)-C(4)-H(4) 120.2 
C(3)-C(4)-H(4) 120.2 C(4)-C(5)-C(6) 119.8(4) 
C(4)-C(5)-H(5) 120.1 C(6)-C(5)-H(5) 120.1 
C(5)-C(6)-C(1) 119.6(4) C(5)-C(6)-C(7) 134.3(4) 
C(1)-C(6)-C(7) 106.1(4) C(13)-C(7)-C(6) 107.9(3) 
C(13)-C(7)-C(8) 127.7(4) C(6)-C(7)-C(8) 124.4(4) 
C(7)-C(8)-C(14) 111.5(4) C(7)-C(8)-C(9) 110.2(4) 
C(14)-C(8)-C(9) 111.7(4) C(7)-C(8)-H(8) 107.8 
C(14)-C(8)-H(8) 107.8 C(9)-C(8)-H(8) 107.8 
C(10)-C(9)-C(15) 114.3(5) C(10)-C(9)-C(8) 113.1(4) 
C(15)-C(9)-C(8) 110.3(5) C(10)-C(9)-H(9) 106.2 
C(15)-C(9)-H(9) 106.2 C(8)-C(9)-H(9) 106.2 
O(1)-C(10)-C(11) 119.0(6) O(1)-C(10)-C(9) 117.9(6) 
C(11)-C(10)-C(9) 123.1(5) C(12)-C(11)-C(10) 133.0(6) 
C(12)-C(11)-H(11) 113.5 C(10)-C(11)-H(11) 113.5 
C(11)-C(12)-C(13) 123.1(5) C(11)-C(12)-C(16) 117.8(5) 
C(13)-C(12)-C(16) 119.0(4) C(7)-C(13)-N(1) 108.0(4) 
C(7)-C(13)-C(12) 131.3(4) N(1)-C(13)-C(12) 120.7(4) 




C(8)-C(14)-H(14A) 109.5 C(8)-C(14)-H(14B) 109.5 




C(9)-C(15)-H(15A) 109.5 C(9)-C(15)-H(15B) 109.5 




C(21)-C(16)-C(17) 118.6(6) C(21)-C(16)-C(12) 122.3(5) 
C(17)-C(16)-C(12) 119.1(6) C(18)-C(17)-C(16) 118.8(7) 
C(18)-C(17)-H(17) 120.6 C(16)-C(17)-H(17) 120.6 
C(19)-C(18)-C(17) 122.3(7) C(19)-C(18)-H(18) 118.8 
C(17)-C(18)-H(18) 118.8 C(18)-C(19)-C(20) 118.4(7) 
C(18)-C(19)-H(19) 120.8 C(20)-C(19)-H(19) 120.8 
C(19)-C(20)-C(21) 121.1(7) C(19)-C(20)-H(20) 119.5 
C(21)-C(20)-H(20) 119.5 C(16)-C(21)-C(20) 120.7(6) 
C(16)-C(21)-H(21) 119.7 C(20)-C(21)-H(21) 119.7 
                                                
Symmetry transformations used to generate equivalent atoms: 
                                                            
  
   




) for 206. The anisotropic 






 U11 + ... + 2 h k a* b* U 
                                                                                 
Atom U11 U22 U33 U23 U13 U12 
O(1) 129(3) 133(3) 78(3) 52(2) -13(2) 23(3) 
N(1) 63(2) 84(2) 47(2) 3(2) 11(2) 40(2) 
C(1) 56(2) 79(3) 47(2) -8(2) -5(2) 28(2) 
C(2) 71(3) 76(3) 45(2) 1(2) 3(2) 26(2) 
C(3) 90(3) 73(3) 63(3) 6(2) -7(2) 36(3) 
C(4) 98(4) 87(3) 76(3) -1(3) 5(3) 52(3) 
C(5) 76(3) 91(3) 54(2) -9(2) 3(2) 41(3) 
C(6) 62(2) 84(3) 43(2) -4(2) -1(2) 33(2) 
C(7) 56(2) 95(3) 43(2) 7(2) -1(2) 30(2) 
C(8) 77(3) 112(4) 46(2) 7(2) 11(2) 41(3) 
C(9) 75(3) 133(5) 40(2) 7(3) -4(2) 30(3) 
C(10) 81(3) 100(4) 79(4) 28(3) -7(3) 21(3) 
C(11) 74(3) 114(4) 79(3) 25(3) 5(2) 45(3) 
C(12) 62(3) 98(4) 77(3) 22(3) 5(2) 36(3) 
C(13) 58(2) 91(3) 51(2) 11(2) 6(2) 38(2) 
C(14) 72(3) 153(5) 56(3) 18(3) 12(2) 45(3) 
C(15) 114(5) 189(7) 44(3) 26(3) 5(3) 42(5) 
C(16) 81(3) 100(4) 89(4) 18(3) 23(3) 55(3) 
C(17) 96(4) 146(6) 116(5) 26(4) 13(4) 72(4) 
C(18) 141(6) 155(7) 153(7) 5(6) 44(6) 112(6) 
C(19) 149(6) 119(5) 119(6) 10(4) 40(5) 80(5) 
C(20) 123(5) 102(4) 108(5) -7(3) 14(4) 63(4) 










 Table 5.   Hydrogen coordinates ( x 10
4





) for 206. 
                                     
Atom x y z U(equiv.) 
H(1) 86 2643 1414 69(12) 
H(2) 114 1552 1978 82 
H(3) 501 784 1841 93 
H(4) 985 715 944 102 
H(5) 1144 1479 190 89 
H(8) 1092 2299 -489 57(11) 
H(9) 111 2485 -651 79(13) 
H(11) 508 4160 -102 108 
H(14A) 1822 3738 -186 148 
H(14B) 2008 3412 -733 148 
H(14C) 2110 3222 -77 148 
H(15A) 341 2704 -1639 196 
H(15B) 687 2267 -1424 196 
H(15C) 1155 3080 -1529 196 
H(17) -431 3958 537 137 
H(18) -572 4592 1284 159 
H(19) -3 4790 2166 148 
H(20) 808 4436 2283 130 
H(21) 1006 3844 1535 104 
   




   
   
 Table 6.   Dihedral angles [
o
] for 206. 
                                         
Atom1  -  Atom2  -  Atom3  -  Atom4 Dihedral 
C(13) - N(1) - C(1) - C(6) 0.1(5) 
C(13) - N(1) - C(1) - C(2) 177.4(4) 
N(1) - C(1) - C(2) - C(3) -177.1(4) 
C(6) - C(1) - C(2) - C(3) -0.1(6) 
C(1) - C(2) - C(3) - C(4) -2.1(7) 
C(2) - C(3) - C(4) - C(5) 2.1(8) 
C(3) - C(4) - C(5) - C(6) 0.2(7) 
C(4) - C(5) - C(6) - C(1) -2.3(7) 
C(4) - C(5) - C(6) - C(7) 178.8(5) 
N(1) - C(1) - C(6) - C(5) 179.8(4) 
C(2) - C(1) - C(6) - C(5) 2.3(6) 
N(1) - C(1) - C(6) - C(7) -1.0(4) 
C(2) - C(1) - C(6) - C(7) -178.5(4) 
C(5) - C(6) - C(7) - C(13) -179.5(5) 
C(1) - C(6) - C(7) - C(13) 1.5(5) 
C(5) - C(6) - C(7) - C(8) -0.4(8) 
C(1) - C(6) - C(7) - C(8) -179.4(4) 
C(13) - C(7) - C(8) - C(14) 79.7(6) 
C(6) - C(7) - C(8) - C(14) -99.2(6) 
C(13) - C(7) - C(8) - C(9) -44.9(7) 
C(6) - C(7) - C(8) - C(9) 136.2(5) 
C(7) - C(8) - C(9) - C(10) 74.7(6) 
C(14) - C(8) - C(9) - C(10) -49.8(6) 
C(7) - C(8) - C(9) - C(15) -155.9(5) 
C(14) - C(8) - C(9) - C(15) 79.6(6) 
C(15) - C(9) - C(10) - O(1) -2.1(7) 
C(8) - C(9) - C(10) - O(1) 125.2(5) 
C(15) - C(9) - C(10) - C(11) 177.3(5) 
C(8) - C(9) - C(10) - C(11) -55.3(7) 
O(1) - C(10) - C(11) - C(12) -171.5(6) 
C(9) - C(10) - C(11) - C(12) 9.0(9) 
C(10) - C(11) - C(12) - C(13) 4.1(9) 
C(10) - C(11) - C(12) - C(16) -179.3(5) 
C(6) - C(7) - C(13) - N(1) -1.4(5) 
C(8) - C(7) - C(13) - N(1) 179.5(4) 
C(6) - C(7) - C(13) - C(12) 175.8(5) 
C(8) - C(7) - C(13) - C(12) -3.3(8) 
C(1) - N(1) - C(13) - C(7) 0.8(5) 
C(1) - N(1) - C(13) - C(12) -176.7(4) 
C(11) - C(12) - C(13) - C(7) 15.5(8) 
C(16) - C(12) - C(13) - C(7) -161.0(5) 
C(11) - C(12) - C(13) - N(1) -167.6(4) 
C(16) - C(12) - C(13) - N(1) 15.9(6) 
C(11) - C(12) - C(16) - C(21) -132.6(5) 




C(13) - C(12) - C(16) - C(21) 44.1(7) 
C(11) - C(12) - C(16) - C(17) 47.1(7) 
C(13) - C(12) - C(16) - C(17) -136.1(5) 
C(21) - C(16) - C(17) - C(18) 2.0(9) 
C(12) - C(16) - C(17) - C(18) -177.8(6) 
C(16) - C(17) - C(18) - C(19) -3.2(12) 
C(17) - C(18) - C(19) - C(20) 2.8(12) 
C(18) - C(19) - C(20) - C(21) -1.2(11) 
C(17) - C(16) - C(21) - C(20) -0.5(8) 
C(12) - C(16) - C(21) - C(20) 179.2(5) 
C(19) - C(20) - C(21) - C(16) 0.1(9) 
                                     
                                     
Symmetry transformations used to generate equivalent atoms: 




























6.2 Crystal data for 282 
 
Table 1.  Crystal data and structure refinement for 282. 
                                                        
 Identification code k11dc3a 
 Empirical formula C23 H21 I N2 O4 
 Formula weight 516.32 
 Temperature 298(2) K 
 Wavelength 0.71073 Å 
 Crystal system Orthorhombic 
 Space group Pbca 
 Unit cell dimensions a = 9.4740(1)Å alpha = 90
o
 
       b = 21.0690(2)Å beta = 90
o
 
       c = 22.6350(2)Å gamma = 90
o
 
 Volume 4518.12(8) Å
3
 
 Z 298 
 Density (calculated) 1.518 Mg/m
3
 
 Absorption coefficient 1.448 mm
-1
 
 F(000) 2064 
 Crystal size 0.45 x 0.30 x 0.10 mm 
 Theta range for data collection 3.58 to 25.03
o
 
 Index ranges -11<=h<=11; -25<=k<=24; -26<=l<=26 
 Reflections collected 65108 
 Independent reflections 3968 [R(int) = 0.0493] 
 Reflections observed (>2sigma) 3224 
 Data Completeness 0.993 
 Absorption correction Semi-empirical from equivalents 
 Max. and min. transmission 0.662 and 0.526 
 Refinement method Full-matrix least-squares on F
2
 
 Data / restraints / parameters 3968 / 0 / 272 
 Goodness-of-fit on F
2
 1.087 
 Final R indices [I>2sigma(I)] R1 = 0.0768   wR2 = 0.2015 
 R indices (all data) R1 = 0.0895  wR2 = 0.2137 







Incomplete phase transistion upon cooling to 150 K. thus, structure completed at 
298 K. 
 








 D-H           d(D-H)   d(H..A)   <DHA    d(D..A)   A 
 




 N1-H1          0.880    2.047   157.73    2.881    O4 [ -x+1/2, y-1/2, z ] 
   
 Table 2.  Atomic coordinates ( x 10
4





) for 282.U(equiv.) is defined as one third of the trace of the orthogonalized 
Uij tensor. 
                                                             
                                                             
Atom x y z U(equiv.) 
I(1) -228(1) 2961(1) 285(1) 119(1) 
O(1) 4507(4) 3488(2) 1500(2) 60(1) 
O(2) 6714(5) 3857(3) 1538(2) 97(2) 
O(3) 4381(7) 4690(2) 2924(2) 92(2) 
O(4) 3637(8) 4594(2) 2004(3) 120(2) 
N(1) 2296(8) 889(2) 1892(3) 90(2) 
N(2) 4586(5) 3744(2) 2507(2) 54(1) 
C(1) 561(7) 2262(3) 862(3) 72(2) 
C(2) -311(8) 1764(5) 1006(4) 93(2) 
C(3) 145(9) 1286(4) 1365(4) 95(3) 
C(4) 1528(8) 1309(3) 1568(3) 72(2) 
C(5) 2418(6) 1830(2) 1444(2) 54(1) 
C(6) 1911(6) 2317(3) 1085(2) 58(1) 
C(7) 3758(6) 1708(2) 1716(2) 56(1) 
C(8) 3629(9) 1121(3) 1975(3) 76(2) 
C(9) 4994(6) 2156(3) 1718(3) 59(1) 
C(10) 6400(8) 1823(4) 1823(4) 95(2) 
C(11) 4779(6) 2654(3) 2184(2) 54(1) 
C(12) 4634(5) 3270(2) 2079(2) 50(1) 
C(13) 5649(8) 3798(3) 1273(3) 71(2) 
C(14) 5303(9) 4022(4) 658(3) 96(3) 
C(15) 6418(8) 4424(3) 380(3) 71(2) 
C(16) 7094(8) 4243(4) -124(3) 82(2) 
C(17) 8060(10) 4635(5) -389(3) 102(3) 
C(18) 8342(10) 5217(5) -158(4) 99(2) 
C(19) 7728(13) 5400(4) 341(5) 126(4) 
C(20) 6782(12) 4999(4) 619(4) 126(4) 
C(21) 4152(9) 4354(3) 2433(3) 77(2) 
C(22) 5095(8) 3630(3) 3101(3) 79(2) 
C(23) 4993(9) 4291(4) 3370(3) 86(2) 
                                    
   




   
 Table 3.   Bond lengths [Å] and angles [
o
] for 282. 
  
I(1)-C(1) 2.108(7) O(1)-C(13) 1.364(7) 
O(1)-C(12) 1.394(6) O(2)-C(13) 1.180(8) 
O(3)-C(21) 1.335(8) O(3)-C(23) 1.435(9) 
O(4)-C(21) 1.197(8) N(1)-C(4) 1.360(9) 
N(1)-C(8) 1.367(10) N(1)-H(1) 0.8800 
N(2)-C(21) 1.360(7) N(2)-C(12) 1.394(7) 
N(2)-C(22) 1.448(8) C(1)-C(2) 1.375(11) 
C(1)-C(6) 1.380(9) C(2)-C(3) 1.363(13) 
C(2)-H(2) 0.9500 C(3)-C(4) 1.390(11) 
C(3)-H(3) 0.9500 C(4)-C(5) 1.412(8) 
C(5)-C(6) 1.393(8) C(5)-C(7) 1.434(8) 
C(6)-H(6) 0.9500 C(7)-C(8) 1.372(8) 
C(7)-C(9) 1.505(8) C(8)-H(8) 0.9500 
C(9)-C(11) 1.500(8) C(9)-C(10) 1.525(9) 
C(9)-H(9) 1.0000 C(10)-H(10A) 0.9800 
C(10)-H(10B) 0.9800 C(10)-H(10C) 0.9800 
C(11)-C(12) 1.326(8) C(11)-H(11) 0.9500 
C(13)-C(14) 1.506(9) C(14)-C(15) 1.494(10) 
C(14)-H(14A) 0.9900 C(14)-H(14B) 0.9900 
C(15)-C(16) 1.361(9) C(15)-C(20) 1.371(11) 
C(16)-C(17) 1.372(11) C(16)-H(16) 0.9500 
C(17)-C(18) 1.360(12) C(17)-H(17) 0.9500 
C(18)-C(19) 1.326(12) C(18)-H(18) 0.9500 
C(19)-C(20) 1.383(12) C(19)-H(19) 0.9500 
C(20)-H(20) 0.9500 C(22)-C(23) 1.523(10) 
C(22)-H(22A) 0.9900 C(22)-H(22B) 0.9900 
C(23)-H(23A) 0.9900 C(23)-H(23B) 0.9900 
C(13)-O(1)-C(12) 116.2(4) C(21)-O(3)-C(23) 110.0(5) 
C(4)-N(1)-C(8) 109.6(5) C(4)-N(1)-H(1) 125.2 
C(8)-N(1)-H(1) 125.2 C(21)-N(2)-C(12) 127.0(5) 
C(21)-N(2)-C(22) 111.8(5) C(12)-N(2)-C(22) 121.1(5) 
C(2)-C(1)-C(6) 122.3(7) C(2)-C(1)-I(1) 117.9(6) 
C(6)-C(1)-I(1) 119.8(5) C(3)-C(2)-C(1) 120.9(7) 
C(3)-C(2)-H(2) 119.5 C(1)-C(2)-H(2) 119.5 
C(2)-C(3)-C(4) 118.1(7) C(2)-C(3)-H(3) 121.0 
C(4)-C(3)-H(3) 121.0 N(1)-C(4)-C(3) 131.3(7) 
N(1)-C(4)-C(5) 107.1(6) C(3)-C(4)-C(5) 121.6(7) 
C(6)-C(5)-C(4) 118.8(6) C(6)-C(5)-C(7) 133.5(5) 
C(4)-C(5)-C(7) 107.6(5) C(1)-C(6)-C(5) 118.1(6) 
C(1)-C(6)-H(6) 121.0 C(5)-C(6)-H(6) 121.0 
C(8)-C(7)-C(5) 105.5(6) C(8)-C(7)-C(9) 129.2(6) 
C(5)-C(7)-C(9) 125.3(5) N(1)-C(8)-C(7) 110.2(6) 
N(1)-C(8)-H(8) 124.9 C(7)-C(8)-H(8) 124.9 
C(11)-C(9)-C(7) 109.6(5) C(11)-C(9)-C(10) 109.4(5) 
C(7)-C(9)-C(10) 113.0(6) C(11)-C(9)-H(9) 108.2 
C(7)-C(9)-H(9) 108.2 C(10)-C(9)-H(9) 108.2 
C(9)-C(10)-H(10A) 109.5 C(9)-C(10)-H(10B) 109.5 




H(10A)-C(10)-H(10B) 109.5 C(9)-C(10)-H(10C) 109.5 
H(10A)-C(10)-H(10C) 109.5 H(10B)-C(10)-H(10C) 109.5 
C(12)-C(11)-C(9) 124.9(5) C(12)-C(11)-H(11) 117.5 
C(9)-C(11)-H(11) 117.5 C(11)-C(12)-N(2) 125.5(5) 
C(11)-C(12)-O(1) 120.0(5) N(2)-C(12)-O(1) 114.5(4) 
O(2)-C(13)-O(1) 122.5(5) O(2)-C(13)-C(14) 128.5(6) 
O(1)-C(13)-C(14) 108.9(6) C(15)-C(14)-C(13) 114.5(6) 
C(15)-C(14)-H(14A) 108.6 C(13)-C(14)-H(14A) 108.6 
C(15)-C(14)-H(14B) 108.6 C(13)-C(14)-H(14B) 108.6 
H(14A)-C(14)-H(14B) 107.6 C(16)-C(15)-C(20) 117.4(7) 
C(16)-C(15)-C(14) 121.8(7) C(20)-C(15)-C(14) 120.8(7) 
C(15)-C(16)-C(17) 120.8(7) C(15)-C(16)-H(16) 119.6 
C(17)-C(16)-H(16) 119.6 C(18)-C(17)-C(16) 120.3(8) 
C(18)-C(17)-H(17) 119.8 C(16)-C(17)-H(17) 119.8 
C(19)-C(18)-C(17) 120.3(8) C(19)-C(18)-H(18) 119.9 
C(17)-C(18)-H(18) 119.9 C(18)-C(19)-C(20) 119.6(8) 
C(18)-C(19)-H(19) 120.2 C(20)-C(19)-H(19) 120.2 
C(15)-C(20)-C(19) 121.5(8) C(15)-C(20)-H(20) 119.2 
C(19)-C(20)-H(20) 119.2 O(4)-C(21)-O(3) 121.2(6) 
O(4)-C(21)-N(2) 128.4(6) O(3)-C(21)-N(2) 110.4(6) 
N(2)-C(22)-C(23) 101.4(5) N(2)-C(22)-H(22A) 111.5 
C(23)-C(22)-H(22A) 111.5 N(2)-C(22)-H(22B) 111.5 
C(23)-C(22)-H(22B) 111.5 H(22A)-C(22)-H(22B) 109.3 
O(3)-C(23)-C(22) 106.2(5) O(3)-C(23)-H(23A) 110.5 
C(22)-C(23)-H(23A) 110.5 O(3)-C(23)-H(23B) 110.5 
C(22)-C(23)-H(23B) 110.5 H(23A)-C(23)-H(23B) 108.7 
                                                   
Symmetry transformations used to generate equivalent atoms: 
                                                            
   




   




) for 282. The anisotropic 






 U11 + ... + 2 h k a* b* U 
                                                                                 
Atom U11 U22 U33 U23 U13 U12 
I(1) 127(1) 119(1) 110(1) -18(1) -50(1) 37(1) 
O(1) 65(2) 62(2) 53(2) 10(2) -10(2) -8(2) 
O(2) 70(3) 140(5) 82(3) 38(3) -11(3) -32(3) 
O(3) 134(4) 49(2) 93(3) -10(2) -9(3) -8(3) 
O(4) 205(7) 58(3) 98(4) 7(3) -33(4) 47(4) 
N(1) 143(6) 45(3) 81(4) 1(3) 14(4) -26(3) 
N(2) 61(3) 47(2) 53(2) 5(2) -7(2) -3(2) 
C(1) 65(4) 74(4) 76(4) -21(3) -1(3) 2(3) 
C(2) 68(4) 123(7) 88(5) -32(5) 4(4) -16(5) 
C(3) 96(6) 96(6) 92(5) -23(5) 21(5) -53(5) 
C(4) 95(5) 56(3) 64(4) -9(3) 15(3) -19(3) 
C(5) 65(3) 42(2) 55(3) -9(2) 11(3) -7(2) 
C(6) 61(3) 50(3) 62(3) -10(2) 2(3) 1(2) 
C(7) 76(4) 38(3) 55(3) -3(2) 7(3) 5(2) 
C(8) 120(6) 47(3) 63(4) 5(3) 5(4) 11(4) 
C(9) 59(3) 61(3) 57(3) -2(3) 3(3) 4(3) 
C(10) 75(5) 108(6) 102(5) -24(5) -2(4) 33(4) 
C(11) 61(3) 49(3) 51(3) 4(2) 2(2) 2(2) 
C(12) 48(3) 53(3) 48(3) 5(2) -3(2) -7(2) 
C(13) 74(4) 83(4) 56(3) 15(3) 3(3) -14(3) 
C(14) 112(6) 113(6) 64(4) 27(4) -10(4) -30(5) 
C(15) 86(4) 71(4) 57(3) 13(3) 3(3) 3(3) 
C(16) 94(5) 93(5) 59(4) -5(3) -11(4) -8(4) 
C(17) 93(5) 145(8) 68(4) -16(5) 16(4) -23(5) 
C(18) 102(6) 113(6) 82(5) 25(5) 4(5) -20(5) 
C(19) 184(11) 58(4) 135(8) -8(5) 51(7) -10(6) 
C(20) 177(10) 83(5) 118(7) -17(5) 78(7) -10(6) 
C(21) 101(5) 50(3) 79(4) -1(3) -7(4) 3(3) 
C(22) 104(5) 74(4) 59(4) -2(3) -20(3) 10(4) 
C(23) 99(5) 82(5) 76(4) -17(4) -10(4) -15(4) 
   




   
 Table 5.   Hydrogen coordinates ( x 10
4
) and isotropic displacement 




) for 282. 
                                     
Atom x y z U(equiv.) 
H(1) 1983 524 2027 108 
H(2) -1245 1752 854 111 
H(3) -465 948 1473 113 
H(6) 2478 2676 997 69 
H(8) 4361 908 2182 92 
H(9) 5036 2372 1325 71 
H(10A) 7171 2130 1785 143 
H(10B) 6523 1485 1530 143 
H(10C) 6411 1639 2220 143 
H(11) 4745 2518 2583 64 
H(14A) 5138 3647 405 116 
H(14B) 4412 4268 673 116 
H(16) 6893 3841 -293 98 
H(17) 8535 4499 -737 122 
H(18) 8982 5493 -353 119 
H(19) 7937 5804 506 151 
H(20) 6375 5125 984 151 
H(22A) 6080 3473 3100 95 
H(22B) 4488 3323 3314 95 
H(23A) 4391 4285 3727 103 
H(23B) 5942 4449 3481 103 
   
   
 
  




 Table 6.   Dihedral angles [
o
] for 282. 
                                         
Atom1  -  Atom2  -  Atom3  -  Atom4 Dihedral 
C(6) - C(1) - C(2) - C(3) -2.2(11) 
I(1) - C(1) - C(2) - C(3) 178.2(6) 
C(1) - C(2) - C(3) - C(4) -1.7(12) 
C(8) - N(1) - C(4) - C(3) 179.2(7) 
C(8) - N(1) - C(4) - C(5) -0.2(7) 
C(2) - C(3) - C(4) - N(1) -175.0(7) 
C(2) - C(3) - C(4) - C(5) 4.3(11) 
N(1) - C(4) - C(5) - C(6) 176.4(5) 
C(3) - C(4) - C(5) - C(6) -3.1(9) 
N(1) - C(4) - C(5) - C(7) -0.8(6) 
C(3) - C(4) - C(5) - C(7) 179.8(6) 
C(2) - C(1) - C(6) - C(5) 3.4(9) 
I(1) - C(1) - C(6) - C(5) -177.0(4) 
C(4) - C(5) - C(6) - C(1) -0.8(8) 
C(7) - C(5) - C(6) - C(1) 175.5(6) 
C(6) - C(5) - C(7) - C(8) -175.1(6) 
C(4) - C(5) - C(7) - C(8) 1.5(6) 
C(6) - C(5) - C(7) - C(9) 6.5(9) 
C(4) - C(5) - C(7) - C(9) -176.9(5) 
C(4) - N(1) - C(8) - C(7) 1.2(7) 
C(5) - C(7) - C(8) - N(1) -1.6(7) 
C(9) - C(7) - C(8) - N(1) 176.6(6) 
C(8) - C(7) - C(9) - C(11) -98.2(7) 
C(5) - C(7) - C(9) - C(11) 79.7(7) 
C(8) - C(7) - C(9) - C(10) 24.1(9) 
C(5) - C(7) - C(9) - C(10) -158.0(6) 
C(7) - C(9) - C(11) - C(12) -116.2(6) 
C(10) - C(9) - C(11) - C(12) 119.4(7) 
C(9) - C(11) - C(12) - N(2) -172.7(5) 
C(9) - C(11) - C(12) - O(1) 7.7(8) 
C(21) - N(2) - C(12) - C(11) -165.2(6) 
C(22) - N(2) - C(12) - C(11) 18.1(9) 
C(21) - N(2) - C(12) - O(1) 14.5(8) 
C(22) - N(2) - C(12) - O(1) -162.2(5) 
C(13) - O(1) - C(12) - C(11) -107.4(6) 
C(13) - O(1) - C(12) - N(2) 73.0(6) 
C(12) - O(1) - C(13) - O(2) 3.2(10) 
C(12) - O(1) - C(13) - C(14) -177.6(6) 
O(2) - C(13) - C(14) - C(15) -6.5(13) 
O(1) - C(13) - C(14) - C(15) 174.4(7) 
C(13) - C(14) - C(15) - C(16) 118.1(8) 
C(13) - C(14) - C(15) - C(20) -63.0(11) 
C(20) - C(15) - C(16) - C(17) -2.4(12) 
C(14) - C(15) - C(16) - C(17) 176.5(8) 
C(15) - C(16) - C(17) - C(18) -1.0(13) 
C(16) - C(17) - C(18) - C(19) 2.8(15) 




C(17) - C(18) - C(19) - C(20) -1.0(17) 
C(16) - C(15) - C(20) - C(19) 4.2(15) 
C(14) - C(15) - C(20) - C(19) -174.7(10) 
C(18) - C(19) - C(20) - C(15) -2.6(18) 
C(23) - O(3) - C(21) - O(4) 179.6(8) 
C(23) - O(3) - C(21) - N(2) -0.8(9) 
C(12) - N(2) - C(21) - O(4) 5.7(13) 
C(22) - N(2) - C(21) - O(4) -177.4(9) 
C(12) - N(2) - C(21) - O(3) -173.9(5) 
C(22) - N(2) - C(21) - O(3) 3.1(9) 
C(21) - N(2) - C(22) - C(23) -3.8(8) 
C(12) - N(2) - C(22) - C(23) 173.4(5) 
C(21) - O(3) - C(23) - C(22) -1.6(9) 
N(2) - C(22) - C(23) - O(3) 3.1(8) 
                                   
                                   
Symmetry transformations used to generate equivalent atoms: 





































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1. Raub, C., Gold Metal and Gold Alloys in Jewellery. In Gold: Progess in 
Chemistry, Biochemistry and Technology, Schmidbaur, H., Ed. Wiley: Chichester, 
1999; pp 105-117. 
2. Puddephatt, R., The Chemistry of Gold. Elsevier: Amsterdam, 1978. 
3. Reiter, K., Die Metalle im Alten Orient unter besonderer Berucksichtigung 
altbabylonischer Quellen. Munster, 1997. 
4. Fischer, W., Die Altorientalischen Reiche I. Frankfurt, 1965; p 227. 
5. Wegner, H. A.; Auzias, M., Angew. Chem. Int. Ed. 2011, 50 (36), 8236-8247. 
6. Bond, G., Gold Bull. 1972, 5 (1), 11-13. 
7. Haruta, M.; Kobayashi, T.; Sano, H.; Nobumasa, Y., Chem. Lett. 1987, 405-408. 
8. Hutchings, G. J., J. Catal. 1985, 96 (1), 292-295. 
9. Vepřek, S.; Cocke, D. L.; Kehl, S.; Oswald, H. R., J. Catal. 1986, 100 (1), 250-
263. 
10. Bond, G. C.; Molloy, L. R.; Fuller, M. J., J. Chem. Soc., Chem. Commun. 1975,  
(19), 796-797; Dauchot, J. P.; Dath, J. P., J. Catal. 1984, 86 (2), 373-383. 
11. Mochida, I.; Iwai, Y.; Kamo, T.; Fujitsu, H., J. Phys. Chem. 1985, 89 (25), 
5439-5442. 
12. Brittan, M. I.; Bliss, H.; Walker, C. A., AIChE J. 1970, 16 (2), 305-314; Desai, 
M. N.; Butt, J. B.; Dranoff, J. S., J. Catal. 1983, 79 (1), 95-103. 
13. Haruta, M.; Yamada, N.; Kobayashi, T.; Iijima, S., J. Catal. 1989, 115 (2), 301-
309; Haruta, M.; Tsubota, S.; Kobayashi, T.; Kageyama, H.; Genet, M. J.; Delmon, B., 
J. Catal. 1993, 144 (1), 175-192. 
14. Council, A. C., ACC Resin Statistics Summary 2010 vs. 2009. American 
Chemistry Council: 2010. 
15. Hutchings, G. J.; Grady, D. T., Appl. Catal. 1985, 16 (3), 411-415. 
16. Hutchings, G. J., Gold Bull. 2004, 37 (1), 3-11. 
17. Smith, D. M.; Walsh, P. M.; Slager, T. L., J. Catal. 1968, 11 (2), 113-130; 
Gel'bschtein, A.; Siling, M.; Scheglova, G.; Vasil'eva, I., Kinet. Catal. 1964, 5, 402. 
18. Shinoda, K., Chem. Lett. 1975, 219-220. 
19. Gel'bschtein, A.; Scheglova, G.; Khomenko, A., Kinet. Catal. 1963, 4, 543; 
Gel'bschtein, A.; Siling, M., Kinet. Catal. 1963, 4 (262); Gel'bschtein, A.; Siling, M.; 
Sergreeva, G.; Shcheglova, G., Kinet. Catal. 1963, 4, 123. 




20. Fujii, C.; Saito, K.; Tasshi, N. (Patent) Jpn. Kokai Tokkyo Koho, 79, 42, 390, 
1979. 
21. McKelvey, D. R., J. Chem. Edu. 1983, 60 (2), 112; Pitzer, K. S., Acc. Chem. 
Res. 1979, 12 (8), 271-276. 
22. Gorin, D. J.; Toste, F. D., Nature 2007, 446 (7134), 395-403. 
23. Bartlett, N., Gold Bull. 1998, 31 (1), 22-25. 
24. Rose, S.; Grant, I.; Pyper, N., J. Phys. B: At. Mol. Phys. 1978, 11, 1171. 
25. Pyykko, P., Chem. Rev. 1988, 88 (3), 563-594. 
26. Pyykko, P.; Desclaux, J. P., Acc. Chem. Res. 1979, 12 (8), 276-281. 
27. Kaltsoyannis, N., J. Chem. Soc., Dalton Trans. 1997,  (1), 1-12. 
28. Desclaux, J. P.; Pyykkö, P., Chem. Phys. Lett.s 1976, 39 (2), 300-303. 
29. Hashmi, A. S. K, Gold Bull.  2003, 36 (1), 3-9. 
30. Schulte, P.; Behrens, U., Chem. Commun. 1998,  (16), 1633-1634. 
31. Hertwig, R. H.; Koch, W.; Schröder, D.; Schwarz, H.; Hrušák, J.; 
Schwerdtfeger, P., J. Phys. Chem. 1996, 100 (30), 12253-12260; Nechaev, M. S.; 
Rayón, V. M.; Frenking, G., J. Phys. Chem. A 2004, 108 (15), 3134-3142. 
32. Fleming, I., Fronteir Orbitals And Organic Chemical Reaction. Wiley: 
Chichester, 1976. 
33. Zamora, F.; Amo-Ochoa, P.; Fischer, B.; Schimanski, A.; Lippert, B., Angew. 
Chem. Int. Ed. 1999, 38 (15), 2274-2275. 
34. Kar, A.; Mangu, N.; Kaiser, H. M.; Beller, M.; Tse, M. K., Chem. Commun. 
2008,  (3), 386-388. 
35. Wegner, H. A.; Ahles, S.; Neuburger, M., Chem. Eur. J. 2008, 14 (36), 11310-
11313. 
36. Zhang, G.; Peng, Y.; Cui, L.; Zhang, L., Angew. Chem. Int. Ed. 2009, 48 (17), 
3112-3115. 
37. Miyaura, N.; Yamada, K.; Suzuki, A., Tetrahedron Lett. 1979, 20 (36), 3437-
3440. 
38. Corma, A.; Gutiérrez-Puebla, E.; Iglesias, M.; Monge, A.; Pérez-Ferreras, S.; 
Sánchez, F., Adv. Synth. Catal. 2006, 348 (14), 1899-1907. 
39. González-Arellano, C.; Corma, A.; Iglesias, M.; Sánchez, F., J.Catal. 2006, 238 
(2), 497-501. 
40. Sonogashira, K.; Tohda, Y.; Hagihara, N., Tetrahedron Lett. 1975, 16 (50), 
4467-4470. 




41. Li, P.; Wang, L.; Wang, M.; You, F., Eur. J. Org. Chem. 2008, (35), 5946-5951. 
42. González-Arellano, C.; Abad, A.; Corma, A.; García, H.; Iglesias, M.; Sánchez, 
F., Angew. Chem. Int. Ed. 2007, 46 (9), 1536-1538. 
43. Lauterbach, T.; Livendahl, M.; Rosell n, A.;  spinet, P.;  chavarren, A. M., 
Org. Lett. 2010, 12 (13), 3006-3009. 
44. Corma, A.; Juarez, R.; Boronat, M.; Sanchez, F.; Iglesias, M.; Garcia, H., Chem. 
Commun..2011, 47 (5), 1446-1448. 
45. Jones, L. A.; Sanz, S.; Laguna, M., Catal. Today 2007, 122 (3–4), 403-406. 
46. Panda, B.; Sarkar, T. K., Tetrahedron Lett. 2010, 51 (2), 301-305. 
47. Luzung, M. R.; Markham, J. P.; Toste, F. D., J. Am. Chem. Soc. 2004, 126 (35), 
10858-10859. 
48. López, S.; Herrero-Gómez, E.; Pérez-Galán, P.; Nieto-Oberhuber, C.; 
Echavarren, A. M., Angew. Chem. Int.l Ed. 2006, 45 (36), 6029-6032. 
49. Nieto-Oberhuber, C.; Muñoz, M. P.; Buñuel, E.; Nevado, C.; Cárdenas, D. J.; 
Echavarren, A. M., Angew. Chem. Int. Ed. 2004, 43 (18), 2402-2406. 
50. Hashmi, A. S. K.; Frost, T. M.; Bats, J. W., J. Am. Chem. Soc. 2000, 122 (46), 
11553-11554. 
51. Belting, V.; Krause, N., Org. Biomol. Chem. 2009, 7 (6); Xia, Y.; Dudnik, A. S.; 
Gevorgyan, V.; Li, Y., J. Am. Chem. Soc. 2008, 130 (22), 6940-6941; Gao, H.; Zhao, 
X.; Yu, Y.; Zhang, J., Chem. Eur. J. 2010, 16 (2), 456-459. 
52. Bai, Y.; Fang, J.; Ren, J.; Wang, Z., Chem. Eur. J. 2009, 15 (36), 8975-8978; 
Zhang, G.; Huang, X.; Li, G.; Zhang, L., J. Am. Chem. Soc. 2008, 130 (6), 1814-1815. 
53. Oh, C. H.; Lee, S. J.; Lee, J. H.; Na, Y. J., Chem. Commun. 2008,  (44). 5794-
5796 
54. Praveen, C.; Kiruthiga, P.; Perumal, P. T., Synlett 2009, 1990-1996; Kim, S.; 
Kang, D.; Shin, S.; Lee, P. H., Tetrahedron Lett. 2010, 51 (14), 1899-1901. 
55. Aponick, A.; Li, C.-Y.; Malinge, J.; Marques, E. F., Org. Lett. 2009, 11 (20), 
4624-4627. 
56. Egi, M.; Azechi, K.; Akai, S., Org. Lett. 2009, 11 (21), 5002-5005. 
57. Du, X.; Song, F.; Lu, Y.; Chen, H.; Liu, Y., Tetrahedron 2009, 65 (9), 1839-
1845. 
58. Blanc, A. l.; Tenbrink, K.; Weibel, J.-M.; Pale, P., J. Org. Chem. 2009, 74 (15), 
5342-5348; Ji, K.-G.; Shen, Y.-W.; Shu, X.-Z.; Xiao, H.-Q.; Bian, Y.-J.; Liang, Y.-M., 
Adv. Synth. Catal. 2008, 350 (9), 1275-1280. 




59. Santos, L. L.; Ruiz, V. R.; Sabater, M. J.; Corma, A., Tetrahedron 2008, 64 (34), 
7902-7909. 
60. Leyva, A.; Corma, A., J. Org. Chem. 2009, 74 (5), 2067-2074. 
61. Harkat, H.; Dembelé, A. Y.; Weibel, J.-M.; Blanc, A.; Pale, P., Tetrahedron 
2009, 65 (9), 1871-1879. 
62. Körner, C.; Starkov, P.; Sheppard, T. D., J. Am. Chem. Soc. 2010, 132 (17), 
5968-5969. 
63. Fortner, K. C.; Kato, D.; Tanaka, Y.; Shair, M. D., J. Am. Chem. Soc. 2009, 132 
(1), 275-280. 
64. Kramer, S.; Dooleweerdt, K.; Lindhardt, A. T.; Rottl nder, M.; Skrydstrup, T., 
Org. Lett. 2009, 11 (18), 4208-4211. 
65. Zhang, Q.; Cheng, M.; Hu, X.; Li, B.-G.; Ji, J.-X., J. Am. Chem. Soc. 2010, 132 
(21), 7256-7257; Yadav, J. S.; Reddy, B. V. S.; Yadav, N. N.; Gupta, M. K.; Sridhar, 
B., J. Org. Chem. 2008, 73 (17), 6857-6859. 
66. Zhao, X.; Zhang, E.; Tu, Y.-Q.; Zhang, Y.-Q.; Yuan, D.-Y.; Cao, K.; Fan, C.-A.; 
Zhang, F.-M., Org. Lett. 2009, 11 (17), 4002-4004. 
67. Davies, P. W.; Martin, N., Org. Lett. 2009, 11 (11), 2293-2296. 
68. Arcadi, A.; Bianchi, G.; Marinelli, F., Synthesis 2004, 610-618. 
69. Iritani, K.; Matsubara, S.; Utimoto, K., Tetrahedron Lett. 1988, 29 (15), 1799-
1802; Kamijo, S.; Yamamoto, Y., J. Org. Chem. 2003, 68 (12), 4764-4771. 
70. Zhang, Y.; Donahue, J. P.; Li, C.-J., Org. Lett. 2007, 9 (4), 627-630. 
71. Baeyer, A.; Emmerling, A., Ber. Dtsch. Chem. Ges. 1869, 2, 679-685. 
72. Evans, B. E.; Rittle, K. E.; Bock, M. G.; DiPardo, R. M.; Freidinger, R. M.; 
Whitter, W. L.; Lundell, G. F.; Veber, D. F.; Anderson, P. S., J. Med. Chem. 1988, 31 
(12), 2235-2246. 
73. Sundberg, R., The Chemistry of Indoles. Academic Press: New York, 1970; p 
489; Remers, W., Properties and Reactions of Indoles. In Indoles Part One, Houlihan, 
Ed. Wiley-Interscience: New York, 1972. 
74. Nichols, D. E.; Nichols, C. D., Chem. Rev. 2008, 108 (5), 1614-1641; 
Aghajanian, G. K.; Sanders-Bush, E., Neuropsychopharmacology - The Fifth 
Generation of Progress. Lippincott: New York, 2002. 
75. Gaffney, T. E.; Chidsey, C. A.; Braunwald, E., Circ. Res. 1963, 12 (3), 264-268; 
Muiler, J. M.; Schlitter, E.; Bein, H. J., Experientia 1952, 8, 338. 
76. Chen, F.-E.; Huang, J., Chem. Rev. 2005, 105 (12), 4671-4706. 




77. Aprison, M. H., Glycine Neurotransmission. Wiley: New York, 1990; Bonjoch, 
J.; Solé, D., Chem. Rev. 2000, 100 (9), 3455-3482. 
78. Svoboda, G. H.; Neuss, N.; Gorman, M. J., J. Am. Pharm. Assoc., Sci. Ed. 1959, 
48, 659. 
79. Miyazaki, T.; Yokoshima, S.; Simizu, S.; Osada, H.; Tokuyama, H.; Fukuyama, 
T., Org. Lett. 2007, 9 (23), 4737-4740; Rowinsky, E. K.; Donehower, R. C., Cancer 
Chemotherapy and Biotherapy. Lippincott-Raven Publishers: Philadelphia, 1996. 
80. Fischer, E.; Jourdan, F., Chem. Ber. 1883, 16, 2241; Fischer, E.; Hess, O., 
Chem. Ber. 1884, 17, 559. 
81. Watson, T. J. N.; Horgan, S. W.; Shah, R. S.; Farr, R. A.; Schnettler, R. A.; 
Nevill, C. R.; Weiberth, F. J.; Huber, E. W.; Baron, B. M.; Webster, M. E.; Mishra, R. 
K.; Harrison, B. L.; Nyce, P. L.; Rand, C. L.; Goralski, C. T., Org. Process Res. Dev. 
2000, 4 (6), 477-487. 
82. Larock, R. C.; Yum, E. K., J. Am. Chem. Soc. 1991, 113 (17), 6689-6690; 
Larock, R. C.; Yum, E. K.; Refvik, M. D., J. Org. Chem. 1998, 63 (22), 7652-7662. 
83. Xu, L.; Lewis, I. R.; Davidsen, S. K.; Summers, J. B., Tetrahedron Lett. 1998, 
39 (29), 5159-5162; Ujjainwalla, F.; Warner, D., Tetrahedron Lett. 1998, 39 (30), 5355-
5358; Park, S. S.; Choi, J.-K.; Yum, E. K.; Ha, D.-C., Tetrahedron Lett. 1998, 39 (7), 
627-630. 
84. Kang, S. K.; Park, S. S.; Kim, S. S.; Choi, J.-K.; Yum, E. K., Tetrahedron Lett. 
1999, 40 (23), 4379-4382. 
85. Larock, R. C.; Doty, M. J.; Han, X., Tetrahedron Lett. 1998, 39 (29), 5143-
5146. 
86. Bartoli, G.; Bosco, M.; Dalpozzo, R.; Palmieri, G.; Marcantoni, E., J. Chem. 
Soc., Perkin Trans. 1 1991,  (11), 2757-2761; Bosco, M.; Dalpozzo, R.; Bartoli, G.; 
Palmieri, G.; Petrini, M., J. Chem. Soc., Perkin Trans. 2 1991,  (5), 657-663. 
87. Harrowven, D. C.; Lai, D.; Lucas, M. C., Synthesis 1999, (08), 1300-1302; 
Chattopadhyay, S.; Chattopadhyay, U.; Mathur, P. P.; Saini, K. S.; Ghosal, S., Planta 
Med 1983, 49 (12), 252-254. 
88. Fukui, K.; Yonezawa, T.; Nagata, C.; Shingu, H., J. Chem. Phys. 1954, 22 (8), 
1433-1442. 
89. Lakhdar, S.; Westermaier, M.; Terrier, F.; Goumont, R.; Boubaker, T.; Ofial, A. 
R.; Mayr, H., J. Org. Chem. 2006, 71 (24), 9088-9095. 
90. Berti, G.; Settimo, A. D.; Nannipieri, E., J. Chem. Soc. C 1968, 2145-2151. 




91. Pelkey, E. T.; Gribble, G. W., Synthesis 1999, (07), 1117-1122. 
92. Joule, J.; Mills, K., Heterocyclic Chemistry. Fourth ed.; Blackwell Science Ltd.: 
London, 2000. 
93. Friedel, C.; Crafts, J. M., Compt. Rend. 1877, 84, 1450-1454; Friedel, C.; Crafts, 
J. M., Compt. Rend. 1877, 84, 1392-1395; Friedel, C.; Crafts, J. M., Compt. Rend. 1877, 
85, 74-77. 
94. Saxton, J. E., J. Chem. Soc.(Resumed) 1952, 3592-3594. 
95. Ketcha, D. M.; Gribble, G. W., J. Org. Chem. 1985, 50 (26), 5451-5457. 
96. Tyson, F. T.; Shaw, J. T., J. Am. Chem. Soc. 1952, 74 (9), 2273-2274; Smith, G. 
F., J. Chem. Soc. (Resumed) 1954, 3842-3846. 
97. Monge, A.; Aldana, I.; Lezamiz, I.; Fernandez-Alvarez, E., Synthesis 1984,  2, 
160. 
98. Anthony, W., J. Org. Chem. 1960, 25 (11), 2049-2053. 
99. Li, H.; Wang, Y.-Q.; Deng, L., Org. Lett. 2006, 8 (18), 4063-4065. 
100. Zhuang, W.; Gathergood, N.; Hazell, R. G.; Jørgensen, K. A., J. Org. Chem. 
2001, 66 (3), 1009-1013; Török, B.; Abid, M.; London, G.; Esquibel, J.; Török, M.; 
Mhadgut, S. C.; Yan, P.; Prakash, G. K. S., Angew. Chem. Int. Ed. 2005, 44 (20), 3086-
3089. 
101. Nair, V.; Nandialath, V.; Abhilash, K. G.; Suresh, E., Org. Biomol. Chem. 2008, 
6 (10), 1738-1742. 
102. Knölker, H.-J.; Reddy, K. R., Chem. Rev. 2002, 102 (11), 4303-4428; 
Burroughes, J. H.; Bradley, D. D. C.; Brown, A. R.; Marks, R. N.; Mackay, K.; Friend, 
R. H.; Burns, P. L.; Holmes, A. B., Nature 1990, 347 (6293), 539-541. 
103. Whaley, W.; Govindachari, T., The Pictet-Spengler Synthesis of 
Tetrahydroisoquinolines and Related Compounds. John Wiley and Sons: New York, 
1951; Vol. VI. 
104. Cox, E. D.; Cook, J. M., Chem. Rev. 1995, 95 (6), 1797-1842. 
105. Youn, S. W., J. Org. Chem. 2006, 71 (6), 2521-2523. 
106. Mergott, D. J.; Zuend, S. J.; Jacobsen, E. N., Org. Lett. 2008, 10 (5), 745-748; 
Goldberg, M. R.; Robertson, D., Pharmacol. Rev. 1983, 35 (3), 143-180. 
107. Nakao, Y.; Kanyiva, K. S.; Oda, S.; Hiyama, T., J. Am. Chem. Soc. 2006, 128 
(25), 8146-8147. 
108. Nakao, Y.; Oda, S.; Hiyama, T., J. Am. Chem. Soc. 2004, 126 (43), 13904-
13905. 




109. Ferrer, C.; Echavarren, A. M., Angew. Chem. Int. Ed. 2006, 45 (7), 1105-1109. 
110. Liu, C.; Bender, C. F.; Han, X.; Widenhoefer, R. A., Chem. Commun. 2007,  
(35), 3607-3618. 
111. Han, X.; Widenhoefer, R. A., Org. Lett. 2006, 8 (17), 3801-3804. 
112. Grimster, N. P.; Gauntlett, C.; Godfrey, C. R. A.; Gaunt, M. J., Angew. Chem. 
Int. Ed. 2005, 44 (20), 3125-3129. 
113. Shankar, R.; Jha, A. K.; Singh, U. S.; Hajela, K., Tetrahedron Lett. 2006, 47 
(18), 3077-3079. 
114. Rubio, A.; Ezquerra, J.; Escribano, A.; Remuiñán, M. J.; Vaquero, J. J., 
Tetrahedron Lett. 1998, 39 (15), 2171-2174. 
115. Dujardin, G.; Poirer, J.-M., Bull. Soc. Chim. Fr. 1994, 131, 900-909. 
116. Harrington, P. E.; Kerr, M. A., Synlett 1996, 1996 (11), 1047,1048. 
117. Bandini, M.; Eichholzer, A., Angew. Chem. Int. Ed. 2009, 48 (51), 9608-9644. 
118. Li, Z.; Shi, Z.; He, C., J. Organomet. Chem. 2005, 690 (23), 5049-5054. 
119. Yao, X.; Li, C.-J., J. Am. Chem. Soc. 2004, 126 (22), 6884-6885. 
120. Bandini, M.; Fagioli, M.; Melchiorre, P.; Melloni, A.; Umani-Ronchi, A., 
Tetrahedron Lett. 2003, 44 (31), 5843-5846. 
121. Leitch, S.; Addison-Jones, J.; McCluskey, A., Tetrahedron Lett. 2005, 46 (16), 
2915-2918; Srivastava, N.; Banik, B. K., J. Org. Chem. 2003, 68 (6), 2109-2114. 
122. Arcadi, A.; Bianchi, G.; Chiarini, M.; D'Anniballe, G.; Marinelli, F., Synlett 
2004, 944-950. 
123. Silvanus, A. C.; Heffernan, S. J.; Liptrot, D. J.; Kociok-Köhn,  .; Andrews, B. 
I.; Carbery, D. R., Org. Lett. 2009, 11 (5), 1175-1178. 
124. Rawson, T.  .; R th, M.; Blackwood,  .; Burdick, D.; Corson, L.; Dotson, J.; 
Drummond, J.; Fields, C.; Georges,  . J.;  oller, B.; Halladay, J.; Hunsaker, T.; 
Kleinheinz, T.; Krell, H.-W.; Li, J.; Liang, J.; Limberg, A.; McNutt, A.; Moffat, J.; 
Phillips,  .; Ran,  .; Safina, B.;  ltsch, M.; Walker, L.; Wiesmann, C.;  hang, B.; 
 hou, A.;  hu, B.- .; R ger, P.; Cochran, A. G., J. Med. Chem. 2008, 51 (15), 4465-
4475. 
125. Napper, A. D.; Hixon, J.; McDonagh, T.; Keavey, K.; Pons, J.-F.; Barker, J.; 
Yau, W. T.; Amouzegh, P.; Flegg, A.; Hamelin, E.; Thomas, R. J.; Kates, M.; Jones, S.; 
Navia, M. A.; Saunders, J. O.; DiStefano, P. S.; Curtis, R., J. Med. Chem. 2005, 48 (25), 
8045-8054. 




126. Barf, T.; Lehmann, F.; Hammer, K.; Haile, S.; Axen, E.; Medina, C.; 
Uppenberg, J.; Svensson, S.; Rondahl, L.; Lundbäck, T., Bioorg. Med. Chem. Lett. 
2009, 19 (6), 1745-1748. 
127. Zriba, R.; Gandon, V.; Aubert, C.; Fensterbank, L.; Malacria, M., Chem. Eur. J. 
2008, 14 (5), 1482-1491; Shimada, T.; Yamamoto, Y., J. Am. Chem. Soc. 2002, 124 
(43), 12670-12671. 
128. Kawasaki, H.; Yamamoto, H.; Fujimori, H.; Arakawa, R.; Iwasaki, Y.; Inada, 
M., Langmuir 2009, 26 (8), 5926-5933; Yamamoto, H.; Yano, H.; Kouchi, H.; Obora, 
Y.; Arakawa, R.; Kawasaki, H., Nanoscale 2012, 4, (14), 4148-4154. 
129. Hashmi, A. S. K.; Grundl, L., Tetrahedron 2005, 61 (26), 6231-6236. 
130. Silvanus, A. Exploring The Synthetic Utility of Divinyl Ketones.(PhD Thesis) 
University Of Bath, 2010. 
131. Guillard, J.; Decrop, M.; Gallay, N.; Espanel, C.; Boissier, E.; Herault, O.; 
Viaud-Massuard, M.-C., Bioorg. Med. Chem. Lett. 2007, 17 (7), 1934-1937; Pin, F.; 
Buron, F.; Saab, F.; Colliandre, L.; Bourg, S.; Schoentgen, F.; Le Guevel, R.; 
Guillouzo, C.; Routier, S., Med. Chem. Comm. 2011, 2 (9), 899-903. 
132. Alfonsi, M.; Arcadi, A.; Bianchi, G.; Marinelli, F.; Nardini, A., Eur. J. Org. 
Chem. 2006, 2006 (10), 2393-2402. 
133. Jia, W.-L.; Wang, R.-Y.; Song, D.; Ball, S. J.; McLean, A. B.; Wang, S., Chem. 
Eur. J. 2005, 11 (3), 832-842. 
134. Alameddine, B.; Aebischer, O. F.; Amrein, W.; Donnio, B.; Deschenaux, R.; 
Guillon, D.; Savary, C.; Scanu, D.; Scheidegger, O.; Jenny, T. A., Chem. Mater. 2005, 
17 (19), 4798-4807. 
135. Shimada, T.; Mukaide, K.; Shinohara, A.; Han, J. W.; Hayashi, T., J. Am. Chem. 
Soc. 2002, 124 (8), 1584-1585. 
136. Hyacinth, M.; Chruszcz, M.; Lee, K. S.; Sabat, M.; Gao, G.; Pu, L., Angew. 
Chem. Int. Ed. 2006, 45 (32), 5358-5360. 
137. Grée, D.; Madiot, V.; Grée, R., Tetrahedron Lett. 1999, 40 (35), 6399-6402. 
138. Menear, K.; Hummersone, M.; Gomez, S.; Javaid, M.; Martin, N. (Patent), 
WO200812280, Phthalazinone Derivatives and Their Use as Medicament to Treat 
Cancer. 2008. 
139. Lane, B. S.; Brown, M. A.; Sames, D., J. Am. Chem. Soc. 2005, 127 (22), 8050-
8057. 
140. Xie, X.; Du, X.; Chen, Y.; Liu, Y., J. Org. Chem. 2011, 76 (21), 9175-9181. 




141. Zificsak, C. A.; Mulder, J. A.; Hsung, R. P.; Rameshkumar, C.; Wei, L.-L., 
Tetrahedron 2001, 57 (36), 7575-7606. 
142. Evano, G.; Coste, A.; Jouvin, K., Angew. Chem. Inter. Ed. 2010, 49 (16), 2840-
2859. 
143. Ficini, J., Tetrahedron 1976, 32 (13), 1449-1486. 
144. DeKorver, K. A.; Li, H.; Lohse, A. G.; Hayashi, R.; Lu, Z.; Zhang, Y.; Hsung, 
R. P., Chem. Rev. 2010, 110 (9), 5064-5106. 
145. Dateer, R. B.; Shaibu, B. S.; Liu, R.-S., Angew. Chem. Int. Ed. 2012, 51 (1), 
113-117. 
146. Davies, P. W.; Cremonesi, A.; Dumitrescu, L., Angew. Chem. Int. Ed. 2011, 50 
(38), 8931-8935. 
147. Couty, S.; Meyer, C.; Cossy, J., Angew. Chem. Int. Ed. 2006, 45 (40), 6726-
6730. 
148. Xu, C.-F.; Xu, M.; Jia, Y.-X.; Li, C.-Y., Org. Lett. 2011, 13 (6), 1556-1559. 
149. Davies, P. W.; Cremonesi, A.; Martin, N., Chem. Commun. 2011, 47 (1), 379-
381. 
150. LiMing, C., Sci. China, ChemSer. B Chem. 2009, 52 (9), 1337-1344. 
151. Correa, A.; Marion, N.; Fensterbank, L.; Malacria, M.; Nolan, S. P.; Cavallo, L., 
Angew. Chem. Inter. Ed. 2008, 47 (4), 718-721. 
152. Marion, N.; Nolan, S. P., Angew. Chem. Int. Ed. 2007, 46 (16), 2750-2752. 
153. Zhang, Y.; Hsung, R. P.; Tracey, M. R.; Kurtz, K. C. M.; Vera, E. L., Org. Lett. 
2004, 6 (7), 1151-1154. 
154. Nicolaou, K. C.; Winssinger, N.; Pastor, J.; DeRoose, F., J. Am. Chem. Soc. 
1997, 119 (2), 449-450. 
155. Barbazanges, M.; Meyer, C.; Cossy, J., Org. Lett. 2007, 9 (17), 3245-3248. 
156. Frederick, M. O.; Mulder, J. A.; Tracey, M. R.; Hsung, R. P.; Huang, J.; Kurtz, 
K. C. M.; Shen, L.; Douglas, C. J., J. Am. Chem. Soc. 2003, 125 (9), 2368-2369. 
157. Tellam, J. P.; Kociok-Köhn,  .; Carbery, D. R., Org. Lett. 2008, 10 (22), 5199-
5202. 
158. Sengupta, S.; Shi, X., Chem. Cat. Chem 2010, 2 (6), 609-619. 
159. Corma, A.; Leyva-P rez, A.; Sabater, M. J., Chem. Rev. 2011, 111 (3), 1657-
1712. 
160. Kimber, M. C., Org. Lett. 2010, 12 (5), 1128-1131; Hill, A. W.; Elsegood, M. R. 
J.; Kimber, M. C., J. Org. Chem. 2010, 75 (15), 5406-5409. 




161. Sheppard, G. S.; Wang, J.; Kawai, M.; Fidanze, S. D.; BaMaung, N. Y.; 
Erickson, S. A.; Barnes, D. M.; Tedrow, J. S.; Kolaczkowski, L.; Vasudevan, A.; Park, 
D. C.; Wang, G. T.; Sanders, W. J.; Mantei, R. A.; Palazzo, F.; Tucker-Garcia, L.; Lou, 
P.; Zhang, Q.; Park, C. H.; Kim, K. H.; Petros, A.; Olejniczak, E.; Nettesheim, D.; 
Hajduk, P.; Henkin, J.; Lesniewski, R.; Davidsen, S. K.; Bell, R. L., J. Med. Chem. 
2006, 49 (13), 3832-3849. 
162. Sherry, B. D.; Toste, F. D., J. Am. Chem. Soc. 2004, 126 (49), 15978-15979. 
163. Patil, N. T.; Lutete, L. M.; Nishina, N.; Yamamoto, Y., Tetrahedron Lett. 2006, 
47 (27), 4749-4751. 
164. Gandon, V.; Lemière, G.; Hours, A.; Fensterbank, L.; Malacria, M., Angew. 
Chem. Int. Ed. 2008, 47 (39), 7534-7538. 
165. Dunetz, J. R.; Danheiser, R. L., Org. Lett. 2003, 5 (21), 4011-4014. 
166. Liu, C.; Widenhoefer, R. A., Org. Lett. 2007, 9 (10), 1935-1938. 
167. Claisen, L., Ber. Dtsch. Chem. Ges. 1912, 45 (3), 3157-3166. 
168. Tseou, H., J. Chin. Chem. Soc. 1937, 5, 224-229. 
169. Chai, Y.; Hong, S.-p.; Lindsay, H. A.; McFarland, C.; McIntosh, M. C., 
Tetrahedron 2002, 58 (15), 2905-2928. 
170. Ireland, R. E.; Mueller, R. H., J. Am. Chem. Soc. 1972, 94 (16), 5897-5898. 
171. Harfenist, M.; Thom, E., J. Org. Chem. 1972, 37 (6), 841-848. 
172. Saito, A.; Kanno, A.; Hanzawa, Y., Angew. Chem. Int. Edi. 2007, 46 (21), 3931-
3933. 
173. Yang, Y.; Petersen, J. L.; Wang, K. K., J. Org. Chem. 2003, 68 (22), 8545-8549. 
174. Ylioja, P. M.; Mosley, A. D.; Charlot, C. E.; Carbery, D. R., Tetrahedron Lett. 
2008, 49 (7), 1111-1114. 
175. Guéritte-Voegelein, F.; Sénilh, V.; David, B.; Guénard, D.; Potier, P., 
Tetrahedron 1986, 42 (16), 4451-4460. 
176. Baldwin, J. E.; Bennett, P. A. R.; Forrest, A. K., J. Chem. Soc., Chem. Commun. 
1987,  (4), 250-251. 
177. Bourgeois, D.; Craig, D.; Grellepois, F.; Mountford, D. M.; Stewart, A. J. W., 
Tetrahedron 2006, 62 (2-3), 483-495. 
178. Craig, D.; Grellepois, F., Org. Lett. 2005, 7 (3), 463-465. 
179. Seebach, D., Angew. Chem. Inter. Ed. 1988, 27 (12), 1624-1654. 
180. Laube, T.; Dunitz, J. D.; Seebach, D., Helv. Chim. Acta 1985, 68 (5), 1373-
1393. 




181. Harker, W. A Mechanistic Insight into the Synthesis of  nantiopure β-Amino 
Acids using the Enamido Ireland Claisen Rearrangement. (PhD Thesis) University Of 
Bath, 2011. 
182. Harker, W. R. R.; Carswell, E. L.; Carbery, D. R., Org. Lett. 2010, 12 (16), 
3712-3715. 
183. Roe, S. J.; Hughes, D. L.; Aggarwal, P.; Stockman, R. A., Synthesis 2009, 2009 
(EFirst), 3775,3784. 
184. Laguzza, B. C.; Ganem, B., Tetrahedron Lett. 1981, 22 (16), 1483-1486. 
185. Borwell, F. G., Fried, H. E., Hughes, D. L., Lynch, T. Y., Satish, A. V., Whang, 
Y. E., J. Org. Chem. 1990, 55 (10), 3330-3336; Bordwell, F. G., Fried, H. E., J. Org. 
Chem., 1991, 56 (13), 4218-4223     
186. Huang, J.; Xiong, H.; Hsung, R. P.; Rameshkumar, C.; Mulder, J. A.; Grebe, T. 
P., Org Lett 2002, 4 (14), 2417-2420. 
187. Spino, C.; Thibault, C.; Gingras, S., J. Org. Chem. 1998, 63 (15), 5283-5287. 
188. Gusev, B. P.; Él'perina, E. A.; Kucherov, V. F., Russ. Chem. Bull. 1980, 29 (3), 
418-420. 
189. Peixoto, P. A.; Severin, R.; Tseng, C.-C.; Chen, D. Y. K., Angew. Chem. Int. Ed. 
2011, 50 (13), 3013-3016. 
190. Punniyamurthy, T.; Bhatia, B.; Reddy, M. M.; Maikap, G. C.; Iqbal, J., 
Tetrahedron 1997, 53 (22), 7649-7670. 
191. Baxendale, I.; Schou, S.; Sedelmeier, J.; Ley, S., Chem. Eur. J. 2010, 16 (1), 89-
94. 
192. Kang, S.-K.; Lim, K.-H.; Ho, P.-S.; Kim, W.-Y., Synthesis 1997, 1997 (08), 
874-876. 
193. Huang, W.; Shen, Q.; Wang, J.; Zhou, X., J. Org. Chem. 2008, 73 (4), 1586-
1589. 
194. Candito, D. A.; Lautens, M., Synlett 2011, 1987-1992. 
 
 
